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Autistic spectrum disorder (ASD) is a complex neurodevelopmental disorder 
associated with high levels of anxiety. This study assessed the feasibility of using 
a complex investigation in a healthcare environment by testing the adoption and 
usability of heart rate variability (HRV) biofeedback as an intervention to help 
people with ASD manage anxiety.  
The first phase entailed patient and public involvement of key stakeholders to 
develop the study protocol. The second phase involved a small-scale pilot trial with 
participants with ASD who had been attending mental health services (n = 20, 13-
24 years; 16 males; 4 females; IQ>70). Participants were randomly allocated to an 
immediate biofeedback group, or a waiting list group who then also received the 
biofeedback intervention after a 6 week wait. Participants were allocated to one of 
two different home trainer HRV biofeedback devices (StressEraser or Inner 
Balance). All participants were offered training and were provided with a 
biofeedback device for home use over a 12-week intervention period. Pre and post 
levels of anxiety and depression were measured using questionnaires, whilst HRV 
was measured using single lead ECG.  
Pre-post participant reports indicated a significant reduction in anxiety in children 
(p = 0.04; d = 0.96) and adults (p = 0.006; d =1.39) but no change in depression 
over the course of the intervention. Pre-post ECG monitoring indicated no change 
in HRV indices and a significant increase in heart rate (p = 0.01; d = 0.73) during 
a stress profile assessment.  
Surveys and usability ratings were collected to assess acceptability of the 
intervention. The majority of participants were able to use HRV biofeedback 
devices with reported benefit, however some participants had difficulties using a 
fingertip sensor device. The feasibility of using HRV biofeedback to manage 
anxiety in this population in a larger trial was found to be acceptable.  
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 Introduction   
 Overview  
This thesis presents research into a technology proposed to help relieve distressing 
symptoms in one of the most prevalent developmental disorders affecting 
communication and behaviour.  
This initial chapter first describes the condition which is now known as autistic 
spectrum disorder or ‘ASD’. The growing prevalence rates and the increasing social 
and financial costs of ASD will be highlighted. A summary of research 
developments within the field of ASD will be described and some of the areas 
which have been proposed as important directions for future research into ASD are 
outlined. The growing importance of the ASD community in helping to shape and 
to define our understanding of the condition will also be acknowledged.  
The structure and scope of the current study will then be reviewed, and the overall 












 Autism and Autistic Spectrum Disorder (ASD) 
“There are now approximately 700,000 people with autistic spectrum 
disorder within the UK and the costs of meeting their needs has been 
estimated to be more than that of cancer heart disease and stroke 
combined” (Iemmi et al. 2017 p.14). 
Autism is a condition which affects how a person communicates with and relates 
to other people. It also affects how they make sense of the world around them 
(National Autistic Society 2010). Individuals with different forms of autism vary, 
however they show all two core features; difficulties with social communication 
and interaction, and restricted, repetitive patterns of behaviour, interests or 
activities (Research Autism 2016).  
Substantial changes to how autism is understood and defined have taken place over 
the years since the term was initially described by the psychiatrist Leo Kanner in 
1943. The term ‘Asperger’s Syndrome’ has been used particularly within the UK 
to describe people with autism and no learning disability, after the of the work of 
Hans Asperger was described by Wing (1981a).  
At the time of writing autism is viewed as a neurodevelopmental disorder which 
develops in childhood. It is described in a dimensional rather than a categorical 
framework (Lord and Jones 2012) and is behaviourally defined according to 
standardised diagnostic criteria. Thus, the Diagnostic and Statistical Manual for 
Clinicians, fifth edition (DSM-5 2013) has replaced the terms Autistic disorder; 
Asperger disorder; Childhood disintegrative disorder, and Pervasive developmental 
disorder not otherwise specified (PDD-NOS), with the collective term ‘Autistic 
Spectrum Disorder’ (ASD) and also recognises the importance of sensory issues in 
people with the condition. The International Classification of Diseases, which is 
widely used in Europe is expected to also reflect these changes in the next edition.  
Whilst the term Asperger syndrome is still used by both clinicians and some able 
people with autism, the term ‘ASD’ will be used throughout this text to describe the 
condition.  






 The Growing Prevalence and Costs of ASD  
Around 1% of the UK population are likely to have some form of ASD, with studies 
reflecting this prevalence both in children (Baird et al. 2006) and in adults (Brugha 
et al. 2012).  
Epidemiological studies over the past 50 years have shown a dramatic increase in 
the numbers of people being diagnosed with ASD. For example, Lotter (1966) 
reported a prevalence rate of 4.5 in 10,000, whilst a review of 23 studies carried out 
by Fombonne (1999) reported 18.7 in 10,000. In the US, the Centre for Disease 
Control produced a widely publicised report of a prevalence rate of ASD in children 
of 1 in 88 (U.S. Department of Health and Human Services 2012) which was 
updated to 1 in 59 in 2018. The reasons for these apparent increases, and the 
differences between incidence and prevalence rates have been debated (e.g. Taylor 
et al. 2013) but are likely to be related to changing definitions of the disorder; 
increased awareness of the condition in women and girls, and recognition of the 
condition in people with no learning disability (Thrum 2012).  
The economic cost of ASD was reviewed in 2007 by Knapp and colleagues at the 
National Autism Project in the London School of Economics, with initial estimates 
of costs at £28 billion per year. A further review carried out in 2017 indicated that 
the costs of ASD are growing and have now been estimated to be £32 billion a year 
(Iemmi et al. 2017).  
A review of research into ASD in the UK was carried out by Pellicano et al. (2013; 
2014).  The level of research output in the UK, as indicated by numbers of research 
publications, was found to have doubled between 2001 and 2011; however even 
with these increases, the level of funding for research in the UK was found to be 
much lower than in the US, and comparatively little research was focused on 
treatments and interventions (Pellicano et al.2013). The National Autism Project 
review has also emphasised that, despite the growing prevalence and high costs, the 
funding for ASD research and interventions lags behind the level of support given 
to other conditions (Iemmi et al. 2017).  






 ASD Research 
  What do we currently know?  
Research over the past 50 years has led to significant changes in how ASD is 
viewed and understood. A number of different theoretical models have been 
developed to explain differences seen in people with ASD, compared to typically 
developing peers.  
During the first half of the 20th century reports from Kanner (1943) noted ‘a lack 
of warmth’ in mothers of autistic children, and authors such as Bettelheim (1972) 
popularised what became known as the ‘Refrigerator mother’ theory of autism, 
suggesting that autism was caused by a lack of maternal affection. During the latter 
half of the 20th century such theories were largely rejected, and theories on ASD 
related to some of the cognitive differences which were demonstrated in 
experimental studies assessing the responses of people with ASD (Sivaratnam 
2015).  
For example, differences described as ‘Theory of Mind’ difficulties have been 
demonstrated in people with ASD in a number of widely reported experimental 
studies (Baron-Cohen 1985). The term ‘Weak Central Coherence’ has also been 
used to describe some of the unique visual differences demonstrated in people with 
ASD (Frith and Happé 1994). ‘Executive function deficits’ have also been described 
in ASD (Ozonoff et al.1991; Hill 2004).   
Studies of monozygotic twins in the 1970’s highlighted a high level of heritability 
in ASD (Folstein and Rutter 1977). A large body of research has since been 
focussed on trying to identify specific genes involved in the development of ASD 
(Geschwind 2011). The search for ASD specific genes has however shown much 
more complex picture with current research suggesting a very large number of 
genes involved (State and Levitt 2011). Research has indicated that there is also an 
important environmental component to ASD (Field 2015).  






Interest in the interactions between genes and the environment has led to an 
increase in epigenetic research investigating how the environment may play a role 
in triggering expression or suppression of genes in the development of ASD 
(Schanen 2006). 
ASD has been described as a specific ‘systematising’ style of cognitive functioning 
which is more common in males (Baron-Cohen 2002). The term ‘neurodiversity’ 
has been used to highlight the view that some differences seen in intellectually able 
people with ASD should simply be accepted and respected rather than modified to 
what has been termed ‘neurotypical’ behaviour (Jaarsma 2012). 
The increasing availability and use of neuroimaging techniques, and the 
development of complex signal processing and physiological monitoring, has 
enabled researchers to assess differences in the central nervous system and the 
autonomic nervous system of people with ASD, compared to those without ASD. 
For example, research using neuroimaging has demonstrated signs of early brain 
‘overgrowth’ in children with ASD (Hazlett et al.2011). Functional neuroimaging 
studies have demonstrated differences in the brain’s response to social information 
in people with ASD (McPartland et al.2011). Eye tracking technology has been 
used to show early differences in the visual preferences of children with ASD 
(Pierce 2016). Autonomic nervous system dysfunction has been recognised as a 
difficulty affecting many people with ASD (Hirstein et al.2001; Cheshire 2012; 
Lydon et al.2014). A widely reported theory has linked difficulties seen in ASD to 
dysfunction in a proposed system of neurons involved in multisensory integration, 
called the ‘Mirror Neuron System’ (Obermann and Ramachandran 2007). 
The numbers of people with ASD reported to have no intellectual disability have 
varied widely depending on methods of measurement and people with ASD have 
been found to score significantly higher on non-verbal intelligence tests (Dawson 
2007). Reviews of prevalence increasingly indicate that over 50 percent of people 
with ASD have no intellectual disability (Kim et al. 2011; Postorino 2016).  






The gender ratio in ASD has previously been reported as 4:1 male to female (Ehlers 
and Gillberg 1993), however it is thought that many girls and women with ASD 
have not been recognised because of their ability to mask symptoms of the disorder 
(Gould and Ashton-Smith 2011; Dean 2017). Gender identity disorder has also 
been reported to be more common in people with ASD (de Vries 2010).  
Moving into the 21st century many of the epidemiological studies have also 
highlighted the importance of recognising the high levels of anxiety, depression 
and sensory difficulties experienced by people with ASD (Ghaziuddin 2005; 
Simonoff et al. 2008). For example, there is an increased risk of early death and 
suicide in people with ASD (Richa 2014; Hirvikoski 2016) and the importance of 
sensory problems is now formally recognised in clinical guidelines (DSM-5 2013).  
 ASD Research – Where should we go from here?  
A review of future directions for research into ASD has been carried out by 
Damiano et al. (2014). A new method called ‘Experimental therapeutics’ for the 
design of studies assessing ASD has been highlighted as a useful and cost-effective 
technique of assessing novel approaches prior to carrying out larger scale trials 
(Damiano et al. 2014). This method involves developing preliminary small-scale 
studies to test out new interventions by measuring key areas relating to the 
neurology or physiology of people with ASD as outcome indicators.  
Assessment of the thoughts and feelings of people with ASD using traditional 
retrospective questionnaires may not accurately reflect their reactions due to their 
intrinsic social and communication difficulties. A potentially more useful type of 
assessment has therefore been proposed, termed ‘Ecological momentary 
assessment’ which may provide a more accurate method of capturing the emotional 
states of people with ASD (Damiano et al. 2014). This method involves carrying 
out more frequent assessments to capture the reactions of people with ASD as they 
occur in real time rather than relying on a single retrospective report.  






The wider use of technology has also been advocated as a potential method for the 
delivery of future interventions to help people with ASD (El Kaliouby et al. 2006).  
Due to difficulties with face to face social interaction the use of computers is often 
an area of interest for people with ASD. For example, the rapid growth of the 
‘neurodiversity’ movement via online groups has highlighted the importance of the 
internet for people with ASD (Jaarsma 2012).  
The use of computer-based techniques can reduce the demands made by verbally 
mediated techniques that can be actually more stressful and confusing for people 
with ASD (National Autistic Society 2010). Technology may be used to deliver 
interventions and to augment both communication and social interaction, and 
growing interest in this area has led to increased contact between the ASD 
community and researchers (Bölte 2010) 
The high level of mental health conditions in people with ASD has also been 
emphasised by number of reviews as an important area for future research, which 
may in turn also help in our understanding the possible mechanisms underlying the 
aetiology of ASD (Pelton and Cassidy 2017). 
Finally, the importance of patient and public involvement in the design; 
development and impact assessment of interventions has been emphasised as 
important to help improve overall outcomes within health care (Mockford et 
al.2012). The term co-production has become a popular byword to emphasise the 
need for user involvement in the development of a range of different clinical 
interventions (Verschuere 2012). A number of reviews within the field of ASD 
research have also acknowledged the necessity to listen to, and to involve the 
increasingly vocal ASD community (Pelicano 2014; Fletcher–Watson 2018).  
 
 






 Listening to the ASD community 
“If you got rid of all the autism genetics, you wouldn’t have science or art. 
All you would have is a bunch of social yak yaks” (Grandin, 2010, p.1). 
Temple Grandin is one of the most widely known people with ASD. She has written 
numerous books regarding her own experiences and has given detailed insights into 
the experiences of people with ASD (Grandin 2006; 2010). Grandin highlights the 
importance of recognising that whilst ASD can be a disability, many people with 
ASD also have abilities and special talents which can make a great contribution to 
society.  However, despite their potential talents, many people with ASD struggle 
both in education and in employment. For example, statistics reported by the 
National Autistic Society (NAS 2010) suggest that only 16 per cent of people with 
ASD are in full time employment.  
An evaluation of the views of people with ASD in the UK, their families and 
practitioners was reported by Pellicano et al. (2014) to highlight areas of focus for 
future research into ASD. Reports from people with ASD and their carers indicated 
a high level of dissatisfaction with the current type of funding carried out in the 
UK, which had focussed mainly on areas within biological and cognitive sciences. 
The report concluded that future research should take account of both the current 
needs of people with ASD, and importantly also involve them in research 
development and planning, “future...research should lie in those areas that make 
a difference to people’s day to day lives” (Pellicano et al. 2014 p.756). 
There has also been a growing recognition of the importance of listening to the 
voices of the ASD community and allowing people with ASD to be different. For 
example, accounts from people with ASD have highlighted how many people with 
ASD enjoy activities which others without ASD often termed ‘neurotypicals’ find 
strange and repetitive (Grandin 2011). These special interests and repetitive 
behaviours are often reported to reduce stress and should not always be targeted as 
things to change or remove (Grandin 2011). 
 






  What issues are important for people with ASD?  
“Lots of autistic people get very stressed or anxious…Everyone should 
understand more about what can cause anxiety or stress for autistic people 
and the simple things they can do to help” (Iemmi et al.2017, p.3). 
One significant area of need directly reported by people with ASD and their carers 
is the high level of stress that they experience. The Autism Dividend Report 
reviewed the costs of ASD and one of the key recommendations was the need to 
understand more about stress or anxiety and to provide further support for people 
with ASD (Iemmi et al. 2017).    
An assessment of direct reports from people with ASD and their carers has been 
conducted by Research Autism (2016). In this survey 98 % of people with ASD 
and their carers reported that “stress is a significant issue” whilst 89% reported 
that it was “difficult or impossible to find effective support” (Research Autism 
2016). Key areas of difficulty reported to be related to stress were “poor sleep; lack 
of confidence; problems with work and relationships and overall health” (Research 
Autism 2016).  
The term ‘meltdown’ is also frequently used by the ASD community to describe an 
important issue affecting many people with the condition. This phenomenon can be 
described as becoming completely overwhelmed and losing control. Many able 
people with ASD have written about this difficulty and the need for further support 
and research (Lipsky 2011). 
These reports and the growing use of direct reports from people with ASD suggest 
that providing people with ASD with support to manage stress, anxiety or 
meltdowns may be a valuable area for further research which could make a 
difference to their lives.   
Thus, it is important to first review what we already know regarding evidence on 
interventions to help people with ASD, before assessing what further interventions 
may be useful. 






 Interventions to help people with ASD  
Research into interventions to help people with ASD has not been without 
controversy. Some interventions have on occasion been adopted without clear 
evidence for effectiveness and have led to unwanted side effects or at times even 
fatal results (Williams 2012; Farmer 2013).  
Interventions have at times been advocated by those with a vested interest in a 
particular mode of therapy or treatment. For example, a report regarding a 
postulated link between ASD and use of the MMR vaccine in a small sample of 12 
children (Wakefield 1998) led to a worldwide reduction in the uptake of vaccination 
rates (Godlee 2011). The postulated link between MMR and ASD has since been 
researched with no evidence for any link (Taylor et al. 2014: Uno et al. 2015).  
Many studies have advocated treatments based on small non-randomised samples, 
and whilst studies using small samples can provide useful information on a 
potential intervention, larger scale randomised studies have been needed to enable 
interventions to be adequately assessed for effectiveness. Systematic reviews of 
behavioural and psychosocial interventions have shown inconclusive results and 
have highlighted the wide variability in populations; interventions and outcome 
measurement in studies (Ospina et al. 2008: Bishop-Fitzpatrick et al. 2013).  
A valuable development for both clinicians, people with ASD and their carers has 
been the production of evidence guidelines for interventions by organisations such 
as the National Institute for health and Clinical Excellence (NICE). In addition, 
charities such as National Autistic Society, Research Autism and Autistica now 
regularly provide people with ASD and their carers with more objective advice on 
research evidence about what interventions can actually help people with ASD.  
Clinical guidelines produced in 2013 concluded that no one intervention was seen 
as better for treating symptoms of ASD, and several interventions such as chelation 
therapy; hyperbaric oxygen; secretin and antidepressants for treatment of core 
symptoms of ASD were not recommended (NICE Clinical Guidelines: 170, 2013). 






 The use of technology to help people with ASD 
“The computer is kind of like what sign language is to the deaf. It’s the 
autistic way of communicating” (Bagatell 2010, p.37). 
The use of technology has been advocated by many people with ASD as a less 
stressful medium for learning which is suited to their visual strengths (Murray 
1999, National Autistic Society 2010).  There is also growing research evidence for 
technology both to aid compliance with traditional treatments and as innovative 
interventions in their own right.  (Mintz 2013; Grynszpan et al.2014).  
The over use of technology in children and young people has also become a 
concern, particularly regarding the effects of excessive video gaming. A number of 
meta analyses have highlighted negative effects associated with gaming such as 
increased aggressive thoughts and decreased prosocial behaviour (Anderson et al. 
2001; 2010). A recent longitudinal study has also highlighted associations between 
time spent gaming and levels of anxiety and depression in children (Lobel 2017). 
Despite concerns regarding overuse, there has likewise been an acknowledgment 
of the potential for technology to help manage the growing levels of mental health 
in the general population. In a report entitled ‘Rebooting psychotherapy research 
and practice’ the use of technology is advocated to help reduce the increasing 
burden of mental illness (Kazdin and Blase 2011). In addition, several systematic 
reviews have highlighted the potential of specific games for psychotherapy 
(Eichenberg et al. 2017) and use of video games for role play; stress reduction, and 
emotion regulation (Villani 2018). Technology may provide researchers and 
therapists with tools to assess and intervene with large numbers of people which 
current traditional models of face-to-face therapy simply cannot support.  
Interventions to help people with ASD manage stress and anxiety or reduce 
meltdowns remains an area of need where further research is warranted. 
Technology may represent a useful method to help people with ASD as it does not 
involve the complex social and communication demands required in interventions 
such as social skills groups or cognitive behaviour therapy (CBT). 






 Study rationale  
“Nearly a decade on the needs of people with autism are still unmet” 
(Iemmi et al. 2017, p.14). 
ASD is now a common condition (Brugha 2012). Reports suggest high costs of 
supporting people with ASD, yet little research has been undertaken into new types 
of interventions specifically designed to meet their needs (Pellicano 2014). 
Methods of intervening to help people with ASD manage anxiety have often 
involved provision of therapy via groups or face to face talking therapy using 
therapies such as CBT which were originally designed for people without ASD, 
and which place additional burden on people with ASD due to their underlying 
social and communication difficulties. It is argued that new interventions should be 
designed from an ASD perspective using methods that are more suited to the 
strengths and interests of people with ASD. 
It is argued that new studies are needed to investigate interventions to help people 
with ASD manage issues that concern them such as anxiety. Many people with 
ASD report that managing stress is one of the biggest issues facing them (Research 
Autism 2016); that they simply want help managing stress, and that current 
interventions are not meeting their needs (Pellicano 2014).  
People with ASD represent an active and vocal community who are not always 
involved in the design and development of research studies into their condition. 
This study was thus designed to with these issues to the fore and aimed to develop 
an intervention to help people with ASD manage anxiety designed from an ASD 
user perspective.   
People with ASD frequently describe themselves as visual thinkers and report that 
visual information rather than verbal information is an important method for 
learning (Grandin 2006). The use of visual aids has become ubiquitous as a method 
to help people with ASD understand and manage difficulties including anxiety (e.g. 
Gray 1994; Buron 2003).  






The use of visual information presented via technology is now being investigated 
as a method of teaching people with ASD to enable them to understand and control 
their reactions (Torrado et al. 2017) and to interpret social situations more easily 
(Daniels et al. 2018).  
Mindfulness based stress reduction and mindfulness based cognitive therapy have 
become popular methods of helping many people manage anxiety (Kabat-Zinn 
1992). Some studies have now directly investigated the use of mindfulness-based 
approaches for people with ASD (Singh et al. 2011). One important component of 
mindfulness-based interventions is a focus of attention on the breath, and 
meditation with a focus on breathing has been found to show changes in ANS 
function (Krygier et al 2013). However, mindfulness-based interventions typically 
involve use of complex cognitive skills in a group therapy setting which can benefit 
parents and caregivers but may not be suited to social and communication 
difficulties of people with ASD (Keenan-Mount et al. 2016).  
Many people with ASD have visual strengths and an interest in technology 
therefore this study considered technology as a potential method of helping to 
provide an intervention to manage anxiety. The focus for technology however was 
not on use of ‘gaming’ which has been associated with reports of increased 
inattention and anxiety in children (Anderson 2010; Lobel 2017).  
Biofeedback was chosen as a method for intervention to help people with ASD 
manage anxiety. Biofeedback is argued to provide a number of advantages over 
traditional CBT and mindfulness-based interventions and breathing techniques for 
the management of anxiety in ASD. First, it can present information in a visual 
manner suited to the typical strengths of people with ASD (Grandin 2006). Second, 
it provides structured information in a systematic manner a factor recommended as 
important for provision of interventions for people with ASD (NICE guide 170). 
Further, biofeedback aims to increase awareness of physiological reactions which 
can be reduced or impaired in people with ASD (Dubois et al. 2016).  
 






Biofeedback technology provides a technique for developing control over specific 
symptoms in a visual and systematic manner without the need for complex 
cognitive techniques or complex group interventions which are potentially anxiety 
provoking for people with ASD (Mottron 2017). The use of technological solutions 
to difficulties experienced by people with ASD may represent what has been termed 
a ‘naturalistic developmental behavioural intervention’ which can help with the 
generalisation of skills due to their use in real world interactions (Schreibman et al. 
2015). 
Assessment and measurement of the thoughts and feeling of people with ASD using 
retrospective questionnaires alone may not accurately reflect their reactions to an 
intervention due to their intrinsic social and communication difficulties. Therefore, 
assessment of self-reported ‘stress levels’ using technology was used for people 
with ASD in this study as this type of measurement can be completed quickly and 
remotely without the need for frequent clinic visits for assessments.  
There is also a need to carry out pilot studies to investigate new interventions prior 
to any large-scale trial. Therefore, this study targeted a small sample of people with 
ASD and collected detailed information on both demographics and mental health.  
 
Many people with ASD show difficulties with physiological reactivity suggesting 
ANS dysfunction (Lydon et al.2014). Measuring physiological changes before and 
after an intervention may represent a more objective measurement of outcome and 
may also help our understanding of some of the underlying difficulties that people 
with ASD experience (Di Palma et al. 2017).  One of the objectives of the study 
was therefore to also measure changes in key physiological indicators, which have 
already been suggested as potential differences in people ASD, as well as using 
more traditional measures using questionnaires. The targets for change in this study 
were not focussed on social and communication skills but were instead focussed on 
assessing measurable changes in behaviour and physiology, related to anxiety.  






 Scope and Structure of Current study 
This study took the form of a small-scale piloting and feasibility study, which 
investigated anxiety management for people with ASD using technology. 
Providing an intervention based on use of technology may be more interesting for 
people with ASD and may be more suited to their needs (Oberleitner et al. 2006).  
The study involved people with ASD in the initial assessment of design, measures, 
equipment and procedure, 
The study then collected detailed information on participant characteristics and 
used technology to monitor progress and use of the intervention over time.  In 
addition, some of the outcome indicators for measurement of change involved 
targeting key areas such as change in physiology and change in observed behaviour, 
as well as using more traditional questionnaire assessments.  
The study was limited by the fact that this is a PhD level project with one 
investigator available to provide the intervention and to collect and analyse data. It 
therefore did not have the scope to trial the intervention against another existing 
treatment or to recruit a large sample of participants. 
The investigator has a high level of experience both working with people with ASD, 
and with people with mental health difficulties, and the study did therefore recruit 
a clinical population of people with ASD who had mental health needs.  
In addition, the investigator undertook an extensive programme of training to 
develop skills in physiological assessment and the delivery of technology-based 
interventions, prior to embarking on this research project.  
  






 Overall Aim of the Study  
The overall aim of this study was to investigate a new approach to helping people 
with ASD manage anxiety using technology.  
Biofeedback was chosen as an intervention because it typically presents 
information in a visual manner and provides a very structured and systematic 
process for developing control over specific symptoms. Biofeedback aims to 
increase awareness of physiological reactions something which has been found to 
be reduced or impaired in people with ASD (Dubois et al. 2016).  
The study assessed key physiological outcomes as well as using other more 
traditional forms of clinical assessment. It monitored progress using technology and 
reviewed problems, risks and benefits to assess the feasibility of carrying out a 
larger scale trial in the future.  
The next chapter will explore in more detail three key background themes relevant 










 Background Information  
 Overview  
This chapter reviews background information on three main themes upon which 
this thesis is based. These themes relate to three of the indicators, Population, 
Intervention and Outcome, within the ‘PICO’ framework used for reporting 
interventions (Richardson et al. 1995). 
First, relevant background research on the population of ASD is presented and 
theories regarding ASD, anxiety and the autonomic nervous system are then 
reviewed. 
Second, a sensor technology-based intervention termed ‘biofeedback’ will be 
described and research regarding biofeedback is reviewed. The use of biofeedback 
in different populations without ASD is outlined and evidence for the use of 
biofeedback in people with ASD is discussed. 
Third, a physiological measurement modality, namely Heart Rate Variability or 
‘HRV’, is defined and standards for measurement of HRV are described. The 
growing use of HRV as an indicator of autonomic nervous system functioning is 
discussed. The development of a specific type of biofeedback, termed HRV 
biofeedback, is described and the use of HRV biofeedback in different populations 
is outlined. The links in relation to these three areas are then described.  
Finally, the rationale for using a home-based technology intervention using HRV 
biofeedback to help manage symptoms such as anxiety in people with ASD will be 
presented, and the overall research hypothesis for the study is proposed.  
 
  






 ASD and anxiety  
“Just imagine how you felt when you did something really anxiety 
provoking… now just imagine if you felt that way most of the time, for no 
reason” (Grandin 2011, p.2). 
The personal account quoted above illustrates the significant impact that anxiety 
can have on the lives of people with ASD, and the importance of understanding 
anxiety when assessing and treating people with ASD.  
People with ASD have spoken about their awareness of ‘difference’ from others 
from an early age which can be viewed as a problem or disability, or simply as a 
difference which requires acceptance (Grandin 2006: Kapp et al.2013) 
 Definitions of anxiety and stress  
The terms ‘anxiety’ and ‘stress’ are often used interchangeably however ‘stress’ is 
also sometimes used to describe a cause of strain or tension. Thus, the Oxford 
English Dictionary (OED) defines stress as,  
“a state of mental or emotional strain or tension resulting from adverse 
or demanding circumstances” OR “something that causes a state of strain 
or tension” (OED online, 2018).  
Anxiety is defined as “a feeling of worry, nervousness, or unease about something 
with an uncertain outcome” (OED online 2018). Whilst these two terms are often 
used interchangeably the term ‘anxiety’ is used for the majority of this text as 
defined above. The term ‘stress’ has previously been used in surveys of people with 
ASD and it is therefore also used in this text in surveys of direct reports from people 
with ASD to describe, ‘a state of mental or emotional strain or tension’ rather than 
a cause of strain or tension. 
 
Assessment of anxiety levels is now seen as a vital part of any initial assessment of 
ASD (Vasa 2016).   






 What levels of anxiety do people with ASD experience?  
High levels of anxiety particularly in people with ASD and no learning disability 
have been reported since the first reports in English of what was termed Asperger’s 
syndrome (Wing 1981a). This group of people with ASD were reported to show,  
“…clinically diagnosable anxiety and varying degrees of 
depression…which seem to be related to the painful awareness of 
handicap and difference from other people.” (Wing 1981a, p. 118). 
Research since this time has continued to report mental health difficulties in people 
with ASD with the most commonly reported disorders being anxiety and depression 
(Stewart et al. 2006). Reviews have also indicated a high level of other co-morbid 
mental health conditions associated with ASD including problems with obsessive 
compulsive disorder; attentional problems and phobias (Simonoff et al.2008; 
Lugnegard et al.2011). Reviews of the levels of anxiety reported in people with 
ASD have however shown wide variations (Ghaziuddin 2005; Stewart et al.2006). 
There are likely to be several reasons for this wide variation:  
(i) People with ASD, by definition, have intrinsic communication 
difficulties and may struggle with understanding and explaining their 
thoughts and feelings; 
(ii) Parent observations and questionnaire reports may also not provide 
accurate information, due to difficulties interpreting the underlying 
feelings of people with ASD, which may not be accurately reflected in 
their observable behaviour (Mazefsky et al.2011; Bitzika et al. 2015);  
(iii) The expression of anxiety in ASD may also be uniquely different to 
anxiety seen in people without ASD. A review of the presentation of 
anxiety in ASD found a range of recognised types of anxiety disorder 
but also patterns of anxiety unique to ASD such as unusual fears and 
phobias (Kerns et al.2014):  
(iv) The use of questionnaires traditionally used for people without ASD 
which require retrospective recall of thoughts and feelings may also be 
particularly difficult for people with ASD to understand and to report 
on accurately (Damiano et al. 2014). 






Current questionnaires designed for the non-ASD population may not adequately 
capture the symptoms of ASD type anxiety which can also overlap with core 
symptoms of ASD symptoms (Jitlina et al. 2017). This issue has led to some 
researchers designing questionnaires specific to ASD such as the ‘Autism Stress 
Survey Schedule’ (Goodwin 2007).  
Due to the ongoing difficulties measuring anxiety in ASD any assessment of 
anxiety should ideally also check for the presence of other mental health conditions 
and use a number of different methods of assessment including direct reports; 
observations from carers, as well as using traditional questionnaires (Vasa 2016).  
Despite variations in reports of levels of anxiety in ASD, a meta-analytic review 
indicated prevalence rates of anxiety in young people with ASD of 40%, compared 
to rates of anxiety of 27% in typically developing peers (van Steensel et al. 2011).  
A further systematic review and meta-analysis of 83 studies carried out by van 
Steensel and Heeman (2017) has also indicated increased risk of anxiety in children 
and young people with ASD compared non ASD peers, particularly with increasing 










 What causes anxiety in ASD?  
Models describing potential mechanisms to explain the development of anxiety in 
ASD have been proposed by a number of research groups. 
One proposed reason for anxiety reported in people with ASD, is that it is not a 
secondary problem related the effects of social and communication difficulties, but 
that it is a sign of an underlying difficulty with the autonomic nervous system and 
is a core feature of the condition (Sugarman et al. 2013). 
A further model proposed by Boulter et al. (2014) is that people with ASD show 
increased anxiety in situations of ambiguity, a cognitive concept described as 
‘intolerance of uncertainty’ (Dugas 1998). South and Rodgers (2017) have 
proposed a detailed model for the development of anxiety in ASD, using a 
framework which links sensory and emotional dysfunction, to the construct of 
intolerance of uncertainty, which can then in turn, lead to the anxiety or repetitive 
behaviours seen in ASD.   
However, there may also be significant environmental and social factors which 
cause anxiety in ASD which are not related to the person with ASD directly, but to 
other people’s reactions to them. For example, a study has shown how people 
without ASD frequently make immediate and unfavourable judgements about 
people with ASD irrespective of the intellectual ability of the person with ASD 
(Sasson et al. 2017). 
The exact reasons for high levels of anxiety in ASD are still unclear but may be 
related to both underlying difficulties within the individual themselves and to 
secondary environmental effects related to some of the consequences of having an 
ASD such as those highlighted by (Sasson et al. 2017).  
  






 What interventions are available for anxiety in ASD?  
A range of different treatments are available to help manage anxiety in people with 
ASD, however they vary in terms of their availability due to limits both on 
resources and in expertise in working with people with both ASD and mental health 
conditions (Wong et al. 2015; Vasa 2016).  
Medical treatments have been used for many years in people with ASD to help 
manage both anxiety and some of the behaviours associated with ASD. For 
example, Melatonin has been used and found to be a treatment which is both safe 
and effective for the treatment of sleep problems in ASD (Gringras and Gamble 
2012). Medications commonly used to manage anxiety in people with include 
selective serotonin reuptake inhibitors (SSRI) antidepressants such as sertraline and 
escitalopram. Anti-psychotic medications such as risperidone have also used to 
manage some of the challenging and repetitive behaviours associated with anxiety 
in ASD. However systematic reviews of the medical treatments for ASD used to 
manage anxiety have suggested that existing evidence for the effectiveness of these 
medications is limited and that side effects and adverse events can occur 
(McPheeters et al. 2011; Dove et al. 2012; Siegel and Beaulieu 2012).  Personal 
accounts from people with ASD on the effectiveness of medications to help anxiety 
have been mixed, with some reporting benefits (Grandin 2011) and some reporting 
significant negative effects (Lipsky 2011). 
A number of non-medical interventions have also been used to help manage anxiety 
in people with ASD. For example, Cognitive behaviour therapy (CBT) has been 
adapted and used as an intervention for adults, teenagers and for younger children 
with ASD, both to improve social responsiveness, and to reduce anxiety (Sofronoff 
et al. 2005; White et al. 2009; Wood et al. 2009). Further studies have reported on 
adaptations of CBT for younger children with ASD (Scarpa and Reyes 2011). 
Group based CBT has been reported to show positive effects as measured by 
changes in social responsiveness reported by parents (Freitag et al. 2016).  






Some studies assessing the effects of CBT have suggested that positive changes in 
young people with ASD have been reported by parents for up to three months’ post 
treatment (White et al. 2015; Maddox et al. 2017).   
Evidence from systematic reviews of studies using CBT treatment have indicated 
some support for the use of CBT in people with ASD (Lang et al. 2010; Ung et 
al.2015). However additional input from parents may be an important factor to 
improve treatment outcomes of CBT in young people with ASD (Reaven 2011).  
A systematic review and meta-analysis on the use of CBT for people with ASD has 
been carried out by Weston et al. (2016). This quantitative synthesis review 
assessed 48 studies and results indicated that overall effect sizes of CBT treatment 
for ASD varied depending on the outcome measures used and the population 
questioned. Thus, evidence from direct reports from people with ASD using CBT 
indicated non-significant effects, whilst results of reports from parents supporting 
the CBT treatment indicated small or medium effect sizes (Weston et al. 2016).    
Mindfulness interventions based on the work of Kabat-Zinn (1982) have become a 
popular method to help neurotypical people without ASD manage anxiety, and 
mindfulness-based interventions have now also been investigated for people with 
ASD. A meta-analytic review assessed the effect of mindfulness interventions on 
anxiety and depression in clinical populations (Hofmann et al. 2010) and 
highlighted moderate effect sizes for improvements in anxiety. A review of the use 
of mindfulness for people with ASD identified nine studies using this type of 
approach for people with ASD (Keenan-mount et al. 2016). The majority of 
interventions identified actually involved teaching mindfulness techniques to 
parents or teachers of young people with ASD (e.g. Jones et al. 2014; Hwang et al. 
2015). Some mindfulness interventions for people with ASD have been reported 
however these have involved removing the more abstract cognitive components 
and using yoga and breathing techniques for people with ASD (Singh et al. 2011; 
de Bruin et al. 2014).  
 






The evidence for non-medical interventions such as CBT to manage anxiety in 
people with ASD is growing however many studies report on small samples using 
parent report only. Investigation of the views of people with ASD and the use of 
individual therapy rather than group therapy has been recommended (Weston et al. 
2016).  
The availability of many non-medical interventions remains limited due to need for 
skilled therapists and the large numbers of people requiring interventions. There is 
significant cost both in terms of therapist training and time involved in providing 
these interventions and many therapists report that they lack confidence and 
training (Cooper et al. 2018). The growth in alternative treatments both 
pharmacological and non-pharmacological, reflects the continuing demand from 
people with ASD and their carers for support (Lofthouse et al. 2012). A guide has 
now been produced aimed at supporting carers and people with ASD in choosing 
interventions, which reviews the numerous interventions available with 
information on the available research evidence for each (Fleming et al. 2015). 
A systematic review of existing treatments for anxiety in ASD carried out by Vasa 
(2014) indicated modest evidence for the effectiveness of CBT and highlighted a 
lack of randomised controlled trials of medication for treatment of anxiety in ASD. 
There remains a lack of robust evidence for the effectiveness of current treatments 
of anxiety in ASD, as compared to the level of evidence supporting interventions 
for anxiety in typically developing peers (Vasa 2014). Evidence reviews suggest 
caution, particularly regarding the use of medication, and highlight the increased 
risks relating to bipolar disorder and suicide risk in people with ASD (Vasa 2016). 
 
Current UK clinical guidelines on treatments for children and young people with 
ASD recommend consideration of CBT for anxiety in ASD and recommend 
following the existing guidelines for non ASD populations when considering 
medical treatment of comorbid disorders seen in people with ASD such as 
depression and obsessive-compulsive disorder (NICE clinical guideline 170: 2013).  






 Reports from people with ASD about their anxiety 
“Eye contact is something that I have always had trouble with.... All of the 
stress that is put on doing it makes me more nervous, tense, and scared... 
just because I am not making eye contact with you does not mean that I 
am not listening to you or paying attention to you. I can concentrate better 
not having to keep eye contact at the same time” (Bovee 1999, p.18). 
A different way to explore the nature of anxiety in ASD, is to examine direct 
accounts from people with ASD and their families. Some of these accounts have 
led to increases in our understanding of the nature of ASD and these accounts can 
also highlight new areas for further research. For example, as illustrated in the quote 
above, many able people with ASD have written about the high levels of anxiety 
they experience if forced to look into someone’s eyes. 
Poor eye contact during social interaction has been described as a symptom of ASD 
since some of the early accounts of the condition were reported (Kanner 1943). 
Reports of poor eye contact have in turn led to improvement in eye contact 
becoming a common target for some of the behavioural interventions designed to 
help people with ASD.  Presuming that improved eye contact will help people with 
ASD develop better social and communication skills has recently been argued to 
be a ‘neurotypical’ solution which does not consider the underlying needs and 
wishes of the individual with ASD (Mottron 2017).  
It is has been argued that teaching individuals with ASD to simply change their 
behaviour to non ASD or neurotypical behaviour, may not always be an appropriate 
target for change without a better understanding of the underlying reasons behind 
ASD behaviour (Mottron 2017).  
If the many personal accounts from people with ASD are to be believed, it is 
possible that some interventions designed to change behaviour such as eye contact 
in people with ASD, may have actually increased stress in some individuals and 
may at times be a trigger for a set of behaviours described by many within the ASD 
community as ‘meltdowns’.  






 ASD Meltdowns  
“For someone with autism, when they reach the point of sensory, 
emotional and information overload, or even too much unpredictability, it 
can trigger a variety of external behaviours that are similar to a 
tantrum...it can trigger a complete shutdown and withdrawal” (National 
Autistic Society, 2016). 
A difficulty linked to anxiety, which has been widely reported by both families and 
people with ASD themselves, is a set of behaviours commonly referred by the ASD 
community to as meltdowns (Lipsky 2011). Meltdowns often involve extreme 
anxiety and agitation and are described by the National Autistic Society (NAS) as 
a reaction to being ‘overwhelmed’ (NAS 2016). 
An important distinction is made by many people with ASD between meltdowns 
and tantrums, in that tantrums are typically seen in children as a result of not getting 
something they want. Tantrums occur in an attempt to gain something and can be 
controlled to some degree by interventions such as distraction, rewards or 
discipline. In contrast, meltdowns are viewed as a sign that the person has become 
completely overwhelmed and overloaded, and someone in the midst of a meltdown 
has little or no control over their behaviour. People with ASD have reported 
extreme fatigue and exhaustion and may not remember what has happened during 
a meltdown (Lipsky 2011, p127).  
The management of ASD meltdowns require a very different approach because of 
their different underlying origin. For example,  
“The goal for the support person at the height of a meltdown is to ensure 
safety, knowing the meltdown will continue until the energy is spent. There 
is no stopping a meltdown in progress” (Endow, 2016).  
Understanding both the ‘sensory and environmental triggers for meltdowns’ is said 
to be essential for helping both people with ASD and their carers to manage this 
behaviour, which can occur in both adults and in children (Lipsky 2011 p.169).  
 






One influential account of the development of poor eye contact, meltdowns and 
anxiety originated from two researchers who were also parents of a young child 
who was eventually diagnosed with ASD (Markram 2007).   
These reports led to the development of a theory known as the ‘intense world 
syndrome’ (Markram 2007), which describes how extreme sensory overload 
developing in very early life leads to severe anxiety, which in turn leads to social 
withdrawal.  This theory focuses on the importance of sensory overload and 
anxiety, which are argued to actually cause many of the problems seen in people 
with ASD, such as poor eye contact; poor communication and repetitive behaviours 
(Markram 2007). 
Green and Ben-Sasson (2010) have likewise highlighted the links between anxiety 
and sensory responsivity in people with ASD and have suggested a number of 
possible mechanisms regarding the interactions between both anxiety and sensory 
responses. 
The repetitive behaviours often observed in people with ASD, have been described 
by some with ASD as a method of coping with both anxiety and sensory issues. For 
example, Grandin reports,   
“When I did stims1 such as dribbling sand through my fingers, it calmed 
me down. When I stimmed, sounds that hurt my ears stopped. Most kids 
with autism do these repetitive behaviors because it feels good in some 
way. It may counteract an overwhelming sensory environment” (Grandin, 
2011). 
These personal accounts, in conjunction with the development of models regarding 
the development of anxiety in ASD (e.g. South and Rodgers 2017), have led to 
growing interest in the importance of both sensory function and autonomic nervous 
system functioning in the development and maintenance of difficulties faced by 
people with ASD. 
 
                                                 
1 a term used to refer to repetitive behaviours seen in ASD such as hand flapping or rocking 






 ASD and sensory functioning  
It is now recognised that sensory issues, such as over sensitivity or under sensitivity 
to noise; light; touch; smell and pain are important areas of difference experienced 
by many people with ASD (Bogdashina 2016; Schauder and Bennetto 2016). 
People with ASD are frequently described as having deficits or difficulties, 
however in some sensory areas such as hearing they have been found to 
demonstrate superior skill in comparison to their neurotypical peers (Remington 
and Fairnie 2017).  
A review of sensory functioning in young children with ASD found that 95% had 
some form of sensory processing dysfunction (Tomcheck and Dunn 2007). Sensory 
difficulties which persist beyond childhood have also been shown in people with 
ASD compared to peers (Crane 2009). Diagnostic criteria now recognise sensory 
issues as part of the disorder (DSM-5 American Psychiatric Association 2013).  
Questionnaire assessments have been used to compare responses of people with 
ASD to peers without ASD. For instance, the Sensory Profile (Dunn 1999; Brown 
and Dunn 2002) is a commonly used questionnaire completed either by carers or 
the individual themselves to assess a range of different sensory responses.  
Experimental research has also been used to assess sensory responses in ASD by 
assessing underlying physiological responses to different sensory stimuli. A 
seminal study reported by Hirstein et al. (2001) suggested there may be different 
subtypes of ASD as indicated by both ‘hyposensitivity and hypersensitivity’ to 
sensory stimuli. Further research has also suggested subtypes of sensory 
responsivity in ASD with more adaptive sensory responses being linked to lower 
anxiety (Uljarevic 2016).  
Some evidence exists for what has been termed ‘hyperarousal’ in ASD (Kushki et 
al. 2014), however, a systematic review of 10 studies has also suggested evidence 
for ‘hypoarousal’ in people with ASD (Watts 2016). 






A systematic review of 57 studies assessed the physiological reactions of people 
with ASD to a wide range of sensory; emotional; social and stress stimuli (Lydon 
et al. 2014).  
In this review, over 78% of people with ASD responded differently to sensory 
stimuli compared to non ASD peers (Lydon et al. 2014). The variability of 
responses, with both over sensitivity and under sensitivity to stimuli was noted.   
Differences in the physiological responses of people with ASD to social and 
emotional stimuli and to stress tests were also reviewed (Lydon et al. 2014). 
Overall, a high level of variability in the physiological responses assessed in people 
with ASD was highlighted and it was noted that observable behaviours reported 
were not always related to internal physiological state (Lydon et al.2014). Further 
research into the physiological responses of people with ASD was advocated,  
“Further investigation…will further our understanding of the disorder, 
potential subtypes within it, associated behaviours, and health outcomes” 
(Lydon 2014 et al. p.19).  
A growing body of research has involved assessment of different physiological 
reactions in people with ASD. People with ASD have been noted to show different 
responses to non ASD peers to a range of tasks, with contrasts and comparisons 
being made between behavioural responses observed in people with ASD, and their 
physiological reactions and autonomic functioning.   
It is thus important to review the different types of assessment which can be used 
to evaluate autonomic nervous system functioning in people with ASD.   
  






 ASD and autonomic nervous system functioning  
The autonomic nervous system (ANS) is the part of the nervous system that 
controls involuntary actions such as the heart beat and widening of blood vessels 
(Fox 2006).  
The sympathetic nervous system is responsible for ‘activation and mobilization’ of 
the body, whilst the parasympathetic nervous system is responsible for ‘recovery 
and restoration’ (Fox 2006).  There is also increasing interest in the enteric nervous 
system, which is thought to link emotional and cognitive areas of the central 
nervous system with the intestinal system (Carabotti 2015).  
ANS activity can be measured indirectly via a range of different methods (Peper 
2008). For example, increased sweat responses typically occur when the 
sympathetic nervous system is activated, and some studies have used physiological 
sensors to measure changes in electrodermal activity produced by the sweat 
response in people with ASD.  
One study using assessment of electrodermal responses, found both hyper and hypo 
responsivity in children with ASD, and also noted decreased responses during 
repetitive behaviour, which was suggested as a possible indication of decreased 
sympathetic nervous system activation (Hirstein et al. 2001). This study has been 
widely reported as possible physiological evidence for the stress reducing effects 
of engaging in repetitive behaviours, such as those reported in personal accounts 
from people with ASD (Grandin 2011).  
Other studies have measured cardiac responses, recording both heart rate and heart 
rate variability using electrocardiogram. For example, individuals with ASD 
showed increased heart rate compared to control participants over a number of 
tasks, suggesting increased cardiovascular arousal levels in people with ASD (Ming 
2005; Goodwin 2006). Increased baseline heart rate and decreased cardiac 
reactivity to stress stimuli tasks has also been shown in people with ASD and 
suggested as demonstrating ‘overall autonomic hyperarousal’ (Kushki 2014, p.1).  






People with ASD have also been noted to show different responses to non ASD 
peers to a range of tasks. For example, ASD subjects showed increased 
parasympathetic nervous system activity in a mental arithmetic ‘stress’ task 
compared to the ‘rest’ condition which involved staring at a white wall, suggesting 
that some people with ASD may show ‘autonomic hyperarousal’ in rest conditions 
(Toichi and Kamio 2003, p.417).  
Pupil light reflexes and measurements of salivary cortisol have also been used to 
assess ANS functioning in people with ASD. For example, atypical pupil 
constriction responses in children with ASD have been linked to observations of 
sensory dysfunction in ASD and suggested as a possible indication of lower 
parasympathetic nervous system responding in ASD (Daluwatte 2013). Levels of 
salivary cortisol have also been measured and have been found to be related to child 
self-reports of anxiety in boys with ASD (Bitsika et al. 2015). Respiratory 
dysfunction has also been highlighted in children with ASD and linked to reduced 
cardiac vagal activity, compared to age matched peers (Ming et al.2016).  
A wide range of research paradigms, using different assessment methods and 
employing many different sensors have been used in research to assess ANS 
functioning in people with ASD, making it difficult to draw general conclusions 
regarding any specific area of difference or dysfunction. A review of the different 
types of methodologies employed to assess ANS dysfunction in children with ASD, 
was carried out by Cheshire (2012). This review noted the complex and at times 
contradictory findings and emphasised the need to integrate and interpret any ANS 
findings with other data, 
“Autonomic phenomena are most meaningful when viewed from 
perspectives of molecular neuroscience, structural and functional 
neuroimaging, and developmental psychopathology.” (Cheshire2012 p.7). 
People with ASD can be seen to show altered ANS responses in a range of different 
areas. Research has now focussed on whether interventions to change some of the 
ANS responses observed in people with ASD may in turn, also help manage some 
of the difficulties reported by people with ASD. 






 Interventions to treat ANS dysfunction in ASD  
A number of pharmaceutical interventions have been employed to help manage 
difficulties which may be related to ANS dysfunction in ASD. Thus, reports of 
symptoms such as increased resting heart rate have led some researchers to 
investigate whether drugs such as the beta-blocker propranolol could be a possible 
method for helping people with ASD. This drug is typically prescribed to treat 
blood pressure but has also been used to treat anxiety and PTSD (Davidson 2006). 
Studies have shown this medication may have potential to manage anxiety 
(Narayanan 2010) and working memory deficits (Bodner 2012) in people with 
ASD.  
The underlying ANS and sensory differences seen in people with ASD have been 
argued to be one of the key reasons for using an intervention termed a ‘low arousal 
approach’ to manage challenging behaviours seen in people with ASD (McDonnell 
et al. 2015). Thus, interventions which reduce sensory information are advocated 
as more suitable methods of intervention which may help to both prevent and 
reduce challenging behaviours and decrease the need for invasive physical 
interventions being used on people with ASD (McDonnell et al. 2015).  
A study using animal models, based on the ‘intense world syndrome’ theory 
(Markram 2007), has suggested that interventions which make the environment 
‘enriched and predictable’ may also help to reduce symptoms of ASD (Favre 2015). 
Sugarman et al. (2013) have outlined a theory termed the autonomic dysregulation 
theory of autism. This theory also focuses on how ANS dysfunction can be seen to 
be linked to features of ASD. Anxiety is proposed as a core feature of ASD rather 
than a secondary effect, and restricted repetitive behaviours observed in ASD are 
proposed as methods used by the individual to reduce increased autonomic arousal 
(Sugarman et al. 2013). One intervention proposed by Sugarman et al. (2013) to 
help regulate the ANS in people with ASD and reduce symptoms of anxiety, is the 
use of technology using ‘biofeedback’. 







“It is becoming main stream to measure our physiology. Biofeedback is a 
logical next step.” (Thompson 2016, p. 55). 
The Association for Applied Psychophysiology and Biofeedback (AAPB), the 
Biofeedback Certification International Alliance (BCIA), and International Society 
for Neurofeedback and Research (ISNR) convened a task force of scientists and 
clinicians in late 2007 to agree a consensus definition of biofeedback,  
“Biofeedback is a process that enables an individual to learn how to 
change physiological activity for purposes of improving health and 
performance. Precise instruments measure physiological activity…and 
rapidly ‘feedback’ information to the user. The presentation of this 
information often in conjunction with changes in thinking, emotions, and 
behaviour supports desired physiological changes. Over time, these 
changes can endure without continued use of an instrument."  (Tan et al. 
2016, p.3).  
Biofeedback has also been described as, 
 “A self-regulation technique through which patients learn to voluntarily 
control what were once thought to be involuntary body processes” (Frank 
et al. 2010, p.85).  
A short biographical review of some of the key individuals who developed 
biofeedback has been provided by Siever (2008). Whilst biofeedback has been 
known about since the 1960’s, there is growing interest in its use in sports 
performance (Blumenstein and Orbach 2014) and in movements such as 
‘personalised medicine’ and ‘the quantified self’ (Swan 2009).   
Biofeedback can be seen to provide a form of individualised health care which is 
focussed on the unique responses of each individual patient. It represents a method 
that goes beyond simply monitoring physiology because it actively involves the 
user, enabling them to learn to change their unique physiological responses to 
improve their health.  
 






 Types of biofeedback  
Biofeedback equipment can be categorised into two types, professional systems and 
small personal use devices. Professional systems allow for a number of different 
sensors to be used either individually or simultaneously to capture different 
physiological measurements to facilitate a wide range of different types of 
assessments and training (e.g. ProComp Infinity®; NeXus-10®). In addition, 
however, an increasing number of small-scale devices are also now commercially 
available and marketed for personal use (e.g. emWave 2®; Wild Divine®; Alive®).  
A number of different physiological sensors can be used individually or in 
combination in biofeedback training (Tan et al. 2016).  Electromyography (EMG) 
biofeedback measures muscle tension as it changes over time. Electrodermal 
activity (EDA) measures sweat responses, whilst thermal or temperature 
biofeedback measures body temperature changes over time. Heart rate and heart 
rate variability (HRV) are measured in HRV biofeedback using either ECG or 
photoplethysmography (PPG) sensors, often in conjunction with respiration. 
Electroencephalography (EEG) biofeedback is often referred to as ‘neurofeedback’ 
and measures brain wave activity over time.  
There are many different types of physiological assessment sensor and different 
protocols have been developed for using biofeedback for an increasing number of 
conditions (Peper 2008). Biofeedback practitioners may also use multimodal sensor 
assessments to plot what has been termed a ‘biofeedback stress profile’ in which 
an individual’s unique profile of responses to stress can be mapped before planning 
a biofeedback treatment to change any maladaptive responses (Matto 2013). 
Irrespective of the type of biofeedback used, the importance of having a trained 
biofeedback practitioner is argued to be essential to provide expert training and 
support to the user to enable them to gain control over their individual physiological 
reactions (Yucha and Montgomery 2008; Pastor 2008). The importance of using 
additional therapeutic techniques such as ‘mindfulness’ to enable users to develop 
skills in biofeedback has also been recognised (Khazan 2013). 






 Biofeedback efficacy – what do we know? 
La Vague et al. (2002) developed a template for systematic evaluation of the 
efficacy of psychophysiological interventions, such as biofeedback. This template 
denotes five levels of clinical efficacy with higher levels requiring adherence to 
much more stringent criteria. Thus, level one indicates treatment which is ‘not 
empirically supported’ and level five indicates treatment which has been found to 
be both ‘efficacious and specific’ to the condition described.  
Biofeedback has been used for a wide range of physical and mental health 
conditions and in a range of different populations (Peper 2008).  Due to variations 
in the design and reporting of many studies, the main professional societies 
involved in biofeedback and neurofeedback produce regular guidelines for use of 
biofeedback, which report on latest research findings and evidence based practice, 
using the template for reporting levels of efficacy (Yucha and Gilbert 2004;Yucha 
and Montgomery 2008; Tan et al. 2016).  
Several systematic reviews and meta analyses have indicated evidence in support 
of biofeedback. For example, biofeedback has been reported as ‘efficacious and 
specific’ for a number of conditions such as stress incontinence (Weatherall 1999); 
pelvic floor dysfunction (Koh et al., 2008), and headache (Nestoriuc et al., 2008). 
 Biofeedback for the treatment of anxiety has been given a rating as efficacious 
(Tan et al. 2016). A systematic review of literature from 2000-2017 on biofeedback 
for stress management indicated significant positive effects for biofeedback in 16 
out of the 17 studies identified and has provided comparisons on psychological and 
physiological measures used; frequency and type of biofeedback training given, 
and implications for future studies (Kennedy 2018).  
Biofeedback for the specific treatment of ASD symptoms has been given a rating 
as ‘probably efficacious’ (Tan et al. 2016). Whilst many different types of 
biofeedback have been noted, most studies using biofeedback in people with ASD 
have focussed only on the use of EEG biofeedback or ‘neurofeedback’. 






 Evidence for the use of biofeedback in ASD 
The most widespread use of biofeedback for people with ASD involves use of 
neurofeedback.  
Neurofeedback is a sub speciality of biofeedback which involves initial EEG 
recordings and often detailed ‘quantitative electroencephalogram’ (QEEG) brain 
mapping using multiple EEG sensors. Neurofeedback assessment aims to identify 
abnormal patterns of cortical activity and then train the individual to alter these 
abnormal patterns to normalise brain activity (LaVaque, et al. 2003).  
Several reviews regarding the use of neurofeedback in ASD have been conducted.  
A report of outcomes of over 150 cases over a 15 year period is reported in two 
papers by (Thompson et al. 2010a, 2010b). The accounts summarise data from 
clients with Asperger’s syndrome and Attention Deficit Hyperactivity Disorder 
(ADHD) who were given between 40-60 sessions of both neurofeedback and other 
types of biofeedback. Decreased symptoms on the Australian Scale for Asperger’s 
Syndrome and the Conner’s rating Scale for ADHD were noted after using 
neurofeedback, and a rationale for the use of neurofeedback in ASD was provided. 
However, these reports despite providing information on both questionnaire and 
EEG changes, describe case histories from clinical practice rather than specific 
research designs. Multiple interventions were used in clients with a range of 
difficulties, and clients were seen over variable periods with no comparator groups, 
making conclusions regarding efficacy of neurofeedback problematic.  
The need for well-designed studies assessing neurofeedback using randomisation; 
has been emphasised (Coben et al.2010). A detailed review of research literature 
from 13 case studies and 5 controlled trials by Holtmann (2011) provided valuable 
comparisons of types of study design and measures used. This review concluded 
that neurofeedback may hold some promise for improvement of ADHD like 
symptoms however, 
“existing evidence does not support the use of neurofeedback in ASD” 
(Holtmann et al. 2011, p.986). 






A randomised controlled trial of neurofeedback in ASD aimed to address 
methodological problems in earlier studies such as lack of comparator group, and 
clear diagnostic assessment of cases (Kouijzer et al., 2013). In this study no 
statistically significant changes in reported symptoms of ASD were observed, 
although significant improvements were noted in measures of cognitive flexibility 
(Kouijzer et al., 2013). A further systematic review of identified 17 studies 
suggested that neurofeedback may be considered as a treatment with “modest 
experimental support” (García-Berjillos et al., 2015, p.151). 
Brain–computer interface (BCI) applications for people with ASD have also 
employed  neurofeedback within a serious game environment (Ritterfeld 2009; 
Friedrich et al. 2014; 2015). This type of neurofeedback has been proposed as a 
method of activating the human ‘mirror neuron system’ which may improve social 
interaction in ASD (Datko et al. 2018; Goodman et al. 2018).  
In summary, research on the use of neurofeedback to help people with ASD is 
continuing to develop, with a need for larger scale, controlled trials to ascertain its 
efficacy. Studies vary considerably with only a small number of studies testing 
neurofeedback against a comparator treatment.  
The review by Holtmann (2010) suggests that neurofeedback may be more 
appropriate as a treatment for symptoms seen in people with ADHD, and the studies 
reported by Thompson et al. (2010) report on cases with comorbid ASD and 
ADHD. Existing guidelines in the UK, do not currently recommend neurofeedback 
for treatment of core problems of ASD (NICE Clinical Guideline 170: 2013).  
 
Interestingly, in their review of case histories reporting the use of neurofeedback in 
people with ASD, Thompson et al. (2010b) report that whilst the focus was on 
describing their rationale for using neurofeedback, they acknowledge that 
improved treatment outcomes in people with ASD and ADHD may also have been 
related to the teaching of diaphragmatic breathing and to their use of biofeedback 
to modify heart rate variability or ‘HRV’ (Thompson et al. 2010b, p. 16). 






 Heart Rate Variability 
“A healthy heart is not a metronome” (Shaffer 2014, p.1). 
 Definitions of Heart Rate Variability  
The quote above from Shaffer highlights the common misconception that normal 
heart functioning should show no variation. In fact, whilst some types of irregular 
heart beat rhythm do indicate potential problems, the healthy heart should show a 
natural variability in the time intervals between individual heartbeats often termed 
‘inter-beat intervals.’ These short millisecond variations give an indication of the 
action of the vagus nerve on the sinoatrial node of the heart. This naturally 
occurring variability in heart rhythm is known as ‘heart rate variability’ or ‘HRV’ 
(Malik 1993).  
Heart rate and HRV can be used as signs of the functioning of the autonomic 
nervous system (ANS). HRV was first used in maternity services when it was noted 
that a decreasing level of HRV was frequently an early indicator of foetal distress 
(Hon 1963).  
HRV has been shown to be an accurate method of assessing cardiac autonomic 
functioning (Malik et al.1996; Stein and Kleiger 1999) and has been used as an 
indicator of physiological arousal (Appelhans and Luecken 2006; Thayer and 
Sternberg 2006). Heart rates that show no variability are usually a sign of declining 
health or a sign that the individual has an artificial pacemaker (Hampton 2013).  
HRV levels are high in infants and decline with increasing age (Nunan 2010). The 
natural variability in heart rate is seen as a sign of the inidviduals adptability or 
resilience (Shaffer et al. 2014). HRV is affected by a number of different internal 
and external factors including breathing, the blood pressure control system and the 










The normal variability in the heart rate termed HRV is shown in Figure 2.1 below.  
Measurement of the Inter Beat Intervals (IBI’s) refers to the time between the R-
waves peaks, shown in Figure 2.2. 
 











Figure 2.2 Measurements from one R wave to the next – known as R-R intervals or 
interbeat intervals (in HRV statistics the “NN” means “Normalised RR”)2. 
 
 
                                                 
2 Figures 2.1 - 2.3 reproduced with permission from D. Matto www.biofeedback.workshop.nl 






Respiratory sinus arrhythmia (RSA) describes a specific phenomenon that occurs 
when HRV changes in phase with respiration. RSA was initially felt to be a 
phenomenon only seen in young people and children but was subsequently linked 
to breathing frequency in adults (Angelone and Coulter 1964). RSA has been 
investigated in a number of experimental studies and has been shown to be linked 
to efficiency of pulmonary gas exchange and improved circulatory efficiency 
(Hayano et al. 1996). The role and function of the autonomic nervous system and 
particularly the vagus nerve in controlling RSA has been debated (Porges 1995). 
Yasuma and Hayano (2004) provide a useful review of developments in our 
understanding and provides a definition of RSA as,  
“Heart rate variability in synchrony with respiration, by which the R-R interval on 
an ECG is shortened during inspiration and prolonged during expiration” 
(Yasuma and Hayano 2004, p.684).  
The synchrony between heart rhythms and respiration can be clearly seen in the 
changes of R wave frequency on an ECG. Biofeedback systems can also show both 
ECG and respiration simultaneously and can be used to show change from normal 
breathing to RSA.  Figure 2.3 shows the increase in synchrony between heart rate 
and breathing during slow breathing relaxation.  








Heart Rate  
 
Figure 2.3 Simultaneous recording of heart rate and breathing showing the change from 
a normal breathing pattern to an RSA pattern highlighting the changes in heart rate in 
synchrony with changes in breathing3. 
                                                 
3 Figures 2.1 - 2.3 reproduced with permission from D. Matto www.biofeedback.workshop.nl 






 Standards for measurement of HRV  
“HRV is an emergent property of interdependent regulatory systems 
which operate on different timescales to help us adapt to environmental 
and psychological challenges” (Shaffer and Ginsberg 2017, p.1). 
There is a growing body of research investigating HRV and it has been viewed as 
an important biomarker for self-regulation (Holzman and Bridgett 2017). In order 
to interpret this information accurately, it is first important to have consensus on 
how this physiological variable is measured, analysed and reported.  
Attempts to agree a consensus on the standards for measurement and reporting of 
HRV were undertaken in 1996 by a joint task group comprising both clinicians and 
technical experts. Standards for the parameters of measurement of HRV were 
agreed and published jointly in the journals ‘Circulation’ and the ‘European Heart 
Journal’ in 1996 (Camm et al.1996; Malik et al. 1996). This report commonly 
known as the ‘Task Force Report’ outlines definitions of terms and measurement 
criteria, as well as outlining some of the clinical applications of measuring HRV. 
Further definitions were also reported by Berntson et al. (1997). 
A review of 44 different studies involving 21,438 participants by Nunan (2010) 
provided initial guidelines and normative data on HRV.  
Reference values for studies assessing HRV in children have also been reported 
(Seppala 2013), and gender differences in HRV in adults have been assessed 
(Koenig and Thayer 2016). References values for short term HRV recordings have 
been reported on a large sample of healthy adults from a single study (Dantas et al. 
2018). Guidelines for calculating effect size distributions for HRV and suggested 










 Measures used to report HRV  
HRV can be measured via either ECG or PPG sensors, however ECG recording is 
recommended as a reference standard for more detailed signal analysis.  HRV 
indices are calculated from a recording of inter-beat intervals or an ‘IBI’ file and 
may be reported in the actual values of milliseconds, or in ‘normalised units’ 
(Shaffer and Ginsberg 2017).  
Respiratory sinus arrhythmia or ‘RSA’ is a phenomenon which has been proposed 
to reflect ‘vagal tone’ (Porges 1995). When RSA occurs, there is typically a 
reduction in heart rate and an increase in aspects of HRV. Thus, these signs are 
often taken as indications of the action of the vagus nerve and the functioning of 
the parasympathetic nervous system. HRV indices can be measured over a 24-hour 
period, however many studies report HRV from short term recordings of 
approximately five minutes. Respiration depth and frequency may also be reported. 
HRV is frequently measured and reported in two main formats; time domain and 
frequency domain. Time domain measures are derived from time interval 
calculations. Frequency domain measures, or power spectral density analysis 
measurements, are usually calculated using a method known as ‘Fast Fourier 
Transform’ spectral analysis (Welch 1967). HRV may also be calculated using non-
linear measurements. This type of measurement can give additional information on 
time domain and frequency domain measures and can be used to index the 
unpredictability of a specific time series (Shaffer and Ginsberg 2017). A 
geometrical model termed a ‘Poincaré’ plot, can also be produced which gives a 
visual display in the form of a scatterplot which can then produce a number of 
variables of non-linearity (Kamen 1996).  
A large number of HRV variables can be derived from ECG data and there remains 
much variation in the types of analysis conducted and the types of indices reported. 
Whilst time domain and frequency domain measurements are commonly described, 
studies have also reported non-linear measurements which have been linked to 
health outcomes (Stein and Reddy 2005; Kemp et al. 2010).   






A summary of common terms used to report HRV with a description of what they 
mean, and the unit of measurement is shown in Table 2.1 - Table 2.3.  
Table 2.1 Time domain measures derived from heart rate data used to report HRV*  
Time Domain 
variables 
Description of term  Unit of 
measurement 
HRV Heart Rate Variability ms 
HRV max-min The range of HRV – highest to lowest interval  bpm 
RR The interval between heart beats often termed ‘beat to 
beat’ intervals / ‘interbeat intervals’ or ‘IBI’ 
ms 
Mean RR The mean RR or mean interbeat interval   
NN The interval between normal heart beat contractions 
i.e. ‘normal to normal’ IBI  
ms 
SDNN The standard deviation of the NN interbeat intervals – 
a direct reflection of overall variability in heart rate 
ms 
RMS-SD The root mean square of successive differences in NN 
intervals – associated with HF variations in HRV – 
this may reflect the activity of the parasympathetic 
nervous system  
 
 
Table 2.2 Frequency domain measures derived from heart rate data used to report HRV* 
Freq. Domain 
variables 
Description of term  Unit of 
measurement 
VLF  Very Low Frequency (range 0 - 0.04Hz) ms2 
LF  Low Frequency (range 0.04 - 0.15Hz) ms2 
HF  High Frequency (range 0.15 - 0.4Hz) – this may 
indicate parasympathetic activity   
ms2 
TP  Total power of all frequencies – this may reflect 
overall autonomic activity  
ms2 
LF/ HF Low Frequency: High Frequency – this may reflect 
balance of the autonomic nervous system  
ratio  
 
Table 2.3 Sample of Non-linear Measures used to report HRV* 
Non-linear  
variables 
Description of term  Unit of 
measurement 
Poincare plot (SD1) Reflects high frequency fluctuations  ms 
Poincare plot (SD2) Reflects low frequency fluctuations ms 
Sample entropy (SampEn) Overall complexity of time series   
*Adapted from the ‘Task Force’ for the European Society of Cardiology / North American Society of Pacing 
and Electrophysiology guidelines (Malik et al.1996). 






 Methodological problems assessing HRV 
There are many important methodological considerations to be taken into account 
in the assessment; measurement; analysis and interpretation of HRV. A number of 
researchers have now produced guidelines on how to lessen some of the 
methodological problems in assessing HRV (Billman 2013; Quintana and Heathers 
2014; Quintana 2016).   
Measures used  
Time domain measures which are commonly reported include the standard 
deviation of the normal to normal beats or ‘SDNN’ and the root mean square of 
successive differences in HF variations or ‘RMS-SD’. A number of other measures 
are also seen as important because of their significance in determining HRV. Thus 
Nunan (2010) recommends reporting of mean RR interval; HR; and the actual 
values of HRV instead of normalised units.  
Frequency domain, or power spectral density measures regularly reported include 
both high frequency or HF and low frequency or LF HRV. Reporting the LF/ HF 
ratio is now not thought to clearly reflect the ratio of sympathetic and 
parasympathetic activity or ‘autonomic balance’ and reporting this ratio should be 
interpreted with caution (Billman 2013a). Reporting of frequency domain measures 
particularly VLF and TP are not thought to provide clear information in short term 
HRV recordings, and recordings of different time periods should also not be 
compared (Nunan 2010). It has also been proposed that the LF band width can 
reflect both PSNS and SNS activity and that the LF band width in short term HR 
recordings may be an indication of overall vagal activity (Porges 1995).  
Tools used  
The high level of accuracy provided by automated algorithms to calculate HRV 
indices from an ECG recording are now seen as an appropriate and accurate method 
to edit raw data, despite the initial Task Force recommendation of manually editing 
HRV (Nunan 2010).  






Environment setting  
The environmental conditions involved in the initial assessment and collection of 
data are important and should always be reported. For example, speaking or paced 
breathing can of itself increase HRV (Mulder 1992; Nunan 2010).  
A standardised test environment for all individual participant assessments is also 
vital to accurate measurement of HRV. For example, factors such as age; time of 
day; body position; hunger; bladder emptying; physical activity; alcohol; caffeine 
and medication all have an impact on HRV and attempts to standardise and report 
these should be taken (Billman 2011; Heathers 2014).   
Study design  
A very wide range of inter-individual differences also have been reported in studies 
measuring HRV (Nunan 2010). Therefore, further studies measuring pre-post 
changes within the same individuals have been recommended (Quintana and 
Heathers 2014).  The need for longitudinal studies, to evaluate changes in HRV 
over time in new populations, has been emphasised (Kemp and Quintana 2013).  
Recent guidelines for reporting articles on psychiatry and heart rate variability or 
‘GRAPH’ guidelines have provided a valuable framework for future research 
studies (Quintana 2016). The guidelines make recommendations in four areas:  
(i) Inclusion of detailed diagnostic and demographic information on 
participants and controls is seen as essential  
(ii)  Reporting information on equipment used; configuration and type of 
electrodes; sampling rate and length of data recording is also important  
(iii) The reporting of the method of data extraction and methods of data 
analysis should also be documented  
(iv) Finally, as the methods for calculating and reporting HRV can vary (e.g. 
Porges 1995) this should also be recorded (Quintana 2016). 
Despite the difficulties measuring HRV outlined above, and the differences in 
reporting and analysing this variable, there is increasing interest in the importance 
of HRV as a predictor of both health and illness (Moss and Shaffer 2017).   






HRV has been argued to be an indicator of the body’s ability to adapt to changing 
environmental demands (Beauchaine 2007; Shaffer and Ginsberg 2017). Many of 
the initial investigations into HRV arose from the use of this measure as an indicator 
of cardiac difficulties (e.g. Tsuji et al.1996), however an increasing number of 
studies have also begun to highlight important links between HRV and both 
physical and mental health (Gevirtz 2013). 
 HRV and Physical Health  
HRV has been shown to decline with age (Umetani 1998; Jandackova 2016). HRV 
has also been investigated extensively in cardiac patients. For example, reduced 
HRV has been associated with increased risk of mortality following myocardial 
infarction (Kleiger et al.1995; Bailey 2001) and the longitudinal ‘Framingham 
Heart Study’ highlighted that reduced HRV was associated with mortality (Tsuji et 
al.1996). 
As far back as 1976 research indicated that decreases in HRV could predict the 
onset of neuropathy in diabetes before the appearance of overt symptoms (Ewing 
et al. 1976). Kemp et al. (2016) highlighted that reduced HRV was linked to insulin 
resistance may be an early indicator of illness such as type 2 diabetes.  
More recently, interest has grown into investigations to assess whether HRV 
indicators might change as a result of any intervention. A systematic review of 33 
RCTs investigating a range of different therapies designed for secondary 
prevention of heart disease, indicated that HRV indices were found to significantly 
increase as a result of secondary cardiac prevention interventions (Nolan 2008).  
Whilst the early focus on HRV has highlighted its role as a predictor of cardiac 
health, many patients with heart disease were also found to have co morbid mental 
health difficulties such as anxiety, (Tully and Cash 2013); depression (Meijer 2013) 
and PTSD (Edmondson 2013) which increased risk of further cardiac illness. 
This has in turn led to increasing interest in the links between HRV and different 
types of mental health conditions. 






 HRV and Mental Health  
The risk of cardiovascular illness is increased in patients with co-morbid depression 
(Whooley 2006). The relationship between HRV and depression has also been 
investigated in people without co-existing cardiac illness. A review and meta-
analysis of 18 studies indicated that people with depression showed lower HRV 
compared to controls, and severity of depression was also related to reductions in 
HRV (Kemp et al. 2010). Importantly, patients taking antidepressant medication 
did not show any improvements in HRV, despite reported improvement in 
symptoms. In addition, one specific type of medication, tricyclic antidepressants, 
was associated with reductions in HRV (Kemp et al. 2010). Such medications may 
actually increase the risk of cardiovascular illness (Kemp et al.2014).  
The relationship between anxiety disorders and HRV has been investigated in meta-
analyses of 36 studies which reported a range of anxiety-based disorders to be 
associated with reduced HRV (Chalmers et al.2014). People with a diagnosis of 
social anxiety disorder have also shown reduced HRV compared to controls 
Alvares et al. (2016). High frequency HRV has been linked to frequency of 
respiration in people with severe mental illness but not in controls (Quintana 2016). 
In a study of bipolar disorder, mania was found to be associated with increased 
heart rate and decreased HRV (Lopes Wazen 2018).  
Studies assessing HRV and mental health have varied from large scale population 
studies comparing HRV to control groups, to smaller scale studies assessing 
changes in HRV within individuals with specific conditions. A review of a body of 
work assessing HRV and its relationship to mental and physical health has 
highlighted the important links between HRV; mental health, and physical illnesses 
and emphasises the need for further research in this area,  
“Over the longer-term, reduced HRV leads to immune dysfunction and 
inflammation, cardiovascular disease and mortality ... Further research 
is urgently needed on the long-term effects of autonomic dysregulation in 
otherwise healthy psychiatric patients, and appropriate interventions to 
halt the progression of a host of conditions associated with morbidity and 
mortality” (Kemp and Quintana 2013, p.288) 






 HRV and Emotion  
HRV has been reported to be an indicator of change in emotions (Rainville et al. 
2006; Rockliff et al. 2008) and has been proposed as a biomarker for emotional 
response (Appelhans and Luecken 2006).  
HRV has also been found to be associated with emotion recognition. For example, 
level of resting state HF-HRV was associated with scores on the Reading the Mind 
in the Eyes Test (Baron-Cohen et al. 2001), a test used to assess the emotion 
recognition difficulties often seen in people with ASD (Quintana et al.2012).  
Reduced resting state HRV has been associated with hypervigilance and 
maladaptive responses to emotional stimuli (Park and Thayer 2014). A review by 
Beauchaine (2015) proposed that reduced HRV is associated with what is termed 
‘emotional dysregulation’ and psychopathology.  
A detailed review of recent research investigating the links between HRV and 
emotion has been carried out by Mather and Thayer (2018). This review highlights 
how HRV has been linked to connectivity in the prefrontal cortex and the amygdala 
which are associated with emotion regulation (Mather and Thayer 2018). 
A new theoretical model, which highlights the links between genetic environmental 
and social influences on HRV and connects them to overall health and well-being.  
termed the ‘GENIAL model’ has also now been proposed (Kemp et al.2017).  
Understanding the interactions between HRV; emotion recognition; social 
interaction and mental health difficulties may help our understanding of health and 
illness. Many people with ASD also have emotion recognition difficulties 
(Mazefsky 2013); social interaction difficulties (Knott 2006); and can have high 
levels of mental health problems such as anxiety (van Steensel 2013). 
Thus, understanding the links between HRV and ASD may further help our 
understanding of the nature of ASD.  






 HRV and ASD  
A number of investigators have used HRV assessment and quantification methods 
described by Porges (1992; 2007), in experimental studies which have supported a 
possible association between levels of HRV and ASD symptoms.  
For example, van Hecke et al. (2009) assessed children with ASD whilst they 
watched videos of familiar and unfamiliar people. Children with ASD showed 
reduced regulation of their heart rate compared to typically developing children and 
when shown an unfamiliar face. The investigators suggested that according to this 
finding may indicate a “precautionary mobilisation to fight or flee” induced by 
seeing unfamiliar people (van Hecke et al. 2009, p. 1128).  
Further research by Bal et al. (2010) examined facial affect recognition in children 
with ASD and typically developing children. Children with ASD showed increased 
heart rate and lower levels of RSA during a two-minute baseline recording 
compared to peers and made more errors and were slower on the facial recognition 
task (Bal 2010). More recently RSA has also been found to be associated with 
social functioning and language skills in children with ASD (Patriquin et al. 2013). 
Other experimental paradigms have suggested a link between HRV, anxiety and 
social interaction in people with ASD (Kushki et al. 2014). HRV has also been 
found to increase after administration of oxytocin, a hormone linked to which has 
been investigated to help social engagement in people with ASD (Kemp 2012). 
A qualitative synthesis review by Benevides and Lane (2015) investigated cardiac 
autonomic measures in ASD. Methodological problems highlighted included the 
need to take into account age race and gender differences in participants; the need 
to use appropriate HRV measures for the length of recording; artefact identification 
in analysis, and the importance the type of task designed as stressful for people with 
children with ASD (Benevides and Lane 2015). The authors also emphasise the 
need for new theoretical frameworks to help guide future research into HRV. 






 Theoretical Frameworks relating to HRV  
“When the heart is affected it reacts on the brain and the state of the brain 
again reacts through the (vagus) nerve on the heart; so that under any 
excitement there will be much mutual action and reaction between these, 
the two most important organs of the body.” (Darwin 1872, p.69). 
Two important theoretical frameworks, which have influenced our understanding 
of how HRV and the ANS affect behaviour are Polyvagal theory (Porges 1995; 
2007;2011) and Neurovisceral Integration theory (Thayer and Lane 2000; 2009).  
 Polyvagal theory  
Polyvagal theory is a theoretical model that was proposed by the behavioural 
neuroscientist Stephen Porges which relates the internal functioning of the ANS to 
social engagement and self-regulation in mammals (Porges 1995; 2001, 2007).  
The quote from Darwin above has been used by Porges to illustrate how the links 
between the heart and the brain have been known about for many years, and that 
the interactions between the heart and the brain are influenced by what is now 
known as the 10th cranial nerve (CNX) or the ‘vagus’ nerve. The word vagus comes 
from the Latin word for wandering, which highlights the fact that the vagus is the 
longest nerve in the ANS which has links to the heart, lungs and digestive system.  
Polyvagal theory (Porges 1995) provided an evolutionary perspective on the 
organisation of the nervous system and described the evolutionary development of 
the vagus nerve into different branches (hence the term poly-vagal). Porges 
proposed that the ANS evolved over time to aid the development of the complex 
social behaviours seen in mammals and linked the regulation of behaviour to the 
branches of the vagus nerve (Porges 2001; 2007). 
Porges proposed that, via evolution, links emerged in the brain between nerves that 
control the heart and brain (Porges 2001; 2007). A set of linked neural systems was 
proposed that link bodily feelings with facial expression, vocal intonation, gesture, 
and eye contact and referred to as the ‘social engagement system’ (Porges 2001).  






The different branches of the vagus correspond to different evolutionary stages of 
development and are activated in order depending on environmental demands 
(Porges 2001; 2007). Thus, when the environment is appraised as safe the 
phylogenetically newer ‘myelinated vagus’ is activated and older defensive vagal 
circuits are inhibited, and this enables social engagement activities such as eye 
contact expression of emotion and facial expression to occur (Porges 2001). 
However, if the environment is viewed as threatening then older vagal pathways 
will be activated resulting in activation of what has been termed as ‘fight, flight or 
freeze behaviours’ (Porges 2001). Social communication is thus only able to occur 
appropriately when the environment is perceived as safe (Porges 2011). 
Porges proposed that specific HRV measures such as respiratory sinus arrhythmia 
(RSA) serve as a marker of vagal functioning and may thus be an indication of an 
individual’s ability to respond to and engage with their environment in an 
appropriate social manner (Porges 2001; 2007). Polyvagal theory has therefore 
been used in a number of studies to explain some of the difficulties observed in 
people with ASD (Van Hecke et al. 2009; Bal et al.2010; Patriquin et al.2013).  
Polyvagal theory is however, not without its critics. Grossman et al. (1991) 
highlighted that RSA is primarily related to respiration and is not always an 
indication of ‘vagal tone’. Grossman and Taylor (2007) provided further evidence 
calling into question some of the evolutionary tenets of Porges theory and 
emphasised that factors such as respiration and physical activity must be considered 
when calculating RSA, and that RSA and vagal tone are not always associated.  
Despite criticisms, Polyvagal theory is still regarded as an important framework 
which has helped in developing our understanding of the role of HRV. Beauchaine 
(2006) emphasises the need for theories to help our understanding of psychiatric 
conditions and argues that too much attention has been given to description and 
categorisation rather than to theory explaining behaviour.  Polyvagal theory has 
provided a much-needed framework and,  
“...has emerged as an important explanatory construct for a wide range 
of psychiatric conditions.” (Beauchaine 2006, p.175).  






 Neurovisceral Integration Theory 
The Neurovisceral Integration Model (Thayer and Lane 2000; 2009) describes a set 
of neural structures called the central autonomic network or ‘CAN’ (Benarroch, 
1993) which are involved in the ‘integration of brain and body functioning’. This 
network comprises a number of structures including the prefrontal cortex, insular 
cortex, amygdala, hypothalamus, ventrolateral medulla, as well as the peripheral 
ANS, and coordinates both central and autonomic nervous system responses to 
environmental change (Thayer and Lane 2000; 2009). This theory has provided an 
important basis for understanding interactions between the brain and the body, 
 Neurovisceral Integration Across a Continuum of Time  
More recently Kemp, Koenig and Thayer (2017) have provided a ‘multidisciplinary 
synthesis’ on research into HRV. The authors propose that whilst the Neurovisceral 
Integration Model provides an important structural framework for understanding 
interactions between the brain and the body, there is also a further temporal 
framework, described as ‘Neurovisceral Integration Across a Continuum of Time’ 
or NIACT (Kemp et al. 2013, p.547).  This extended model emphasises the 
importance of neurovisceral integration across time stating that, “the extent to 
which the brain and body are integrated will contribute to eventual mortality” 
(Kemp et al. p.548).  
This framework draws evidence from research into HRV and integrates research 
from a range of different disciplines. Evidence from recent meta analytic studies 
are shown to link HRV to a number of physical and mental health outcomes. The 
authors highlight the role of the vagus nerve in regulating multiple brain and body 
systems and propose that vagal dysfunction leads to risk of morbidity and mortality. 
Importantly HRV is seen as an index of vagal function and this new model views, 
“HRV as a psychophysiological marker of health and wellbeing” (Kemp et al.  
p.548). If indeed HRV is a marker of health and well-being, it may be useful to 
further investigate the circumstances in which it might be possible for an individual 
to increase HRV.  






 Is it possible to increase HRV? 
Respiratory sinus arrhythmia or ‘RSA’ describes a phenomenon that occurs when 
breathing and heart rate changes synchronize (Porges 1992). When this happens, 
there is typically an increase in HRV.  
In the 1980’s reports emerged in Russia suggesting that with specific training in 
developing RSA, people were able to produce large increases in their levels of HRV 
using biofeedback techniques (Lehrer et al. 2000). 
This biofeedback technique which was described as resonant frequency 
biofeedback training was then reported with a specific protocol for training by 
Lehrer et al. (2000). The technique involves teaching an individual to find their 
own unique breathing rate at which resonance occurs between two systems, the 
heart rhythms or associated with respiration, and low-frequency heart rhythms 
proposed to be related to the activity of the baroreflex system (Lehrer et al. 2000). 
When these two systems are in a specific 0o phase sequence then large increases in 
HRV are said to occur (Lehrer et al.2000). 
This process has since been described as ‘resonant frequency feedback’; RSA 
biofeedback; HRVB and HRV biofeedback, occurs when breathing is slowed to a 
rate of somewhere between 5-7 breaths per minute, which is slower than normal 
breathing rates (Lehrer et al. 1997; Lehrer and Gevirtz 2014).  
This technique teaches the individual to breathe within the low-frequency heart 
rhythm range and HRV recordings typically show a peak in HRV frequency 
waveforms at 0.1Hz, in conjunction with slow regular breaths synchronised with 
changes in heart rate (Lehrer and Gevirtz 2014).  
Heart rate activity in the low frequency range is thought to reflect the influence of 
both the parasympathetic and sympathetic nervous system (Berntson et al. 1997). 
Porges suggests that RSA may be an indicator of the overall functioning of the 
Poly-vagal system described as the vagal brake or an index of parasympathetic 
tone (Porges 1995; 2007). 






Experimental research has further investigated the effects of breathing on HRV 
indices. For example, Sasaki and Maruyama (2014) compared controlled breathing 
at 15 breaths per minute (0.25Hz) and at 6 breaths per minute (0.1Hz) to 
spontaneous breathing. During controlled breathing at 0.1Hz, the LF/ HF ratio was 
found to increase greatly, and HF decreased, whilst HR and respiration remained 
unchanged. The authors suggest that this occurs because some HF components 
become synchronised with respiration frequency at 6 breaths per minute which 
corresponds with LF band width (Sasaki and Maruyama 2014). 
As noted earlier anxiety has been found to be associated with reduced levels of 
HRV (Chalmers et al. 2014), and research has investigated whether specific 
interventions can reduce anxiety and increase HRV.  For example, autogenic 
training was found to increase HRV in participants with high trait anxiety under 
experimental conditions (Miu et al. 2009)  
McCraty and Childre (2010) from the Institute of HeartMath use a term called 
‘Coherence’ to describe a change or shift in heart rate rhythms which they propose 
increases a system’s ability to self-regulate. The importance of experiencing 
positive emotions is emphasised to increase a system’s ability to self-regulate, 
reduce stress and improve health (McCraty et al. 1995;2009).  
Coherence as described by HeartMath is largely similar to what is described by 
RSA, although importantly this shift in heart rhythm is said to only occur when 
positive emotions such as gratitude are generated (McCraty and Childre 2010). 
Coherence can also be seen in the spectral analysis of HRV by a, “large increase 
in power in the low frequency band around 0.1Hz” (McCraty et al.2009, p.14).  
Reports produced by the Institute of HeartMath describe various methods of 
helping to generate positive emotions, such as the ‘Heart Lock-In®’ technique 
(McCraty et al. 2009). HeartMath LLC also produce a number of commercially 
available devices for helping users achieve this state of psychophysiological 
‘Coherence’ using the technique now known as HRV biofeedback. 






 HRV Biofeedback 
“Mind-body medicine is so prominent right now, and this is a way to help 
people learn mindfulness more quickly. This is a tool that should be in 
most psychologists’ toolboxes.” (Austad, 2016, p. 52). 
HRV measurement has been used in conjunction with sensor technology to develop 
a specific method of biofeedback now referred to as HRV biofeedback (Lehrer and 
Gevirtz 2014). 
The protocol originally described by Lehrer et al. (2000), involving ten sessions of 
individual training, has been widely used as the ‘gold standard’ for training in HRV 
biofeedback. More recently, a five-session protocol for training has also been 
produced (Lehrer and Vaschillo 2013). Following baseline assessment using multi-
channel biofeedback recording apparatus, respiration and heart rate variables are 
recorded simultaneously, and the individual is then taught to breathe at the unique 
breathing rate which produces the largest variations in HRV. The protocol then 
involves practicing and sustaining this technique to enable the user to increase their 
levels of HRV (Lehrer et al.2000).  
To support the maintenance and development of resonant frequency breathing, 
individuals can practice paced breathing, or use ‘home trainer’ HRV biofeedback 
devices. These devices employ a less invasive measurement approach referred to 
as photoplethysmography (PPG) which uses infra-red sensors to detect blood 
volume pulse from which HRV can be derived. Several certified devices exist 
within the market place, which have conformity with health, safety, and 
environmental protection standards for these products. These types of ‘home 
trainer’ device have now made HRV biofeedback more accessible for individual 
use. These devices can be adjusted by the user to different breathing rates but are 
usually set at a default rate of six breaths per minute. Assessment of the accuracy 
of some devices has also been carried out (Heilman 2007; 2008). A number of 
research studies have also investigated their effectiveness when used as stand-alone 
interventions without employing the full Lehrer training protocol using 
multichannel recording (Reiner 2008; Ratanasiripong 2012; de Bruin et al. 2016).  






 HRV Biofeedback mechanism and efficacy  
A number of reviews discussing the possible mechanisms of effect underlying HRV 
biofeedback have been described (Gevirtz, 2013; Moss et al. 2013; Lehrer and 
Gevirtz 2014; Lehrer, 2017). The exercising and strengthening of the ‘baroreflex 
response’ originally proposed by Lehrer et al. (2003) has been noted as one possible 
mechanism of effect (e.g. Lehrer and Gevirtz 2014). The baroreflex links via the 
brainstem to the amygdala, a centre for emotional control, which may be one of the 
mechanisms by which HRV biofeedback may help people with mental health 
conditions such as anxiety and depression. Further proposed mechanisms of effect 
include a strengthening of vagal responses; stimulation of cholinergic anti-
inflammatory responses, improved gas exchange with increased cardiac and 
pulmonary function, or a placebo effect (Moss 2013; Lehrer and Gevirtz 2014).  
Research has been conducted on the use of HRV biofeedback to reduce stress and 
anxiety in a range of non-clinical populations such as students (Ratanasiripong 
2012; Meier and Welch 2016); stressed adults (de Bruin et al.2016) and call centre 
workers (Kennedy and Pretorius 2008).  
HRV biofeedback has also been reported to improve the outcome of a number of 
physical health conditions such as hypertension (Nolan et al.2010; Cullins et al. 
2013); alcohol dependency (Penzlin 2017); chronic fatigue (Windthorst et al.2017) 
coronary heart disease (Lin et al.2015). HRV biofeedback has also been used to 
improve performance in sports (Morgan 2017). HRV biofeedback has been 
reported to reduce symptoms in a number of mental health conditions such as 
anxiety (Reiner 2008; Henriques 2011); PTSD (Zucker et al.2009; Tan et al.2011) 
and depression (Karavidas et al. 2007; Patron 2013; Caldwell and Steffen 2018). 
Many initial studies reported on either on small samples of people with specific 
conditions or did not randomise participants into different conditions (Reiner 
2008). However, a number of randomised controlled trials (RCTs) of HRV 
biofeedback have now been carried out. A summary of RCTs since 2009 using 
HRV biofeedback is presented in table 2.4 below using the population; 
intervention; comparator and outcome or ‘PICO’ framework (Richardson 1995).  






Table 2.4 Evidence from RCTs using HRV biofeedback devices presented using the population; intervention; comparator and outcome or ‘PICO’ framework. 
Author year and 
location  
Design Population   Intervention  
- aim 
Intervention 
 - length 
Intervention  
- device  
Comparator(s)  Outcome  
 










Compared effects of 
HRVB + psychotherapy 
to psychotherapy  
  







HRVB + psychotherapy showed 
significant increase in HRV and 
decrease in depressive symptoms over 
a 6-week intervention  
 










Assessment of 3 self-







Physical activity  
HRVB was as effective as 
Mindfulness or Physical activity for 



















No treatment  
HRVB group showed decreases in 









Asthma To assesst effectiveness 
of HRVB to control 
asthma  





HRVB not more effective than 
controller medication for Asthma 
Lemaire, J. 
(2011) 





Physicians  Reduction of self-
reported stress  
28 x 15min emWave  
(HeartMath) 
Info booklet on 
wellbeing 
programme  
HRVB group showed significant 
decrease in stress scores compared to 
control  
Meier, N. & 








Reduction of anxiety  
Increase in HRV  
3x 10min Nexus system 
(Mind media)  
Walking  HRVB reduced anxiety more than 
walking intervention. Both HRVB and 
exercise increased HRV 








Design Population   Intervention  
- aim 
Intervention 
 - length 
Intervention  
- device  
Comparator(s)  Outcome  
 







Hypertension Reduction of 
hypertension  





HRVB group decreased BP and 
increased HRV compared to controls 
Prinsloo, G. 
(2013) 







To assess the effects of 
HRVB on cognitive 
ability and affect   





HRVB group showed ↑reaction times 
and ↓anxiety compared to controls 
after a single short session of HRVB  
Ratanasiripong, 














Counselling  HRVB plus counselling group showed 
significantly greater reductions in 
anxiety compared to counselling   







Musicians  Reduction of 
performance anxiety  
1 x 30min  Biofeedback 
system  
(J&J engineering) 
No treatment / 
Slow breathing  
HRVB / slow breathing both showed 
significant ↑ in HRV compared to 
control – no difference between 
HRVB and slow breathing  






(18-30yrs)   
Students 
 
To assess physiological 
response to stressor 
tasks  
4-8 x 30min emWave 
(HeartMath) 
No treatment  HRVB showed ↑parasympathetic 
responses to stress but no change in 
resting HRV, and no difference on 
reports of stress compared to controls  










To improve prognosis 
of CAD 
 6 x 60min 
 
ProComp Infiniti 
(Thought technology)  
Psychoeducation 
+ medical care  
HRVB group showed significant ↓ in 
admissions & ↓depression and 







PTSD To reduce symptoms of 
depression in PTSD  
28 x 20min StressEraser Progressive 
muscle 
relaxation  
HRVB showed ↓depression and 
significant increases in HRV compared 
to controls 
RCT – Randomised controlled trial; RT – Randomised trial; HRVB – Heart rate variability biofeedback.   






A randomised study by Meier and Walsh (2016) compared short term 
interventions of walking and biofeedback for students experiencing stress and 
found biofeedback to be more effective for reducing anxiety and increasing 
calmness on questionnaire reports. However, importantly no clear effect was 
shown for either intervention on physiological measures of HRV (Meier and 
Walsh 2016). 
An RCT assessing three separate interventions using either biofeedback; 
mindfulness or physical activity showed that all three interventions showed 
positive effects on questionnaire measures including mindful awareness and 
attentional control (de Bruin et al. 2016).  No physiological measures were used 
in this study. 
Positive effects of HRV biofeedback have been reported in a one year follow up 
of an RCT using short term HRV biofeedback in patients with chronic heart 
disease. Increases in LF HRV indices, as well as reduced hospital admissions 
were found in post intervention and at one year follow up (Yu 2018). However, 
an RCT carried out to investigate the efficacy of HRV biofeedback for control 
of asthma, has reported that biofeedback was not better than medication (Lehrer 
et al. 2018).  
The number of studies on HRV biofeedback continue to grow, however there are 
wide variations in study design, and it is important to recognise that the 
methodologies employed have involved different devices, training protocols and 
diverse outcome measurements.   
Due to the large number of existing studies and the diverse methodologies used 
it is therefore useful to review existing critical appraisals to investigate the 
overall efficacy of HRV biofeedback.  
  






One of the first critical reviews of studies using HRV biofeedback was carried 
out by Wheat and Larkin (2010). This review noted that whilst positive outcomes 
are reported in many studies, when physiological outcome measures and 
questionnaire reports or observations have both been used to evaluate outcomes, 
they have not always shown a high degree of concordance (Wheat and Larkin 
2010). The need for further studies using both physiological assessment in 
conjunction with measurement of clinical outcomes has been emphasised, to 
assess the possible mechanisms of effect in HRV biofeedback (Wheat and Larkin 
2010).  
A review of clinical evidence from all types of biofeedback for mood and anxiety 
disorders has been conducted by the Canadian Agency for Drugs and 
Technology in Health (CADTH 2017). This review highlighted some 
improvements in both PTSD and depression using HRV biofeedback and some 
improvement in PTSD and anxiety using neurofeedback. However, only five 
RCTs were included in the final review and no studies were identified which 
assessed the use of home biofeedback equipment in patients (CADTH 2017). 
Overall, there was a recommendation for larger scale randomised control trials 
with an alternative treatment as a comparator, and for the development of 
guidelines on the use of biofeedback and neurofeedback for anxiety and mood 
disorders (CADT 2017).  
A systematic review of 63 studies employing all types of biofeedback as an 
intervention for a range of psychiatric disorders has been carried out 
(Schoenberg and David 2014). Over 80% of articles included in this review 
described clinical improvement related to biofeedback with 65% to a statistically 
significant level. A range of biofeedback modalities including HRV biofeedback 
were investigated in this review, and multimodal biofeedback was noted as most 
effective in improving symptoms (Schoenberg and David 2014). This report 
aimed to highlight how biofeedback can be used with positive results as an 
adjunct to treatment in a range of psychiatric disorders, however only ten studies 
reviewed involved HRV biofeedback.  






A furthermore specific systematic review assessed the efficacy of HRV 
biofeedback as a psychophysiological treatment for depression and PTSD (Blase 
et al.  2016). Critical appraisal of outcomes was carried out using the GRADE 
method (Dijkers 2013) and out of an initial 789 studies using HRV biofeedback 
identified, 6 RCTS and 4 other relevant studies were selected. 
Significant outcomes were seen in biofeedback conditions compared to controls. 
The authors noted,  
“Significant outcomes of this limited number of randomised studies 
indicate there may be a clinical improvement when HRV biofeedback 
training is integrated into the treatment of PTSD and depression” 
(Blase et al. p.300).  
A quantitative meta–analysis has been carried out to assess the effect of HRV 
biofeedback training on stress and anxiety (Goessl et al. 2017a). In this review a 
random effects meta-analysis was carried out on 24 studies identified.   The 
authors concluded that,  
“HRV biofeedback training is associated with a large reduction in self-
reported stress and anxiety. Although well-controlled studies are 
needed, this intervention offers a promising approach for treating stress 
and anxiety with wearable devices” (Goessl et al. 2017, p1).  
In summary, there are a growing number of studies using HRV biofeedback as 
an intervention for a wide range of conditions in a number of different 
populations. There are a number of confounding factors such as use of different 
devices and protocols which make comparisons between studies problematic. 
Overall, there is a need for further randomised controlled studies and assessment 
of outcome should ideally utilise both physiological and psychological 
measurements.  Further information on the qualitative experiences of users of 
HRV biofeedback may also be useful to further assess some of the effects of this 
intervention. However, the most recent reviews suggest further research is 
warranted to investigate the potential of HRV biofeedback, and a meta-analysis 
does suggest potential efficacy of this intervention as a method to reduce stress 
and anxiety.  






 Rationale for the use of HRV Biofeedback in ASD 
HRV biofeedback has been proposed as an important adjunct to other 
interventions available, which may help people with mental health conditions 
manage difficulties such as anxiety more effectively (Lehrer 2017; Caldwell 
2018).  
The relationship between anxiety and ASD is now viewed by some as central to 
development of many ASD symptoms, rather than being a secondary 
consequence of social and communication symptoms (Markram 2007; Sugarman 
et al. 2013).  
A number of interventions have been used to try to help manage anxiety in 
people with ASD. Conventional therapies such as CBT have shown moderate 
success, however adaptations have been needed to accommodate the social and 
communication difficulties seen in people with ASD. In addition, many 
conventional ‘talking therapies’ require significant time and therapist expertise 
making them costly, in a time of limited healthcare resources.  
Despite widespread use (Farmer et al. 2013), evidence for the effectiveness of 
medication to treat some of the difficulties experienced by people with ASD 
remains limited, and there is a possibly of increased risks in people with ASD 
(Vasa 2016). 
It is proposed that a new approach to managing difficulties faced by people with 
ASD is needed, that appeals to their strengths and interests rather than simply 
trying to adapt existing therapies designed for the non ASD population.  
The use of technology has been advocated as a potential method of helping 
people with ASD (Murray 1999; Bagatell 2010). Biofeedback has been 
highlighted as a potential intervention that reduces the need for complex verbal 
interaction and involves use of real time visual or auditory feedback which may 
appeal to the nonverbal strengths, and the technology interests seen in many 
people with ASD.  






Current evidence has highlighted that people with ASD show signs of ANS 
dysfunction (Hirstein et al. 2001) and show significant difficulties with 
symptoms such as anxiety (van Steensel 2017). 
HRV biofeedback may help regulate ANS function and has been investigated as 
an intervention to help manage symptoms such as anxiety in people without ASD 
(Reiner 2008; de Bruin 2016). 
HRV biofeedback is visual and requires fewer verbal and social demands that 
many traditional talking therapies. It has shown some positive effects helping 
people without ASD and may also be a potential intervention to help people with 
ASD. 
It is therefore hypothesised that HRV biofeedback could be used as a possible 
intervention to help regulate ANS dysfunction and reduce symptoms such as 
anxiety in people with ASD. 
 
Whilst the exact mechanism of effect is still debated, the provision of an 
intervention such as HRV biofeedback via technology may be a useful method 
of engaging people with ASD in an area of interest, without the complex social 
and communication demands of traditional cognitive and behavioural therapies, 
and without some of the potential risks of medication. 
Previous research has focussed on use of neurofeedback in people with ASD and 
current research into its effectiveness is ongoing.  
HRV biofeedback combines a method of delivery using visual information and 
technology, which may be suited to the visual strengths of people with ASD 
(Grandin 1995), with an aim to intervene in area of possible underlying 
dysfunction.    
  






 Summary  
This chapter has highlighted relevant background information on literature 
relating to ASD, biofeedback and HRV. It is argued that HRV biofeedback could 
be a useful method to help manage anxiety in people with ASD. 
The next chapter will present a systematic review of literature relating to the 
intersection between the three themes of ASD, biofeedback and HRV to examine 
what specific research exists on the use of HRV biofeedback in people with ASD 




















Figure 2.4 Three main themes upon which the thesis is based. 
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Autistic Spectrum Disorder 
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 Systematic Literature Review 
 Overview  
It has been proposed in Chapter 1 that a new approach to managing difficulties 
faced by people with ASD is needed, one that appeals to their strengths and interests 
rather than simply trying to adapt existing therapies designed for the non ASD 
population. Chapter 2 has reviewed current research on HRV, biofeedback and 
ASD to inform the background context and develop a rationale for the current 
study. It concluded that there is emerging support for HRV biofeedback, although 
further research is needed. 
Chapter 3 will now report the findings of a systematic review to assess what 
literature exists on the use of HRV biofeedback in people with ASD. Literature 
from library electronic databases; key journals and unpublished doctoral theses is 
reviewed and presented in a PRISMA flow diagram (Liberati 2009). Literature 
identified is then appraised and future directions for further research are discussed.  
  






 Systematic literature search  
Literature search question: What literature exists on the use of HRV 
biofeedback in people with ASD? 
 Search Methodology  
Initial reviews of published database literature carried out from 28th to 30th January 
2015 indicated a very heterogeneous range of studies with few randomised 
controlled trials into the use of HRV biofeedback and no randomised trials reported 
specifically on ASD.  Therefore, search methods employed included systematic 
electronic database searching, and review of reference lists from key texts, hand 
searching selected journals and unpublished theses. 
A systematic approach to the search strategy was employed following the PRISMA 
guidelines (Liberati et al., 2009). The search strategy used was also linked to a 
clearly defined research question related to the Population, Intervention, 
Comparator and Outcomes (PICO) framework (Schardt et al., 2007).  
A preliminary search was carried out using electronic library databases using two 
terms related to the population – namely people with ‘autistic spectrum disorder 
and the intervention ‘heart rate variability biofeedback’.   
This initial search yielded insufficient results from databases interrogated. 
Therefore, the second theme was broken into two separate parts describing the 
intervention type – ‘biofeedback’ and the specific measurement modality – ‘heart 
rate variability’.  
Searches were therefore carried out using three key themes related to population 
intervention and outcome measurement as outlined below,  
• Theme 1: Population – ASD (common synonyms were also included)  
• Theme 2: Intervention – Biofeedback  
• Theme 3: Outcome measure – Heart rate variability   
 






 Search strategy  
A comprehensive search of electronic library databases was then undertaken to 
identify relevant literature on the three key themes identified in the research 
question and PICO framework specific to this review. The following five databases 
were searched, 
• Medline; Psychinfo and Embase via the OVID platform;  
• CINAHL plus  
• Scopus   
 
Searches were carried out on 11th August 2016 and were repeated on 19th July 2017. 
Inclusion criteria  
• All languages were included in the review  
• All date ranges were included; i.e. no restriction was set on the date range 
for each database.  
• Both published and unpublished literature was included in the review.  
Exclusion criteria  
• Literature without an English abstract was excluded.  
• Studies not including ASD were excluded from the final review.  
• Studies not containing HRV biofeedback were excluded from the review.  
 Search terms used 
Keywords were identified initially by consulting with experts in the areas of ASD 
and heart rate variability and were then further refined with advice from a librarian. 
Searches were carried out using the advanced search option of each database. 
Keyword searching was carried out by exploding search terms and then using 
truncation characters specific to each database to identify relevant MESH terms and 
keywords. Terms were then combined using the Boolean operator ‘AND’ to 
combine themes and limit the search.  






A summary of databases searched, search terms used, and final dates of each search 
are outlined in Table 3.1.  
Table 3.1 Library electronic database search strategy showing themes based on PICO 
framework; search terms; databases used; dates of search and inclusion and exclusion 
criteria.  
Research question Population Intervention Comparator Outcome 
 
 
“An Investigation into 
the use of Heart Rate 
Variability Biofeedback 
















Search terms used Theme 1 Theme 2  Theme 3 





























• Medline via Ovid 
• Psychinfo via Ovid 
• Embase via Ovid 
• CINAHL plus 
• Scopus 
 
19th July 2017 
 
 
All languages  
 










Results of database searches shown in Table 3.2. 

























Total Number remaining once 
duplicates removed 
Number remaining once 
exclusion criteria applied 
 
HRV +  
ASD  
 













3 4 8 0 4 19 11 2 






 Literature search results  
Literature search results were reviewed to assess what literature currently exists on 
the use of HRV biofeedback in people with ASD. The titles and abstracts of the 
literature accessed were reviewed and duplicates were removed. All potential 
articles were screened in full and exclusion criteria were then applied excluding all 
articles not relating to persons with ASD. 
Only articles which involved the use of HRV biofeedback as the main intervention 
for people with ASD were included in the final review.  Articles which mentioned 
the use of HRV Biofeedback within the context of an overall review but did not 
focus on HRV biofeedback as the main intervention were excluded.  
A summary of final records identified from library electronic databases with 















Table 3.3 Summary of records identified from electronic library database searches, with two records highlighted for inclusion.   
Library database searching of literature: 
 
Inclusion / Exclusion  
with reason 
1. Bacchini, P.H.F., Lopes, E.C., De A. Barbosa, M.A.G., Ferreira, J.O., Da Silva Neto, O.C., Da Rocha, A.F. and De A. Barbosa, T.M.G 
2014"Developing an affective Point-of-Care technology," IEEE Symposium on Computational Intelligence in Healthcare and e-health (CICARE), 
Orlando, FL, p. 77-84.   
Not HRV biofeedback  
Exclude 
2. Friedrich E.V.C., Suttie N., Sivanathan A., Lim T., Louchart S. and Pineda, J.A. (2014). Brain-computer interface game applications for combined 
Neurofeedback and biofeedback treatment for children on the autism spectrum. Frontiers in Neuroengineering, 7, (21), p. 1-7.  
Autism + biofeedback review 
Exclude 
3. Krivonogova, E. (2013). Non-communicable disease epidemic: epidemiology in action (EuroEpi 2013 and NordicEpi 2013): Aarhus, Denmark 11 
to 14 August 2013. European Journal of Epidemiology, 28 (1), p.130. 
Not Autism  
Exclude 
4. Power, E.M., (2016). Evaluating the Effectiveness of Biofeedback in Improving Emotional Regulation for a Student with Autism Spectrum 
Disorder. (Doctoral dissertation, The Chicago School of Professional Psychology). ProQuest Information and Learning; US. No. 10085662. 
Autism + HRV+ biofeedback  
Intervention Include √ 
5. Reid A. and Nihon, S. (2013). The effects of heart rate variability on sensorimotor rhythm: A pilot study. Journal of Neurotherapy, 17(1), p.43-48. Not Autism Exclude 
6. Santhirasegaram, L. (2011). A book finally written: Case study of effective intervention five years’ post closed head injury. Journal of Neurotherapy, 
15(4), p.441-443.  
Not Autism   
Exclude 
7. Thompson L., Thompson M. and Reid, A. (2010). Functional neuroanatomy and the rationale for using EEG biofeedback for clients with Asperger's 
syndrome. Applied Psychophysiology Biofeedback, 35 (1), p.39-61. 
Autism + biofeedback review 
Exclude 
8. Thompson L., Thompson M. and Reid, A. (2010). Neurofeedback outcomes in clients with Asperger's Syndrome. Applied Psychophysiology 
Biofeedback, 35(1), p.63-81.  
Autism + biofeedback review 
Exclude    
9. Thompson M. and Thompson, L. (2011). Setting up for success with asperger's and autistic spectrum disorder. Journal of Neurotherapy, 15(4), p.426-
427.  
Autism + biofeedback review 
Exclude    
10. Thompson M., Thompson L., Reid A. and Santhirasegaram, L. (2011). Neural networks: An exploration of functions influenced by Neurofeedback. 
Journal of Neurotherapy, 15(4), p.447-448. 
Not HRV biofeedback  
Exclude 
11. Westlake, G. (2013). Evaluation of a biofeedback intervention in college students diagnosed with Autism Spectrum Disorders. (Doctoral dissertation, 
Arizona State University). ProQuest Information and Learning; US. No. 3595257. 
Autism + HRV+ biofeedback  
Intervention Include √ 






Additional manual searches were then carried out by reviewing reference lists from 
the publications obtained from combined search terms and by reviewing the 
Journals ‘Applied Psychophysiology and Biofeedback’, ‘Journal of Neurotherapy’ 
and the magazine ‘Biofeedback’ published by the Association of Applied 
Psychophysiology and Biofeedback. The titles and abstracts of all the literature 
accessed were reviewed and duplicates were then removed. Full texts were then 
screened for eligibility using the inclusion and exclusion criteria. A summary of the 
additional records identified from other sources with reasons for exclusion is 




   
  






Table 3.4 Summary of additional literature identified from three sources: manual searching of references, journals and grey literature, with three records 
highlighted for inclusion. 
Additional manual searching of references, journals and grey literature Inclusion/Exclusion with reason 
1. Aguinaga, Nancy (2006). An Investigation of the Effectiveness of Computer-assisted Biofeedback for Students 
Diagnosed as Having Autism Spectrum Disorder (Doctoral dissertation, University of Central Florida). Electronic 
Theses and Dissertations. 951.   
ASD + HRV + biofeedback 
Intervention  
Include   √ 
2. Berger, M.J. (2007). The Efficacy of Selected Biofeedback Techniques in Mitigating Symptoms Associated with 
Autism Spectrum Disorder. Biofeedback, 35(2), p.62-68. 
ASD + HRV + biofeedback 
Intervention  
Include   √ 
3. McCoy, K.M., Westlake, G., Zucker, S.H. and DiGangi, S.A. (2014). Evaluation of a Biofeedback Intervention in 
College Students Diagnosed with an Autism Spectrum Disorder. DADD Online Journal, 1(1), p.121- 135. 
ASD + HRV + biofeedback 
Intervention  
Include   √ 
4. Sugarman, L.I., Garrison, B.L., Williford, K.L. (2013). Symptoms as Solutions: Hypnosis and Biofeedback for 
Autonomic Regulation in Autism Spectrum Disorders. American Journal of Clinical Hypnosis, 56, p. 152-173. 
ASD + HRV biofeedback - review 
Exclude   × 






The combined results of library electronic database searching, and manual 
searching are summarised in the PRISMA flow diagram in Figure 3.1 PRISMA 




































Full texts screened 













































Records excluded  
n=10 
Not HRV Biofeedback n=4 
Not Autism n=2 
Review only n=4 
 
Records identified  
via manual  





Full texts included  










 Critical appraisal of literature   
A critical appraisal of the final studies included in the review is described below. 
Each study was initially reviewed using the PICOTS framework (Schardt et al. 
2007; Davies 2011).   
A number of more detailed evaluation tools exist for reviewing the quality of 
published studies such as the critical appraisal skills programme (CASP 2006), or 
the outcome of studies (Dijkers 2013). However, as the records identified were 
mainly unpublished dissertations the studies met few of the appraisal criteria. 
Studies were therefore appraised by reviewing an adapted form of the framework 
for ‘10 questions to help you make sense of qualitative research’(Chenail 2011). 
The framework used for appraising the studies identified is outlined in Table 3.5. 
 
Table 3.5 Summary of framework questions used to appraise literature.  
Appraisal area Guiding questions 
Rigour 1. Was there a clear statement of the aims of the research? 
2. Is the methodology appropriate to the stated aims? 
3. Was the research design appropriate to address the aims 
of the research? 
4. Was the recruitment strategy appropriate to the aims of 
the research? 
5. Was the data collected in a way that addressed the 
research issue? 
6. Has the relationship between researcher and participants 
been adequately considered? 
7. Have ethical issues been taken into consideration? 
8. Was the data analysis sufficiently rigorous? 
Credibility 9. Is there a clear statement of findings? 
Relevance 10. How valuable is the research? 






The final studies included in the overall review are shown in Table 3.6. Two of the 
reports; Westlake (2013) and McCoy (2014), describe research from the same PhD 
project and are therefore reviewed as a single study. 
Table 3.6 Final studies included in the literature review.  
Final results of combined literature search terms  
 
1. Aguinaga, Nancy, (2006). An Investigation of the Effectiveness of 
Computer-assisted Biofeedback for Students Diagnosed as Having 
Autism Spectrum Disorder (Doctoral dissertation, University of 
Central Florida). Electronic Theses and Dissertations. 951.   
 
2. Berger, M.J., (2007). The Efficacy of Selected Biofeedback 
Techniques in Mitigating Symptoms Associated with Autism 
Spectrum Disorder. Biofeedback, 35(2), p.62-68. 
 
3. Power, E.M., (2016). Evaluating the Effectiveness of Biofeedback in 
Improving Emotional Regulation for a Student with Autism Spectrum 
Disorder (Doctoral dissertation, The Chicago School of Professional 
Psychology). ProQuest Information and Learning; US. No. 10085662. 
 
4. Westlake, G. (2013) Evaluation of a Biofeedback Intervention in 
College Students Diagnosed with Autism Spectrum Disorders. 
(Doctoral dissertation, Arizona State University). ProQuest 
Information and Learning; US. No. 3595257.  
and 
McCoy, K.M., Westlake, G., Zucker, S.H. and DiGangi, S.A., (2014). 
Evaluation of a Biofeedback Intervention in College Students 
Diagnosed with an Autism Spectrum Disorder. DADD Online 
Journal, 1(1), p.121- 135. 
 
 
These four studies are now reviewed, first with reference to the PICOTS framework 
to describe and summarise and secondly with reference to the adapted CASP 
framework to appraise each study. 
 






 Study 1: Aguinaga (2006)  
 PICOTs framework  
Author and Year; 
Location and 
literature format  
Aguinaga, N., (2006).  




Participants were three young people with autism aged 9-10 years 
(2 females; 1 male) who were assessed in a special needs’ classroom 
environment.  
Design of study  
Intervention 
This study employed a single subject multiple baseline design.  
Participants were assessed on their ability to engage in academic 
tasks before and after using a computer assisted biofeedback 
programme (Freeze-Framer). Performance on academic tasks was 
also measured. Parent and teacher reports were collected on 
perception of ‘generalization of self-regulation behaviour’ 
(Aguinaga, 2006 p. iii), before and after the intervention period. 
Sample size and  
Comparator 
The sample size was n=3. Within subject comparisons were made 
before and after using the HRV biofeedback intervention There was 
no separate control group.  
Key findings and  
Outcome 
All participants showed increased ‘speed to engagement’ in 
academic tasks. Time spent ‘on task’ also improved for all 
participants. One out of the three participants also showed improved 
academic performance on tasks.  
Teacher reports indicated a perception of ‘generalisation of self-
regulation of behaviour’ in all participants, whilst parent reports did 
not indicate any perception of change in the home environment. 
Participants with greater cognitive ability showed more 
improvement on tasks.   
Time frame for 
study  
This study involved biofeedback sessions lasting 3-4 minutes once 
per day, five days per week for five weeks in total, with each 
participant beginning the intervention in phases one after another.  
Setting  This study was carried out in a classroom setting in a school for 
children with disability. 






 Study 1: Aguinaga (2006) Appraisal  
Rigour  
Aims  This dissertation makes a clear statement of aims to examine the 
impact of a type of heart rate variability biofeedback on the 
engagement of students with autism in academic tasks.  
Design and 
Methodology    
The design took into account the nature of employing a new 
intervention in a vulnerable young population. Biofeedback was 
used once a day, five days per week at the set time on the same 
computer in the participant’s usual classroom. Baseline data was 
collected from participants at the same time each day five times per 
week in the same classroom. Participants were given support in use 
of the device by a member of the research team. Participants then 
immediately completed an individualised academic task which was 
scored according to the specified research aims. A checklist was 
followed to ensure training and recording of data was collected in 
the same manner by all members of the research team. The method 
was congruent with the aims of the research.  
Recruitment Participants were recruited by the researcher and special education 
teacher identifying suitable potential participants according to pre-
set selection criteria. Written information was then given to parents 
and teachers and written consent forms were signed prior to 
intervention. A verbal assent form was also read aloud to all 
participants.  
Data collection 
and Measures  
All participants were assessed before and after using biofeedback. 
Data was collected on speed to engagement, time on task and 
academic performance.  A short questionnaire was used to collect 





The researcher and several other members of a research team spent 
time with participants – all contact was in the participant’s usual 
classroom. The short nature of sessions and the involvement of 
other researchers made it unlikely that the researcher had a 
profound influence on treatment results. 






Ethical issues Consent was deemed adequate. Written information was given to 
carers prior to obtaining consent. Assent was also sought verbally 
from all participants. All consent and assent record forms used were 
provided. The researcher noted that parents would have benefitted 
from having more information on the biofeedback programme and 
its aims and recommended more involvement of parents in any 
future research.  
Data analysis Descriptive statistics were used to assess pre-post participant 
behaviour before and after using biofeedback.  
Credibility  
 
Is there a clear 
statement of 
findings?  
The study findings are stated clearly. The wider relevance of 
findings is limited due to the small sample size. Strengths of this 
study related to the detailed level of observations of behaviour 
carried out in a natural classroom setting, rather than in a clinical 
environment.  
The study also employed a clear and replicable methodology 
regarding the use of biofeedback for to help young children with 
autism engage in academic tasks. 
Relevance  
 
How valuable is 
the research?  
This research study has relevance as it adds information on the use 
of this intervention in a learning-disabled population in a classroom 
environment.  
The value is limited by the small sample size and lack of a control 
group. 
  






 Study 2: Berger (2007) 
  PICOTS framework description  
Author and Year 
Location and 
literature format  
Berger, M.J., (2007).  




This report presented results intervention with a single adolescent 
male diagnosed with ASD.  
Design of study 
Intervention  
Single case design and report of future treatment potential.  
The intervention employed HRV biofeedback using biofeedback 
games produced by Somatic Vision. The treatment regime used 
several additional biofeedback measurements such as skin 
conductance and hand temperature to measure outcomes. In 
addition, the participant practiced biofeedback guided meditation 
exercises.  
Sample size and  
Comparator 
The sample size in this study was n=1 
There was no comparator.   
Key findings and  
Outcome 
Pre-post comparisons were made using a single parent rated 
questionnaire, the Autism Treatment Evaluation Checklist. Results 
indicated ‘measurable improvement on sensory/ cognitive 
awareness and on health/ physical behaviour ratings and dramatic 
improvement in sociability’ (Berger, 2007 p. 62)  
The participant showed improvement on self-ratings of calmness. 
In addition, physiological assessments used before and after 
biofeedback training showed a slowed breath rate and improved 
hand temperature.  
Time frame for 
study  
The case study involved 18 x 1hour biofeedback sessions over a 
period of 6 weeks, plus home practice of biofeedback guided 
meditation exercises.  
Setting  The location for the biofeedback sessions was unclear. 
 






 Study 2: Berger (2007) Appraisal  
Rigour    
Aims  The stated aims were to outline the potential of biofeedback as an 




This single case study design did meet the aim of showing the 
potential for this type of treatment and to assess whether it would 
help the participant to relax. The nature of study design did not 
allow for any comparisons with other subjects; however, the 
methodology was appropriate to meet the stated aims.  
Recruitment The nature of participant recruitment in this study is unclear 
Data collection 
and Measures  
Pre-post comparisons were made using parent report via a 
standardised questionnaire and using several pre-post physiological 
measurements from biofeedback devices used with the participant 
and a participant rating scale. The study shows strength in this area 
due to the use of pre-post questionnaire measurement in 
conjunction with pre-post physiological measurements, and pre-




The nature of the study design and intervention indicates that there 
would have been close contact between the participant and the 
researcher, particularly in the initial set up of the treatment regime. 
Ethical issues The nature of the researcher’s initial recruitment method and 
subsequent contact with the participant is not discussed. There may 
have been a relationship which then influenced the outcome. It 
would have been useful to have had clarification as to how long the 
researcher spent with the participant in the hour-long biofeedback 
sessions and how much training from the researcher was involved.  
Data analysis Statistical tests were carried out in this study on the pre-and post-
ratings of behaviour on the parent rating scale. Significant changes 










Credibility   
Is there a clear 
statement of 
findings?  
There is a clear statement of findings in this study.  
Whilst HRV biofeedback was the main treatment modality, the 
additional use of home meditation practice is a confounding 
variable that may have also influenced results of the study. This 
study showed strengths in that pre-post measures were obtained 
from both participant and parent. In addition, several physiological 
measurement modalities were used and the detail in recording and 
the pre-post recording enabled statistical analysis of change over 
time. 
The study was limited because of the small sample size and lack of 
additional information regarding participant characteristics, such as 
cognitive ability and level of anxiety. There was evidence of a 
significant positive effect from the intervention over several pre-
post measures.  
The strength of this evidence is however limited due to the fact that 
this was a single case study and confounding variables such as 
participant researcher relationship and the additional use of 
mediation practice were not discussed.  
Relevance   
How valuable is 
the research?  
This study shows relevance as a proof of concept case design in a 
new area where there exists no current published research. The 
researcher clearly acknowledges the need for larger studies to 











 Study 3: Power (2016)  
 PICOTS framework description 
Author, Year and 
Location and 
literature format  
Power, E.M., (2016).  
Chicago School of Professional Psychology. 




This study involved assessment of an intervention with a single 8-
year-old boy with autism. 
 
Design of study 
Intervention 
This was a single case study design.  
The intervention involved use of a hand held HRV biofeedback 
device (emWave2) with recordings made using the device during 
the baseline assessment and during the intervention to assess 
change in ‘cardiac coherence’.  
 
Sample size and  
Comparator 
The sample size was n=1.  
The subject acted as their own control. No other comparator is 
described. 
 
Key findings and  
Outcome 
A significant negative change in cardiac coherence was noted 
during the intervention period compared to the baseline period. 
Thus, the participant showed greater levels of cardiac coherence 
during the baseline assessment period compared to the intervention 
period.  
Time frame for 
study  
Four initial baseline sessions took place over four days with each 
session lasting on average 12 minutes. Ten intervention sessions 
took place over the course of ten days each lasting on average 7 
minutes. 
Setting  Each session involved the participant being taken out of their 
classroom to be assessed by the researcher in separate room within 
the school environment.  
  






 Study 3: Power (2016) Appraisal 
Rigour  
Aims  This study aimed to assess the impact of HRV biofeedback using a 
commercial device on a single participant with ASD.  
Design and 
Methodology  
The study employed a single subject experimental A-B design, 
deemed appropriate to test out a new intervention in a new and 
vulnerable population.  
The methodology involved an initial detailed neuropsychological 
assessment followed by baseline measurement of HRV using the 
emWave2 device whilst the boy played with Lego blocks.  
This detailed assessment was then followed by an intervention period 
of 10 sessions training him to think positive thoughts and breathe 
deeply.  
 
Recruitment The recruitment strategy used in this study involved teachers 
recommending a student who had difficulty with emotional 
regulation for the intervention. Written parental consent was 




Detailed neuropsychological testing was carried out as part of the 
regular assessment of each student which collected information on 
the participant’s cognitive ability levels. Finally, questionnaires rated 
the severity of autism symptoms. Intervention measures used 
included pre-and post-teacher rating scales and data from the 





The researcher spent short periods of time (30 minutes) with the 
participant during the intervention and baseline periods, however the 
neuropsychological assessment process would have entailed several 
hours of direct contact prior to this.  
 
 


































A number of ethical issues arose in this study, many of which were 
noted by the researcher.  
Sensory issues and cognitive rigidity commonly seen in people with 
autism were highlighted by the researcher as possible reasons for the 
poor results of the intervention. For example, ‘the student’s sensory 
response to the emWave2 equipment proved to cause some 
difficulties during the baseline and intervention phases’, (Power 
p.67).  
 
An important issue raised by this study was the anxiety noted in the 
participant regarding sessions with the examiner. This may have been 
related to the change in his routine ‘the student appeared to become 
anxious on days that he would be meeting with the examiner and 
would check with his teacher an average of four times on intervention 
days to see if the examiner was coming’ (Power, p.66.) 
 
The examiners visits varied depending on her schedule and school 
events ‘this ultimately dictated when the student could be pulled from 
his classroom which impacted the student’s anxiousness regarding 
inconsistency in his weekly schedule’ (Power p.67). The participant 
was given a visual schedule regarding visits by the examiner, but it 
was acknowledged that the times of visits were inconsistent, which 
may have increased anxiety.  
 
In addition, issues were noted within the actual intervention sessions  
‘The participant reported that he was ‘upset because he did not know 
how to change the colors of the machine   … and stated that ‘he was 
trying his hardest to think positively and take deep breaths’ (Power 
p.64).  
 
Data analysis Statistical assessment was carried out using tests which were 
appropriate to single case design.  
 





























implications   
The author gives a clear account of findings and highlights factors 
such as sensory sensitivity; need for routine seen in many people with 
autism, and a lack of time that may have led to problems with this 
intervention. Strengths of this study relate to the very detailed level 
of observations of task behaviour, carried out in an educational 
environment.  
Some ethical issues are raised by this study concerning the stress of 
continuing to use biofeedback and the impact this may have on a 
vulnerable participant. The boy reported feeling stressed at not being 
able to do the biofeedback properly and it is possible that instruction 
to carry out deep breathing may have led to hyperventilation and 
anxiety.  
 
A potential confounding variable in this study relates to the possible 
influence of the lengthy neuropsychological assessment prior to the 
baseline and intervention. This may have had an impact on the 
participant independently from the any actual biofeedback training. 
It is also possible that the chosen baseline play activity was more 
relaxing for the participant than the biofeedback sessions with the 
examiner.   
This study involved the youngest participant studied (8 years) and 
this age group may require different training techniques. Some of the 
implications of this research relate to the need for training to ensure 
participants can use devices correctly. 
 
Relevance  
How valuable is 
this research? 
This study is limited because of the small sample size and the lack of 
information on other aspects of participant’s behaviour that could 
have been obtained from contact with parents.  This research is 
however valuable because of the information on the potential for 
negative effects from use of biofeedback.  
 






 Study 4: Westlake (2013)  
 PICOTS framework description  
Author Year and 
Location  
Westlake, G. (2013) and McCoy (2014).  
Arizona state university unpublished dissertation and an online journal.   
Population  College students with and without ASD participated in this study  
Design of study 
Intervention 
The study was a two-group experimental design. 
The intervention involved initial basic training in use of the desktop 
HRV biofeedback equipment. After basic instruction participants then 
completed a 10-minute session using the system once per week for 10 
weeks. No other training or input from support staff or the researcher 
was provided. No background information was collected on participants 
other than gender. Participants completed biofeedback sessions on their 
own in the same room and recorded their HRV scores and session time 
on a record sheet manually after each session for later data analysis.  
Sample size and  
Comparator 
Intervention: n = 10 students with ASD (all male)                       
Comparison: n = 37 students not ASD (28 male, 9 female)   
Key findings and 
Outcome 
The study used exploratory data analysis to review trends in data 
collected over the ten-week period.  Within and between groups 
comparisons were made to examine trends between the first five weeks 
and the second five weeks of the intervention. Participants with ASD 
showed a greater increase in mean HRV scores compared to students 
without autism in the second five weeks of the study. Participants with 
ASD also showed higher median scores and less variability in their 
scores compared to students without ASD, in the second five weeks of 
the study. Both groups showed a decline in participation over the course 
of the study with only 60% of autism students remaining at the end of 
the study and 66% of non-autism students remaining at the end of the 
ten-week period. A possible pattern between participant drop out from 
the study and their biofeedback progress was also discussed with the 
suggestion that those with little progress may have to dropped out 
Time frame  
Setting 
The Intervention lasted 10 weeks.  
The study was located in a Disability Resource Centre. 










Aim  This feasibility study aimed to assess whether HRV biofeedback 
intervention would help young adults with ASD manage anxiety.  
Design and 
Methodology   
This study design was deemed as appropriate to the stated aims. The 
methodology used did not however address the stated aims as no 
direct measure of anxiety is used and no pre-post measurement of 
anxiety is carried out.  There was also an inconsistency in the 
reporting of the sample size of the control group through the study. 
  
Recruitment The study design involved recruiting two groups, those with a 
diagnosis of ASD and students from psychology classes.  
Two different recruitment strategies were used. Students in the 
control group were recruited directly from introductory psychology 
courses. Students with ASD were referred directly into the study by 
advisors who were supporting students with ASD at the university. 
It was not clear whether any participants in the control group may 
also have had ASD.  
 
Data collection 
and Measures  
There were a number of limitations with data collection in this 
study. No data was collected on participant characteristics such as 
race or age cognitive ability or pre-existing anxiety levels. 
Participants recorded their HRV coherence scores and session time 
from the experimental device on a record sheet manually after each 
session. No independent physiological measures of HRV or anxiety 





The researcher had no contact with any of the participants thus 
excluding any potential direct effect of a researcher participant 
relationship on results.  
 






Ethical issues The referral into the study of people with ASD by advisers may 
have led to inclusion of participants with ASD who did not want to 
participate or who did not have high anxiety.  
Data analysis Exploratory data analysis was used rather than hypothesis testing 
and statistical tests. The methods used to visually review trends in 
the data may have been open to interpretation and this was 
acknowledged. In addition, the level of ‘coherence’ measured by 
the device was taken to be an indication of participant’s level of 
HRV and their anxiety. The assumption that measures of HRV 
recorded from the biofeedback device are a sign of actual 




Is there a clear 
statement of 
findings?  
The findings of this study were unclear. The rationale for reporting 
findings of trends between the first five weeks and the second five 
weeks of the study, rather than the first and last week of the study 
is unclear.  
The discussion of potential links between attrition from the study 
and biofeedback progress is unclear, as both participants with high 
scores and low scores dropped out of the study.  
There were a number of limitations in this study due to the lack of 
demographic information and lack of independent measurement of 
anxiety prior to commencing the intervention. The different 
recruitment strategies employed and the lack of any independent 
measurements of anxiety or HRV make it difficult to draw 




How valuable is 
this research?  
This research is relevant because of the information it adds in a new 
area with no published literature.  
Despite limitations, this was the only known study with a sample 
size greater than three and with a comparator group 
 
A summary of key similarities and differences emerging from the design, 
measures and interventions employed in these studies is described in Table 3.7. 






Table 3.7 Critical appraisal summary of four studies showing key differences in design measures and intervention. 
Theme  Study Author and Year  
 Aguinaga 2006 Berger 2007 Westlake 2013  Power 2016 
Design multiple case study  single case study design 2x group design single case study design 
Sample size   
Age  
n=3  






8 years  
Recruitment and consent Teacher + carer consent   Unknown  ASD Mentor  Teacher + carer consent   
Control group or comparator  No  No   Yes (n=37) assumed not ASD  No  
Random allocation used No No No No 
Allocation concealment No No No No 
Location of intervention  School / college  Unclear /home practice School / college  School / college  
Measures     
Demographic information  Age, gender  Gender only Gender only Age, gender  
Type of assessment used in 
addition to biofeedback  
Timing of behaviour on 
academic tasks  
Participant self-rating of 
calmness  
Parent report  
None  Psychometric testing of 
participant prior to 
intervention 
Carer reports collected  Parent and Teacher  Parent only None  Teacher only 
Participant report collected None  Participant self-rating  None Indirect reports via teacher  
Type of physiological 
measurements + assessments  
Scores on biofeedback device 
used as measure of HRV  
Skin conductance, and 
temperature 
Scores on biofeedback device 
used as measure of HRV  
Scores on biofeedback 
device used as measure of 
HRV  
Intervention      
Length of biofeedback  3-4 minutes x25 sessions  60 minutes x18 sessions  10 minutes x10 sessions 7 minutes x10 sessions  
Biofeedback device used  Freeze-framer  Somatic Vision + RESPeRATE  emWave2 desktop   emWave2 
Adoption of device / usability No  No  Attrition rate calculated No  






 Synthesis of evidence on HRV biofeedback in ASD  
In order to provide a synthesis of the evidence available from this literature the 
three areas of study design; measures used, and interventions employed shown in 
Table 3.7 are now reviewed further to assess whether any clear themes are apparent. 
 Design of studies assessing HRV Biofeedback in ASD  
The studies reviewed in this literature appraisal are typical of those in a new area 
of research namely small group or single case study design. The existing studies 
are limited in terms of sample size with no studies having more than ten people 
with ASD. They have added useful information regarding the potential of HRV 
biofeedback for both positive and negative outcomes in people with ASD.  
Sample size  
Single case study and small group comparisons have been appropriate in a new area 
for a vulnerable population. However, there is now a clear need for larger scale 
studies with greater sample size. Future studies should aim to follow randomised 
control design with adherence to principles such as the CONSORT guidelines for 
the reporting of trials (Schulz et al., 2010).  
Recruitment  
Current studies show the potential for selection bias in the recruitment of 
participants. These studies involved children being selected by teachers or 
recommended by mentors for inclusion in research, rather than using more 
widespread recruitment strategies. In addition, the study involving two groups did 
not use a similar selection strategy for each group. To minimise potential for bias, 
studies should clarify a clear procedure for recruitment, to reduce selection bias.  
Consent and information for participants 
The studies reviewed did not clarify how much information was given to parents 
or carers regarding each intervention, prior to obtaining consent.  






One of the studies noted increased difficulty using biofeedback after intervention 
and reports of increased anxiety in the participant. Thus, participants and carers 
and participants with ASD should be given detailed information on the nature of 
the intervention with possible risks as well as benefits outlined in any further 
development of this research area. This information should also be presented in a 
format that is accessible to both carers and people with ASD.  
Random allocation  
The studies identified used small-scale samples to explore the potential for an 
effective treatment and therefore they did not employ random allocation. As further 
evidence of potential effectiveness becomes available, it will become necessary to 
formally test the effectiveness of HRV biofeedback. The risk of bias must be 
addressed through random allocation to groups and use of allocation concealment. 
Only one study used a comparator group, and this was limited by the lack of random 
allocation and the different recruitment strategies used. In addition, the lack of 
detail regarding participant characteristics in this study made it impossible to 
determine if the two groups in this study were different with regard to either levels 
of anxiety or presence of ASD symptoms.  
Location of intervention  
Three of the four studies reviewed were set in an educational environment. One of 
the potential reasons for the negative outcome of using biofeedback seen in the 
study by Power (2016) was suggested as being due to use of an unfamiliar 
environment and an erratic training and intervention schedule. It is of note that the 
study design used by Aguinaga (2006) used the participant’s classroom which was 
a familiar environment and all training biofeedback and intervention sessions were 
all given every day and at the same time each day. Some of the key issues reported 
by people with ASD and their carers are difficulties coping with new situations and 
any change in their environment (National Autistic Society, 2017). The importance 
of using a safe and familiar environment should be acknowledged in any study 
aiming to help people with ASD manage anxiety.  






 Measures used to assess HRV biofeedback in ASD 
Demographic information 
Minimal demographic information was collected in three out of the four studies 
reviewed. The information collected by Power (2016) involved collecting 
information on neuropsychological functioning rather than demographic 
information. The lack of detailed demographic information collected in these 
studies made it difficult to understand the specific characteristics of participants 
and draw conclusions about how these participants compared to the wider 
population of people with ASD, and whether specific participant characteristics 
may be related to outcome of biofeedback. Collecting data on levels of ASD 
symptomology and levels of premorbid anxiety would enable more information to 
be gathered on the potential for biofeedback to elicit change in specific groups and 
could help to elucidate whether there was any relationship between level of ASD 
symptoms and anxiety and use of biofeedback.  
Participant reports 
Information in current studies was mainly obtained via proxy parent or teacher 
reports. Whilst this information is important, direct reports from people with ASD 
on the effectiveness and usability of any interventions are essential when designing 
and developing new intervention specifically tailored to the needs of people with 
ASD. The report of a single case by Berger (2007) was useful in that direct 
participant reports were used in conjunction with parent reports and physiological 
assessments. Three studies focused on younger participants with more limited 
verbal skills which made it more difficult to obtain written or verbal reports.  
The study by Westlake (2013) assessing college students with ASD did not collect 
any direct reports or data from either group of participants other than scores on the 
device and length of practice sessions. This would have been a valuable opportunity 
to collect information from users on both use and effectiveness of biofeedback.  
Future research could focus on obtaining the views of people with ASD to obtain 
their insights and opinions on both usability and effectiveness of HRV biofeedback. 






Measurement of HRV in people with ASD 
The studies reviewed all used the biofeedback intervention device itself as a 
measurement of underlying participant HRV. Scores recorded by the device were 
assumed to be equivalent to the individual’s actual HRV measurement and were 
also seen as an indication of participant anxiety.  To test the effectiveness of any 
HRV biofeedback intervention, future studies should include independent measures 
of HRV independent from the biofeedback device itself, and independent measures 
of stress or anxiety.  
 Interventions used for people with ASD 
Analysis of the actual biofeedback interventions used in the studies reviewed 
highlights the heterogeneity of intervention design which again makes any 
comparisons between studies difficult. This difficulty is widespread within the 
current research literature and has been highlighted in several of the reviews of the 
of studies in other population’s (Yucha, 2002; Yucha and Montgomery, 2008).   
Length and frequency of intervention sessions  
One example of this variability in intervention type is the length of session time 
used for biofeedback practice which varied from 3 minutes to 60 minutes within 
studies. Sessions also varied in frequency from 10 to 25 minutes with sessions 
either daily or several times per week. It is not clear whether longer sessions are 
needed to improve treatment outcomes in this type of intervention. 
Training provided  
In addition, the length of time spent training participants in use of biofeedback is 
not clearly specified in studies reviewed. It is possible that people with ASD will 
have difficulties with understanding how to use biofeedback devices and those 
current methods of training are not appropriate and need to be changed. The amount 
of training time needed and any difficulties with training could be assessed in future 
studies to determine whether any training difficulties relate to the overall outcome 
of the intervention.  






Type of device used 
Different HRV biofeedback devices were used in each study, all of which involved 
differing user interface and reward systems. The devices used included a number 
of HeartMath devices (emWave Desktop; emWave2 and Freeze-framer) all 
produced by (Quantum Intech Inc. Boulder Creek; CA). Somatic Vision produces 
a range of software programs which integrate gaming software into HRV 
biofeedback and skin conductance technology (Somatic vision Inc. Encinitas; CA). 
Usability of biofeedback device  
An important factor not considered in any of the studies reviewed is an analysis of 
the usability of different devices in terms of interface, form and overall functioning. 
There are significant differences in the size shape and visual information provided 
by different devices. It is possible that this will have an impact upon adoption and 
compliance. Whilst all HRV biofeedback devices claim to help users regulate 
breathing they vary widely in how they present information to users. Devices also 
may not use the same underlying algorithms for calculating HRV which again 
highlights the issue that independent calculation of HRV would be useful to 
understand how this intervention might work, and whether it has any actual impact 
on HRV.   
Adoption of biofeedback intervention 
None of the studies reviewed lasted for longer than ten weeks. Information on 
attrition rates was gathered in the study by Westlake (2013) however, because no 
participant reports were collected, and no premorbid information was gathered it 
was not possible to clearly explain reasons for drop out. It would be useful for future 
research to consider how individuals with ASD adopt this type of intervention, 
including information about attrition / drop-out rates and comparing differences 
between those who used the device and those who did not.  






 Conclusion  
Based on a review of the existing literature on the use of HRV biofeedback in 
people with ASD, a number of themes emerge regarding gaps in the research 
literature in this area. First, there is a need for larger more controlled studies 
investigating the use of HRV biofeedback in people with ASD. Whilst studies with 
people with ASD are at an early stage of development, the recent systematic review 
and meta-analysis supporting the efficacy of HRV biofeedback (Goessl, et al. 2017) 
suggests that further work in this area is warranted.  
Second, no studies have yet been conducted in a clinical population of people with 
ASD, using portable home use HRV devices. Third, no studies have involved 
measurement of HRV separate from the biofeedback device. Rather than relying 
on the device itself as a measure of change in HRV, independent assessment of the 
variable which HRV biofeedback devices purport to measure would be valuable to 
help elucidate whether this type of device could help individuals to change HRV. 
Finally, no studies have reported on the adoption and usability of HRV biofeedback 
devices as a potential intervention for individuals with ASD. Longer term 
interventions and use of follow-up debriefing interviews would be useful to help 
understand some of the reasons why and how participants use this intervention. 
Analysing information from those who dropped out may also be useful to 
understand potential problems or risks related to this intervention.  
Reflecting upon these four preliminary studies, the following chapter will outline a 
study involving an initial usability evaluation, followed by a pilot study to 
investigate the adoption, usability and effectiveness of an HRV biofeedback 
intervention for a clinical population of children and young adults with ASD. The 
intervention will employ small portable HRV biofeedback devices to help young 
people with ASD manage symptoms such as anxiety, in a home-based environment. 
It will also aim to measure levels of HRV and anxiety directly in people with ASD 
before and after using an HRV biofeedback intervention. 







 Overview  
A rationale for investigating the use of a technology-based intervention to help 
manage anxiety in people with ASD has been proposed (Chapter 1). A review of 
background information has shown that people with ASD show signs of both ANS 
dysfunction, and high levels of anxiety (Lydon 2014; van Steensel 2011) and the 
growing evidence for HRV biofeedback as an intervention to manage anxiety in a 
range of different populations has been presented (Chapter 2). A systematic review 
of the literature has indicated that this intervention has not been thoroughly trialled 
in this population (Chapter 3). 
Building upon existing work, it is proposed that HRV biofeedback could offer a 
potential means to help regulate ANS function and manage symptoms such as 
anxiety in people with ASD.  
This chapter describes the overall study aim and the specific research objectives. 
The underlying theory underpinning the study is reviewed and the development of 
a two-phase design is described. The initial evaluation phase of the study involved 
researcher training, followed by evaluation of participant information; measures; 
equipment; risks and initial testing of procedure to inform the main part of the 
study. This evaluation phase is presented, and amendments made to the final pilot 
study design are summarised. The phase 2 study design is then presented according 
to consolidated guidelines for reporting of pilot and feasibility trials ‘CONSORT’ 
(Eldridge et al.2016). Finally, the measures, equipment procedure and a data 










 Study Aim and Objectives 
The overall aim of the study and the specific research objectives are stated below.  
 
Aim  
To investigate the use of HRV biofeedback in people with ASD. 
Objectives  
1. To provide a home-based HRV biofeedback intervention to people with ASD.  
2. To assess anxiety and physiological arousal before and after using a HRV 
biofeedback device.  
3. To assess usage of HRV biofeedback in a sample of people with ASD.  
4. To evaluate the risks, benefits and acceptability of this technology.  













 Theoretical Framework  
Previous researchers have provided theories which can help to understand the 
possible mechanisms underlying HRV biofeedback (Porges 2001; Thayer and Lane 
2000; Lehrer et al. 2000; Gevirtz 2014).  
Two prominent theories ‘Polyvagal theory’ and the ‘Neurovisceral Integration 
Model’ were presented in Chapter 2, which can help to explain some of the findings 
relating to our understanding of HRV. Both of these theories propose that vagally 
mediated HRV is an indication of self-regulatory mechanisms exerted to control 
emotions or behaviour.  
A recent meta-analysis of research has provided support for these theories 
suggesting that HRV indices can be used as biomarkers of self-regulation (Holzman 
2017). In addition, advances in brain imaging and neurobiology have now shown 
the direct links between stress, the heart and the brain (Tawakol 2017). 
Whilst both theoretical models provide valuable frameworks to guide future 
research, Polyvagal theory was chosen to help guide this thesis due to the specific 
predictions it makes regarding people with ASD. Impairments in the ‘social 
engagement system’ described by Porges, are suggested as features of several 
disorders including ASD. For example, Porges states,  
“Many of the behavioral attributes of autism appear to be convergent with 
a compromise in this hypothetical social engagement system” (Porges 
2013, p. 262) 
Underlying difficulties with the CNS and the ANS in people with ASD are 
theorised to lead to an inability to switch into a more adaptive state in which social 
behaviours can take place (Porges 2013). Thus, one of the central consequences of 
impairments in the social engagement system may be heightened anxiety (Porges 
2013). It is therefore hypothesized that methods of slowing and controlling heart 
rate via HRV biofeedback may be one possible way to help people with ASD 
regulate underlying ANS function and reduce levels of anxiety.  






A theoretical model showing how an HRV biofeedback intervention might work 
is presented in Figure 4.1. 
  
 
        Key emotions and  Autonomic nervous system  




Figure 4.1 Model showing one possible mechanism of effect of HRV biofeedback to 
enhance vagal regulation of ANS via resonance frequency breathing, linking key emotions 
and behaviours involved in the intervention on the left, with key physiological changes 
expected on the right.  
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Polyvagal theory may explain one possible mechanism behind the anxiety states 
often seen in people with ASD. It may in turn give insights into the translation of 
research into more effective interventions (Bridges 2015). 
The research hypothesis underpinning the study, initially proposed Chapter 2, can 
be thus expanded, to give further explanation on the possible mechanism of effect 
of the intervention. 
HRV biofeedback will enable young people with ASD to control their breathing 
and heart rate using resonant frequency breathing, thus helping to activate their 
‘social engagement system’.  
This in turn will regulate autonomic nervous system arousal and reduce reported 
symptoms such as anxiety, or behavioural difficulties such as meltdowns. 
 
The mechanism of how the intervention is hypothesized to work is essential to 
determining the outputs of the study to be assessed and measured, and Polyvagal 
theory has provided a conceptual framework for the development of potential 
measures needed, and information to be collected. This theory has also informed 
the development of the study design and specific predictions made from the 
research hypothesis.  
As outlined above, it is hypothesised that HRV biofeedback will be able to help 
people with ASD to establish resonant frequency breathing and thus regulate 
underlying ANS dysfunction. The specific predictions derived from this hypothesis 
are that use of HRV biofeedback will enable participants to increase HRV indices 










 Outcomes Expected and Plan for Data Collection  
The expected outcomes from this study were directly related to the research 
hypothesis. Thus, outcomes expected were an increase in participant resting state 
HRV; a reduction in participant anxiety, and signs of change in participant 
behaviour as observed by carers.  
Quantitative data was therefore collected on measures of participant resting state 
HRV and participant self-reports of anxiety pre and post use of HRV biofeedback.  
In addition, carers were asked to rate the frequency of participant anxiety attacks 
or ‘meltdowns’ both at the beginning and then again at the end of the intervention. 
Data was also collected from direct participant reports on their usage of the device 
over the period of the intervention.   
Debriefing reports from both participants and carers and researcher notes were also 
used to provide qualitative and quantitative information on perceived benefits and 
any problems with the intervention devices and any other changes in participant 
behaviour.  
Finally, data was also collected on participants who dropped out to ensure 










 Overall Design  
The study followed revised MRC guidelines (Craig and Dieppe 2008) for the 
development and evaluation of complex interventions, namely a feasibility and 
piloting study to test methodology and procedure, to assess dropout rates, and to 
determine risks and potential benefits prior to conducting any large-scale trial.  
The study thus involved an initial evaluation (Phase 1) followed by a small-scale 
pilot (Phase 2) which involved a detailed follow up of a sample of people with ASD 
using repeated measures of the specified outcomes in a randomised control 
experimental design.  
The study involved the collection of both quantitative and qualitative data to 
maximise information on potential problems from a range of different data sources, 
which has been emphasized as particularly important in the development of an 
intervention in a new population (O’Cathain 2015). 
Due to the differences in physiology reported in many people with ASD (Lydon et 
al. 2014) and the stated hypothesis predicting a change in HRV, pre and post 
intervention assessments of physiological responses were seen as important 
measurement outcomes. The study therefore used pre-post questionnaire 
assessment but also recorded participant physiological reactions before and after 
the intervention to assess any changes in underlying physiology.   
 
The overall study design is shown in Figure 4.2 below.  









Figure 4.2 Two phase study design, comprising researcher training and evaluation of 
equipment, methods and procedure, leading to the development of a randomised pilot trial 
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 Phase1: Study development 
 Researcher Training  
The initial phase of this study began with training of the researcher, a consultant 
clinical psychologist, with experience in assessment and intervention in mental 
health and ASD. Prior to commencing the final phase of the study, the researcher 
received training to acquire skills in (i) ECG recording (ii) HRV assessment and 
analysis (iii) use of portable and (iv) multichannel biofeedback systems.  
ECG training involved attending over 20 hours’ cardiac physiology classes and 
additional one to one training in ECG placement. Clinical interpretation of ECG 
recordings was beyond the scope of researcher training and was carried out 
anonymously by a senior chartered cardiac physiologist. HRV training involved 
attending accredited courses from the Biofeedback Certification International 
Alliance. HRV analysis was carried out by the researcher with supervision 
according to guidelines from training and using recommended software (Kubios 
Premium version 3.0.0). Biofeedback training involved undertaking accredited 
courses as part of the process for gaining Biofeedback Certification International 
Alliance certification. Each of the four areas of training fed into and supported the 
others to enhance overall learning. A summary of key areas of training undertaken 
by the researcher is shown in Figure 4.3 below. 
 
Figure 4.3 Summary of researcher training in cardiac physiology; HRV analysis; use of 



















 Stakeholder Evaluations of Methods and Procedure   
A wide variety of equipment exists for both assessments of HRV and for 
biofeedback practice.  To assess these areas for use in people with ASD 
independent advice was sought from a number of different groups. The aim of this 
phase was to evaluate information; measures; equipment and to check any 
difficulties with the initial study procedure and potential risks, for people with 
ASD. In order to do this a series of usability evaluations was approved by Ulster 
University in 2014 and then conducted in 2015 (appendix I). 
The first part of this evaluation involved a series of meetings with ASD experts 
from both the voluntary sector (n=3) and NHS clinical teams (n=3), and also with 
two groups of adults with ASD (n=15).  
The study initial design, a number of questionnaire measures and written materials 
including participant information forms and consent forms were all reviewed. The 
usability of several types of intervention device and assessment equipment was also 
assessed. Potential risks of undertaking the HRV biofeedback intervention with 
people with ASD were also considered.  
The second part of this evaluation involved a trial of equipment and procedure for 
the physiological assessment, which was carried out with a small group of volunteer 
undergraduate students not diagnosed with ASD (n=9).  
The aim of this second part of the evaluation phase was to assess the timings 
required to undertake assessment and recording of physiological data, and also to 
assess any problems associated with assessment equipment, software and any risks 
with the overall physiological assessment process, prior to carrying out a trial in 
people with ASD. This evaluation involved detailed pre-post physiological 
assessment of physiology using what has been termed a ‘psychophysiological stress 
profile’ paradigm (Matto 2015) which involved the simultaneous assessment of 
skin temperature; electrodermal skin response and breathing rates as well as 
assessment of HRV using ECG.  






Physiological assessment equipment trialled was a commercially-available multi-
channel biofeedback monitoring system (Nexus-10 Mark II® Mind Media B.V. 
Herten; Netherlands), which is widely available in both Europe and the United 
States for monitoring a range of different physiological reactions (Hughes 2008).  
Initial evaluations were sought from ASD adults and experts within voluntary 
sector and the NHS which then led to the initial testing of procedure with volunteer 
students.  A summary of the different groups involved in the evaluation process is 
shown in Figure 4.4. 
 
Figure 4.4 Different groups involved in initial Phase 1 evaluations, including NHS and 






 Preliminary study design  
The initial design for the Phase 2 pilot which was evaluated, involved randomising 
participants into two different groups, with each group trying a different home use 
HRV biofeedback device over a 12-week intervention period. A delayed 
intervention ‘control’ group would first wait 12 weeks, before being randomised 
into the two device groups and then also starting the same 12-week intervention. 
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Figure 4.5 Preliminary pilot study design showing randomisation into delayed and 
immediate intervention groups and allocation of two types of biofeedback.  
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The initial stakeholder engagement enabled people with ASD and those with 
expertise in the area to offer direct reports and insights regarding the final pilot 
study. The reports obtained from the series of evaluations were categorised into 
areas relating to study design; participant information; measures; equipment; 
procedure and risks involved. A summary of information obtained in the series of 
evaluations is reported below.  
Amendments to Phase 2 preliminary design  
The initial pilot design proposed involved randomisation of participants into 
immediate and delayed intervention groups. The delayed intervention group would 
act as a waiting list control and would wait 12 weeks before being given a device. 
Both professionals and people with ASD reported that this delayed waiting time 
was too long and that this time should be reduced to ensure the delayed intervention 
group did not drop out of the study. The waiting time was therefore reduced from 
12 to 6 weeks.  
Involvement of carers for both adults and children   
The stakeholder meetings with professionals and people with ASD highlighted the 
need to involve carers of people with ASD in any evaluation of an intervention, 
irrespective of whether participants were adults or children. The importance of 
obtaining reports from carers was emphasised to obtain perspectives on any 
observed effects of the intervention, which may not have been apparent to 
participants. All adult participants were therefore also asked to nominate a trusted 
adult or carer to also complete interviews and to be present during the physiological 
assessment. Carers were asked to provide information on participant behaviour and 
demographic information. 
Amendments to participant information 
The need for more accurate and specific visual images in all areas affecting 
participant information was emphasised. Further photographs of the researcher 
were included. A video of the participant information booklet and links to video 
clips from manufacturers of the devices were included with participant information. 






At the end of the study all participants were also offered a summary of the results 
of the study using accessible formats.  
Choice of measures 
The measures selected for initial evaluation were chosen on the basis that they 
showed good reliability and validity; were simple and easy to use or were designed 
specifically for the population in question.  
Thus, measures evaluated were the State Trait Anxiety Inventory (Spielberger et 
al.1983); the Beck scales (Beck 1993; 1996) and the Child Behaviour Check List 
(Achenbach 2001), which were chosen as they have been widely used in non ASD 
populations for assessing anxiety and depression and show good reliability and 
validity. The Personal Wellbeing Index was also reviewed due to its short and easy 
to use format (Cummins and Lau 2005).  The Autism Stress Survey Schedule was 
reviewed as it was identified as one of the only existing ASD-specific 
questionnaires assessing stress and anxiety symptoms (Goodwin 2007).   
Use of simple short questionnaires or short Likert rating scales was reported by all 
of the stakeholder groups as easier for people with ASD to understand and use. 
Adults with ASD involved in the evaluations reported that completing short reports 
or tick boxes would be preferable to completing long questionnaires, interviews or 
audio recordings. The ASD Stress Survey Schedule was reported to be confusing 
and too long. The Personal Well-being Index was viewed as not specific to anxiety.  
A decision was made to use the Beck questionnaires due to use of short, easy to 
understand scales with good reliability and validity (Beck 1993; 1996). A decision 
was made not to carry out lengthy interviews and to rely on short questionnaires 
and quantitative rather than more detailed qualitative data for participant data. 
 Including a measurement of depression was also felt to be important because 
anxiety and depression are frequently associated in the same individual (Sterling 
2008) and because measurement of levels of depression would also allow for 
assessment of mental health risk in participants.  






NHS and voluntary sector experts noted that conducting pre- and post-interviews 
with carers rather than using questionnaires could be a more useful method of 
obtaining information on any observed behavioural effects of the intervention. 
 A series of short questions was therefore agreed that focussed on asking carers for 
information on current participant behaviour; main concerns and the frequency of 
anxiety attacks or ‘meltdowns’ in participants. This latter area was assessed due to 
the reports that this can be one of the most difficult areas to manage for people with 
ASD and their carers (Myles and Southwick 2005). Again, a decision was made 
not to carry out lengthy interviews and to rely on short reports from standardised 
questions.   
Changes to Equipment  
Potential biofeedback devices were selected for evaluation on the basis that the 
device or an earlier version of a device had already been used in previous research 
studies. A number of portable biofeedback devices suitable for personal use were 
chosen for review chosen for review (see appendix II and figure 4.7). Devices were 
chosen due their previous use in research studies in non ASD populations (Kennedy 
2008; Beckham 2013; Whited 2014; van der Swan 2015).  
The nonverbal nature of the intervention; the immediate visual feedback and 
portability of devices, were all seen as positive aspects of the intervention suited to 
the needs of people with ASD.  
Physiological assessment equipment  
The initial monitoring equipment evaluated was one of the main multi-channel 
professional biofeedback monitoring systems available, the Nexus-10® II (Mind 
Media B.V., Herten: NL). This system was chosen due its ability to make multi-
channel recording and assessment using multiple physiological sensors and due to 
the availability of equipment and support services within Europe.  






The protocol initially proposed involved assessment and training of participants in 
a clinic setting, using three physiological sensors, measuring HRV, EDA and 
respiration, before and after using a small personal use HRV device at home. 
Both professional experts and ASD adults who viewed the physiological 
assessment equipment expressed concerns about anxiety that could be caused by 
this assessment due to the use of multiple wires, electrodes and Velcro combined 
with using an unfamiliar clinic setting. Direct testing of the physiological 
equipment and the assessment procedure using a standardised 
‘psychophysiological stress profile’ paradigm (Matto 2015) was therefore 
undertaken with a small group of undergraduate students. This assessment 
highlighted similar concerns from non ASD students regarding the complexity of 
this type of assessment, and its potential to cause anxiety to participants.  
As result of meeting with the second ASD user group (March 2015) and a 
consultation with international experts (KH June 2015) a decision was made to not 
use the multi-channel biofeedback monitoring equipment (Nexus-10 Mark II®). 
Instead a wireless single lead ECG recorder (Actiwave Cardio; CamNtech UK) was 
chosen, which recorded less information, but had already been used successfully to 
record physiological information both with children and with people with ASD 
(Hegarty–Craver 2017).  
Changes to Procedure   
Both professional experts and people with ASD emphasised that initial assessment 
and the intervention itself would be more likely to be acceptable if it was introduced 
in the participant’s home.  
The clinic setting for physiological assessment was seen as problematic as this 
would be likely to increase participant anxiety simply due to the use of an 
unfamiliar setting. Subsequently a decision was therefore made to carry out all 
assessments and delivery of the intervention in the participant’s home.  
 






Evaluation of Risks  
Professional experts in ASD noted that whilst portable, home-use HRV 
biofeedback devices had been used successfully in other populations these devices 
had not yet been adequately trialled in people with ASD. It was therefore agreed 
that devices would only be assessed using a small sample of young adults and 
teenagers with ASD and would not be used with young children, or with those with 
a learning disability who may not fully understand the study. It was also agreed that 
regular monitoring of participant progress during the intervention would take place 
to ensure no problems arose with use of the device.  
The use of technology such as text messaging or email to enable participants to 
complete regular progress reports was seen by professional experts and adults with 
ASD as a useful method of monitoring use of the biofeedback device, which could 
highlight any potential problems and would not involve lengthy interviews with 
participants.  
Concerns were expressed regarding the need for training to be able to ensure 
participants did not become more anxious if they were unable to use the device 
quickly. The need to help participants achieve success early in training was noted, 
by both people with ASD and ASD experts.   
The potential for participants to become either distressed; aggressive or overly 
attached to the researcher was highlighted by NHS and voluntary sector experts. It 
was agreed that all participants would be offered a follow-up session if needed and 
provided with information on additional support services available.   
 
Further details of direct reports from the Phase 1 evaluations from different groups 










 Risk Evaluation and Ethical Considerations: Phase 2  
Before commencement of Phase 2, a further review of risks and ethical 
considerations involved was conducted by consulting the Clinical Director of 
Cardiac Physiology at Ulster University and the South-Eastern Health and Social 
Care Trust Infection Prevention Control team.  
There was a risk of potential anxiety or inconvenience to participants when they 
are asked to undertake physiological assessments. All potential participants were 
therefore shown all the equipment to be used and had an opportunity to try it at 
home before consent was obtained.   
The pilot study involved the assessment of a vulnerable clinical population who 
have intrinsic social and communication difficulties and may have poor insight into 
their stress levels and mental health which may compromise participant autonomy. 
Therefore, both assent and consent were sought from all participants and their 
carers. Participants were also allowed to take time to consider participation in the 
study after an initial home visit and demonstration of equipment.  
To ensure that participants felt at ease during physiological assessment all 
assessments and training were provided at home. In addition, all participants had a 
carer present during the attachment of sensors and the physiological recording. The 
presence of another adult during visits also reduced potential risk to the researcher 
carrying out home assessments alone with adult participants. A lone worker 
protocol was therefore followed. 
There was a risk that some participants could show a pattern of chronic over 
breathing or shallow breathing prior to any biofeedback training causing them to 
potentially feel dizzy when starting treatment. This was addressed by carrying out 
a breathing assessment using questionnaire (van Doorn 1983) and providing advice 
on correct breathing technique in training prior to intervention.  
 






Regular reports on progress from participants were used to monitor any potential 
mental health concerns. This information was first sent to participants via their 
phone or email address. Reports were then returned by participants via a secure 
email link to a South Eastern Health and Social Care Trust address with only the 
participants unique identifier code and no other personal information or IP 
addresses recorded. Any increased concerns raised about a participant’s mental 
health during the course of the study led to referral to the appropriate local mental 
health service and subsequent exclusion from the study.  
All participants and their carers were given a support pack outlining mental health 
support services available to them in their local area and out of hours’ services 
should they have mental health concerns at any time during the course of the study. 
To ensure there were no other unknown contraindications to participation each 
participants’ GP was informed of their involvement in the study and notified of 
participant drop-out or any follow up referrals made at the end of the study.  
Whilst participants with known cardiac conditions were excluded from the study, 
there was a possibility that monitoring could detect an unknown potential cardiac 
risk in participants. Anonymous review of all ECG recordings was therefore 
undertaken by a Senior Cardiac Physiologist. Where analysis of ECG recordings 
indicated any unusual heart rate patterns, a further 12 lead assessment was carried 
out via a participant GP.  Any participants with confirmed cardiac concerns were 
subsequently excluded from the study. 
There was a risk of cross infection. Participants with compromised skin conditions 
were therefore excluded from the study. In addition, all equipment was cleaned 
with 70 % isopropyl alcohol wipes between each use and new electrodes were used 
for each participant assessment. There was a risk of allergic reaction or bruising 
during placement of electrodes. This was addressed by careful placement of 
electrodes and cleaning the site for electrode placement with water and soap (rather 
than alcohol). 
 






There was a potential risk of participants with ASD becoming anxious or upset 
whilst watching the images used in the physiological assessment task (Louwerse et 
al.2014). The images chosen were therefore those that did not have high negative 
emotion valence score (Lang 1997). Participants were also informed that they could 
stop the study at any stage without compromising any of the treatment or services 
available to them and would be given a support pack and offered an opportunity to 
talk to the investigator or someone else outside the research team.  
All participants who reported that they wished to continue using the biofeedback 
device at the end of the study, were allowed to keep it (no other incentives were 
offered to participants or carers). A follow up biofeedback support session was 
offered to all participants up to six months after the study finished.  
Data confidentiality and storage 
To ensure confidentiality and stay within the law, all personal information recorded 
from participants and carers has been stored in accordance with the Data Protection 
Act (1998). All research data will continue to be held securely for 10 years’ post-
completion in compliance with Ulster University storage regulations and will then 
be securely destroyed.  Each participant in the pilot study was issued with a unique 
personal identification number or PIN. Consent forms, confidential patient details 
and data that link the participant names to PIN codes were kept separate from 
anonymized questionnaires and interview reports and are only accessible to the 
researcher and principal investigator. Hard copies of questionnaires, interview 
notes and printings of ECG recordings were anonymised and contained only the 
participant identification number and are stored in a locked filing cabinet in the 
researcher’s office within Ulster University. Anonymized physiological recordings 
are stored in a password protected portable hard drive in a locked filing cabinet 
within Ulster University. 
 






 Phase 2: Pilot Study  
The findings from stakeholder evaluations in Phase 1 were used to develop the 
second Phase of the study which involved a small-scale pilot trial. As outlined in 
section 4.4, the purpose of this pilot was to assess outcomes, adoption and usability 
of the intervention and to review the potential risks and benefits in this new 
population. The methods for this pilot trial of an HRV biofeedback intervention in 
people with ASD are now described below.  
 Participants  
Inclusion criteria 
Participants were aged 13-24 years; male or female and English speakers. All 
participants were required to have already received a diagnosis of ASD using 
recognised assessment tools such as the Autism Diagnostic Observation Schedule 
(Lord 2001) via one of the existing ASD assessment clinics within South Eastern 
Health and Social Care Trust. Demographic information was collected on; age; 
gender; smoking; drug and alcohol intake; physical activity; medication and 
technology use (Quintana 2016).  
Exclusion criteria 
In order to avoid confounding factors and minimise risk of harm, participants were 
excluded if they had a drug or alcohol addiction; a known cardiac condition; 
learning disability; suicidal risk; psychosis; severe eczema or psoriasis; significant 
infections such as MRSA or an immunosuppressing condition or if they were taking 
medication known to suppress HRV such as narcotics, benzodiazepines; beta 
blockers, or tricyclic antidepressants (Kemp 2010; Gevirtz 2014). Participants were 
not automatically excluded if they were attending therapy or taking other 
medications, however record was made at assessment of any treatment and of 
prescribed medication taken. Participants were withdrawn and referred on to 
appropriate support services if they or their mental health worker indicated that one 
of the exclusion criteria was met during the course of the study.  






 Recruitment  
Participants were selected from the clinical population of adolescents and young 
adults aged 13-24 years referred to services for people with ASD without a learning 
disability within South Eastern Health and Social Care Trust. 
The initial aim was to recruit 40 participants, 20 adults and 20 children. A phased 
approach to recruitment was taken, due to initial caution expressed within the 
evaluations and ethical approval guidance.  
The study ethical application had therefore specified that participants recruited for 
the first three months should be adults only. This phased approach was intended to 
assess if there were concerns about using this intervention that might highlight 
difficulties or risks which would preclude use of the intervention with children 
(who may have less insight into the nature of the study).  
Potential participants were identified by a number of methods. First, the researcher 
held meetings with the adult ASD team and the child and adolescent ASD 
intervention teams to explain the project and answer any queries or concerns. Next, 
members of the adult ASD team gave out participant information packs during 
clinic sessions to clients on their caseload who had been confirmed to meet 
inclusion criteria.  
All potential participants were given an information pack with an invitation letter; 
participant information leaflet outlining the study and copies of relevant assent or 
consent forms for participants and carers. Video links to further information about 
individual devices were included; samples of information sent to participants and 
carers is reported in appendix IV. 
Participants and carers were invited to contact the researcher directly via phone or 
email (or via their keyworker, if preferred). Once any queries were addressed the 
researcher arranged a home visit to obtain written consent from both participants 
and carers.  






 Randomisation  
In order to decrease the risk of group allocation bias, random assignment to 
treatment or control group was carried out after all pre-intervention assessments so 
the researcher was initially blind to who was allocated to each group during all 
baseline assessments.  
Allocation was made in blocks to ensure that adequate numbers of participants were 
allocated to each condition. A randomised number sequence was generated via 
computer. Randomised numbers were then placed in a drawer in sealed numbered 
opaque envelopes. Envelopes were then opened in order once each new participant 
had completed the first baseline assessment.  
Following allocation to groups, assessment using questionnaire, interview and ECG 
assessment was then carried out as outlined in figure 4.6 below. After each initial 
assessment was completed a further participant device allocation envelope was then 
opened to determine which of the two different biofeedback devices they would 
receive. Allocation to devices was also planned in two blocks of twenty to ensure 
balance between groups. 
 
 
 Pilot study design  
The Phase 2 pilot trial involved a detailed follow up of a sample of people with 
ASD, using repeated measures in a randomised experimental design. The design 
shown in figure 4.6 follows the CONSORT extension to randomised pilot and 
















Figure 4.6 CONSORT (2010) flow diagram summarising Phase 2 Pilot study design, 
starting with screening and enrolment, before allocation into intervention groups, showing 
type of assessment and final follow up.  
 
Screened prior to eligibility 
ASD; 13-24 years; IQ>70  
 
Allocation 0 weeks 
Assessment 
 Declined to participate  
Follow-Up 12 weeks 
Screened 
Randomized  
Enrolment Assessed for eligibility  






 Measures  
Measures used related to the outcomes predicted by the research hypothesis and 
were refined according to Phase 1 evaluation findings.  
Pre-Intervention baseline assessment  
Participant self-report questionnaires – Anxiety and Depression  
Participants were asked to complete short self-report questionnaires on anxiety and 
depression. Measures used included the Beck Anxiety Inventory (Beck et al.1993); 
the Beck Depression Inventory-II (Beck 1996). Younger participants were asked to 
complete the Beck Youth Inventories-II for young people aged 13-17 years (Beck 
2005). Despite not being designed specifically for people with ASD, these 
questionnaires were viewed as appropriate for this population in the evaluation, due 
to the clear and concise listing of symptoms in a literal manner, combined with a 
simple and quick rating format. 
The Beck Anxiety Inventory consists of a list of 21 common symptoms of anxiety 
in which respondents rate each symptom as occurring ‘not at all’ ‘mildly’ 
‘moderately’ or ‘severely’. Ratings are then scored from 0-3 on each symptom with 
a total possible score of 63. Scores from 8-15 are considered to indicate ‘mild 
anxiety’;16-25 ‘moderate anxiety’ and scores of 26-63 indicate ‘severe anxiety’ 
(Beck 1993, p.5). The Beck Anxiety Inventory has been widely used to assess 
anxiety since its first development and demonstrates good reliability and validity 
(Cronbach’s alpha of 0.94; concurrent validity of 0.58; Fydrich et al. 1990).  
The Beck Depression Inventory-II consists of 21 short statements which are rated 
by participants and are then scored on a four-point scale of 0-3, with a maximum 
score of 63. Scores, from 14-19 are described as ‘mild depression’; 20-28 as 
‘moderate depression’ and 29-63 as ‘severe depression’ (Beck 1996, p.11). 
Internal reliability alpha coefficients of the Beck Depression Inventory-II are higher 
than the earlier version at 0.92 and 0.93 for clinical samples and students 
respectively (Beck 1996, p.14). 






The Beck Depression Inventory-II has been widely used to assess depression and 
shows good test retest stability and discriminant validity compared to anxiety (Beck 
1996, pp.25-28). 
The Beck Youth Inventories-II consists of a series of short self-report questionnaires 
which assess depression, anxiety anger, disruptive behaviour and self-concept. This 
scale was developed to address the clinical concerns that the reading level of the 
adult versions was too difficult for some children (Beck 2005, p. vii). Individual 
subscales within this questionnaire can be used independently or combined (Beck 
2005, p.1). In order to minimize any additional burden on participants only the 
anxiety and depression subscales were used in the study. Both of these subscales 
have been found to show good internal consistency with Cronbach’s alpha 
coefficients from 0.89 to 0.95 for differing age groups (Beck 2005, p.39), good test-
retest reliability (Beck 2005, p.40), and good discriminant validity in identifying 
anxiety and depressive symptoms (Beck 2005, pp.56-57). Each subscale contains 
20 short statements which are rated in terms of their frequency, with each subscale 
taking ‘5-10 minutes to complete’ (Beck 2005, p.1). Scores are calculated by 
totalling raw scores which range from 0-3 with a total possible raw score of 60 on 
each scale. Raw scores are converted to standardised T-scores which enable 
comparisons to age and gender matched norms. T-scores are interpreted as follows; 
55-59 ‘mildly elevated’; 60-69 ‘moderately elevated’ and 70 plus ‘extremely 
elevated’ (Beck 2005, p.12). 
Participant breathing symptoms questionnaire 
Because of the potential for participants breathing too deeply or quickly when 
learning HRV biofeedback participants were also given a short questionnaire to 
check for potential symptoms of hyperventilation ‘Nijmegen Hyperventilation 
Syndrome questionnaire’ (van Doorn et al.1983). This short questionnaire contains 
16 items which are rated on a 1-5 scale. The efficacy of this measure has been 
assessed and found to show good discriminant validity distinguishing between 
those with and without hyperventilation syndrome (van Dixhoorn 1985).  






Carer Interview and Questionnaires 
Carers were asked to provide information on the participant’s behaviour in a 
standardised interview. Demographic data was also collected using a short form 
devised by the researcher asking for information regarding gender; age; education; 
physical activity; use of technology; alcohol and medications known to affect HRV. 
In addition, carers completed a standardised questionnaire to check the level of 
social and communication symptoms in participants, the ‘Social Communication 
Questionnaire’ (SCQ) by Rutter et al. (2003). The SCQ is a 40-item parent report 
questionnaire that can be used as a screening questionnaire for ASD. Carers were 
given the SCQ Autoscore Form: ‘Lifetime’ format (Western Psychological 
Services Product No. W-381B). This short questionnaire asks carers questions 
regarding the individual’s entire developmental history and is rated in a simple yes 
/ no format taking ‘less than 10 minutes to complete’ (Rutter et al. 2003, p.1). The 
SCQ has been extensively researched and demonstrates good internal consistency 
with alpha coefficient scores ranging from 0.84 to 0.93 with increasing age (Rutter 
et al. 2003, p.20) and good discriminant validity compared to other screening 
measures (Charman 2007). In this study the SCQ was used to look at levels of ASD 
symptomatology in a sample of young people already diagnosed with ASD. In line 
with this use the authors also advise that it can be used on a “group basis to compare 
levels of ASD symptomatology” (Rutter et al. 2003, p.2).  Whilst all participants 
had already undergone detailed assessment and had been given a diagnosis of ASD 
this questionnaire was used to provide background information on the level of ASD 
symptomatology in each participant.  
Carers and participants together also completed ‘The Sensory Profile for 
Adolescents and Adults’ (Brown and Dunn 2002) to check levels of sensory 
symptoms in participants. This questionnaire asks 60 questions rated on a 5-point 
Likert rating scale. Scores are obtained in four different ‘quadrants’ relating to areas 
of sensory behaviour; Low registration; Sensation seeking; Sensory sensitivity and 
Sensation avoidant. Internal consistency alpha coefficients range from 0.64 to 0.77 
for quadrant scores (Brown and Dunn 2002, p.52) 






Intervention monitoring – Participant progress reports  
During the intervention participants were also asked to complete short daily 
progress reports on their stress levels and their use of the device over the 12-week 
intervention period. The progress report was devised by the researcher based on 
initial Phase 1 evaluations and served a twofold purpose; to track participant stress 
levels, and also to monitor usage of the device over the course of the intervention. 
This brief report asked questions on sources of stress; levels of stress and usage of 
the biofeedback device.  
Post intervention Debriefing and Usability Assessment  
Participants repeated the questionnaire measures and undertook repeat ECG 
recording whilst carers completed a final interview. Participants and carers were 
then asked to complete short reports devised by the researcher to rate positive and 
negative aspects of the intervention and other problems encountered.  
An overall review of usability of the technology was also carried out with both 
participants and carers at the end of the study, using the ‘System Usability Scale’ 
developed by Brooke (1986). This questionnaire was developed to enable quick 
and standardized assessment of the usability of different technology products. The 
scale is comprised of 10 short statements which are rated on a 5-point scale. The 
total possible overall score is 100 with higher scores indicating higher levels of 
usability. Empirical evaluations of the System Usability Scale indicate good 
reliability (Bangor et al. 2008). The scale gives a single score overall score which 
can be used for, “assessing competing products that may have the same functional 
properties implemented with very different interfaces” (Bangor 2008, p.590).  
 
A summary of questionnaires and interviews used; person reporting, and time taken 
for each measure is presented in Table 4.1. Samples of all measures used are shown 
in appendix III.  
















Carer Demographic information and Carer Interview; Social Communication questionnaire (Rutter, M.D., 
2003) 
 Sensory Profile (Brown, C.E. 2002) 
45 minutes 
15 minutes 
 Participant Beck Anxiety Inventory (Beck, A.T., et al.1988); Beck Depression Inventory II (Beck, A.T. 1996) OR 
(Beck Inventory 13-17 years (Beck, J.S. 2005) Nijmegen Q’aire (Van Doorn,1983).  
10 minutes  
5 minutes 
   HRV recording using single lead ECG  15 minutes 
    
Intervention 
monitoring 
Participant  Online progress report  1 minute 
    
Post 
intervention* 
Carer Carer Interview  
Debriefing interview form  
15 minutes   
5 minutes   
 Participant  Beck Anxiety Inventory (Beck, A.T., et al.1988); Beck Depression Inventory II (Beck, A.T. 1996) OR 
(Beck Inventory 13-17 years (Beck, J.S. 2005) 
10 minutes  
 
  Debriefing interview form  
System Usability scale (Brooke, J.,1986) 
10 minutes 
5 minutes   
  HRV recording using single lead ECG  
 
15 minutes 
*A total time of 2 hours was allocated to each home visit to allow for all assessments and interviews to take place. 




 Equipment  
Intervention equipment (HRV Biofeedback devices) 
A number of different types of HRV biofeedback devices are currently available 
for home use.  
These devices typically derive HRV from an infra-red photoplethysmography 
(PPG) sensor, which measures rate of blood flow usually via either the fingertip or 
the earlobe. Peripheral blood flow can be used to assess heart rate and the thin tissue 
in both the fingertips and earlobes are commonly-used sites for measuring blood 
volume pulse (BVP), which can be used to estimate HRV (Peper 2010).  
HRV personal use devices available differ in terms of form factor; feedback 
mechanisms; data storage; training guidelines and underlying software, all of which 
may affect user experience and effectiveness. To explore these aspects, participants 
were randomly allocated to a device after their initial allocation into an intervention 
group. The study then collected data on device usability and user experience. Group 
A were provided with a home trainer biofeedback device, which used PPG ear 
sensors (Inner Balance®, HeartMath™: Quantum Intech Inc., Boulder Creek; CA). 
Within this group, participants in ownership of a tablet computer or smartphone 
were invited to use the newer version of the platform (Inner Balance). Participants 
not wishing to use their tablet or smartphone were provided with a standalone 
device (emWave2®). Both devices used the same processing algorithms but differ 
in the way in which information is presented to the user. Group B were provided 
with a second home trainer biofeedback device which used a fingertip PPG sensor 
contained within a standalone device (StressEraser®: Helicor Ltd.; New York). 
Images of the biofeedback devices which were available for participant use are 
presented in Figure 4.7. Further information on HRV biofeedback devices is 

































Figure 4.7 Portable ‘home trainer’ biofeedback devices available for use in the study. 
 
  





Physiological assessment equipment 
Following the concerns about the multi sensor assessment equipment reported in 
Phase 1 of the study (Nexus-10® Mark II), a wireless single channel ECG was used 
for all physiological assessments in Phase 2 (Actiwave® Cardio: CamNtech Ltd., 
Cambridge UK). This small single channel wireless ECG waveform recorder, 
which is worn on the chest does not require any external leads or Velcro to connect 
to the recorder. The small size and wireless recording enabled monitoring to be 
carried out in a wide range of applications in different environments.  
The single channel ECG recorder has been passed as   a “Class 2a Medical Device 
conforming to the essential safety and health requirements and provisions of EC 
Council Directives 93/42/EEC, Annex V” (Actiwave user guide 2.0.2 p.2). The 
device is supplied with a docking station and reader software to enable information 
recorded on the device to be extracted to a PC for further analysis.  
The Actiwave Cardio can be worn on either the upper or lower chest and attaches 
via spring loaded contacts to standard 4mm studs on ECG electrode pads (Actiwave 
user guide 2.0.2 p.8). Additional equipment needed included standard ECG 
electrodes with 4mm male snap connectors, and cardio prep-pads for initial skin 
exfoliation. Initial practice with this equipment involved self-testing; testing with 
an ECG simulator device and testing with a senior cardiac physiologist.  
The equipment used for physiological assessment is shown in Figure 4.8. Further 

















































Figure 4.8 Wireless ECG recorder and reader used to carry out physiological assessment.  
  





Provisional ethical approval from the Office for Research Ethics Committees 
Northern Ireland was granted in December 2015. Further clarification of participant 
information booklets and equipment was requested, and final approval was granted 
in January 2016 for commencement of Phase 2 of the study on 21st March 2016 
(see appendix I). 
Initial assessment  
All assessment and training was carried out by the researcher. All participants were 
offered assessment and training in their home environment, with their carer present.  
After further checks on exclusion criteria were made, consent and assent was 
obtained. All participants completed baseline questionnaires followed by a 
physiological assessment. Carers completed a standardised interview and 
questionnaires on social, communication and sensory difficulties.  
Intervention and Monitoring  
Following baseline assessment, participants were randomised into an immediate 
intervention group or a delayed intervention control group (see Phase 2 design page 
120).  Immediate intervention participants were then offered two separate 60-
minute training sessions of home instruction in use of their allocated biofeedback 
device (either device A or B). Delayed intervention participants waited six weeks 
before being reassessed again on baseline measures and allocated a biofeedback 
device and provided with home training in its use. Once the intervention had 
commenced, all participants were asked to complete regular reports on their stress 
levels and how frequently they used the device.  
Training  
Each training session lasted for 60 minutes once per week for two weeks. Each 
session involved initial demonstration of the allocated device by the researcher and 
a review of device functions using existing training protocols, guidelines and video 
clips (see appendix II).  
 




This demonstration was then followed by an initial practice session involving the 
participant using the device with direct coaching from the researcher. Finally, a 
practice plan was agreed outlining a time for practice that suited the participants’ 
routine with a recommendation of at least 10 minutes’ practice per day. 
Debriefing  
All participants were reassessed after they finished the intervention by repeating 
the questionnaires and physiological assessment procedure. Participants then 
completed a short debriefing interview and a usability rating of their device.  Carers 
were asked the same standardised interview questions which had been completed 
at baseline and also completed a short debriefing interview. In order to control for 
differing home environments, the procedure followed a standardised format using 
the same initial interview script; assessment procedure; training guidelines and the 
same debriefing interview script (see appendix IV). 
 ECG Recording  
Measurement of heart rate and HRV in participants was carried out with adherence 
to guidelines for assessment and reporting of HRV (Task Force; Camm et al. 1996) 
and guidelines on the reporting of HRV in psychiatric populations (Quintana 2016). 
Set up of equipment took place whilst participants completed questionnaires. All 
equipment was cleaned with 70% isopropyl alcohol prior to each assessment and 
again after each use. Set up involved programming the ECG recorder by inputting 
start time, date and recording ID – only the participant’s PIN, gender and task 
number were entered. The ECG recorder then recorded participant heart beats using 
two electrodes attached to the chest connected by a short lead. The recorder 
identified heart beats and R wave peaks within the ECG signal to enable calculation 
of R-R intervals. The sampling rate was set at 1024Hz with a 10-bit resolution, a 
recommended rate for this type of assessment (Berntson et al. 1997; Heilman – 
personal correspondence 2015). A 50Hz band pass filter was applied to remove 
contamination from background power line interference.  
Once set up was complete, the recorder was attached. To avoid contamination or 
cross infection new electrodes were used for each individual assessment.  




Checks were made to ensure the participants skin was not broken or red prior to 
each assessment. Each participants skin was first cleaned with simple soap and 
water wipes, prior to electrode placement. Skin was then lightly wiped using 
specialist exfoliation pads designed for ECG assessments to remove any existing 
dead skin, sweat and sebum. Alcohol wipes were not used as it was advised that 
these would be more likely to cause irritation (Actiwave user guide v.2.0.2). 
Electrodes were then applied to the central sternum area of the chest, according to 
manufacturer’s instructions (Actiwave user guide v.2.0.2). The first electrode was 
placed directly onto the centre of the chest and the recorder was then attached onto 
it. The second electrode was attached to the left side so that the ECG recorder was 
positioned across the chest in approximately V1 – V5 positioning – see Figure 4.9. 
Two different placement positions are recommended as suitable depending on the 
user’s anatomy and size. 
 
Figure 4.9 Illustration of two different electrode placement positions for HRV 
assessment recommended for single lead ECG Actiwave Cardio recorder (reproduced 
with permission of CamNtech Ltd). 
To minimise problems with diurnal variation participants were seen at the same 
time of day for each repeat assessment, and records were made of any medications 
taken. Participants were instructed to sit upright at a dining room or kitchen table, 
in a straight-backed chair and watch a series of images displayed on a computer 
(PowerPoint™ presentation) via a 15-inch laptop.  




Adjustments were made to the laptop height to ensure participants viewed the 
screen at a comfortable height without having to look up or down. The screen was 
positioned within one metre of each participant.  
Participants were encouraged to remain seated and upright throughout the three 
assessment stages. Two 30 second breaks were allowed between individual sections 
of the assessment task, to allow for movements and stretching. Instructions for the 
task were presented on the laptop screen. Participants were reassured that the task 
was not a test and that they should simply relax and enjoy watching the images.  
Deliberately controlling breathing rates and talking have been argued to alter HRV 
(Denver et al.2007). Therefore, instructions were given to ‘just relax’ and to 
breathe normally to ensure participants did not try to actively adjust their breathing 
rates. The software used to analyse ECG recordings produced a derived estimate of 
respiration to enable checks that breathing rates were within the normal parameters 
used for analysis of HRV (Task Force guidelines: Camm et al. 1996). Separate 
respiration gauge belts were not attached to participants following concerns about 
straps and Velcro reported in the Phase 1 evaluations.  
The assessment lasted for a total of 14 minutes. Researcher notes were also made 
of any difficulties with the assessment and responses to the task, including 
problems with electrode placement and any excess movement. At the end of the 
recording, the recorder was removed from the electrodes and placed on its docking 
station which was connected to the laptop. Participants were given hypoallergenic 
wipes to aid removal of electrodes at the end of the assessment. Records were made 
of any reactions or reports of discomfort during attachment or removal of 
electrodes.  
Finally, the ECG reader software downloaded data from the recorder to the laptop 
via the dock and USB cable. All ECG recordings were initially downloaded using 
the proprietary software (CamNtech, Cambridge: UK) and saved as European Data 
Format files. A timing manager program recorded the exact viewing times of each 
PowerPoint slide thus enabling each section of the task to be recorded accurately.  




HRV data was extracted from each of the three sections of the assessment and 
analysed using specialist software (Kubios HRV Premium version. 3.0.0). 
Artefact identification and correction was conducted on all HRV recordings by 
using a ‘smoothness priors based detrending approach’ to analysis by setting the 
software to ‘smooth priors’ and also by using the ‘automatic’ artefact correction 
(Tarvainen 2006, p.20). Using this type of standardised approach to removal of 
artefact with HRV analysis software has been advocated as an appropriate 
alternative to using a manual editing process (Nunan 2010; Huang 2018). 
 
 Psychophysiological assessment task 
The task used for assessment of HRV followed a standard ‘psychophysiological 
stress profile’ paradigm used for assessing resting state HRV developed after 
consultation with experts in this area4.  
Participant HRV was assessed for a 14-minute period at the beginning and at the 
end of the intervention. Delayed intervention participants were also assessed at the 
initial assessment six weeks prior to starting the biofeedback intervention, whilst 
immediate intervention participants were assessed after six weeks of intervention.  
Thus, three separate assessments were planned for each participant. These 
additional assessments were carried out to enable group comparisons to be made 
between immediate and delayed groups, comparing six weeks of intervention (in 
the immediate group) to six weeks of no intervention (in the delayed group). 
The task involved three separate parts, each part lasting a minimum of three 
minutes, with additional time allocated for set up and short breaks. The format for 
tasks followed a commonly used protocol of ‘baseline assessment’ task followed 
by a ‘mild stress’ task, and finally a ‘recovery’ task (Matto 2015).  
                                                 
3Personal correspondence with Richard Gevirtz, June 2015  
 




The mild stress task used was the ‘Reading the Mind in the Eyes Test’. This 
assessment has been used to assess emotion recognition has been found to be a 
more difficult task for people with ASD (Baron-Cohen 2001; Kushki et al. 2014).  
The baseline and recovery tasks involved using images from the ‘International 
Affective Picture System’ (Lang et al. 1997; 2005) a database of visual images 
which have normative ratings regarding their emotional content. Images used were 
selected rated as having positive and non-social content. 
First, participants watched a series of images of scenes from nature that did not 
contain any people or animals – this initial part of the recording enabled a baseline 
to be established and allowed participants to get used to the recording.  
Second, a series of images from the ‘Reading the Mind in the Eyes Test’ or RMET 
(Baron-Cohen 2001) was presented. This part of the assessment involved showing 
a series of images of eyes from human faces. Participants were asked to choose one 
of four words on the screen which best described the emotion shown on the face. 
Images used were all taken from the images in this test and varied in each 
assessment. 
The third and final part of the assessment task, involved presenting a further series 
of images from the ‘International Affective Picture System’ or IAPS which were 
rated as having positive and non-social content (Lang et al. 1997; 2005). Examples 
of images similar to those used in the physiological assessment task, are presented 
in Figure 4.10. The actual images used in the IAPS task are not to be reproduced 
except within the context of a research study – however the reference numbers of 
the specific images used are listed in appendix III. 




Psychophysiological assessment via 15minute ECG recording 















(ii) ‘Stress test’  
(Reading the Mind in the Eyes Test)  
 
 









Figure 4.10 Sample of images from three-part psychophysiological stress profile 
assessment involving (i) Baseline recording (ii) Stress task and (iii) Recovery task.  




 Chapter Summary  
This chapter has described the methods used to develop a two-stage piloting and 
feasibility study, the first stage of which involved a training and evaluation phase, 
which in turn led to the development of the second stage, a small-scale randomised 
pilot study.  
Chapter 5 will now report findings on the demographic information collected and 
baseline measurement data from both carers and participants. Analysis of pre and 
post data and an assessment of usability, risks and benefits of the intervention will 
be then presented in Chapter 6.  
 
 




 Participant Data 
 Overview  
This chapter will first present information on recruitment into the study. The figures 
for overall recruitment, randomisation and retention of participants are reported and 
then summarised in a CONSORT flow diagram.  
Next the overall data analysis plan is outlined, and the demographic data collected 
in the study is described.  
Key concerns reported regarding participant behaviour; triggers for anxiety and 
strategies used to manage anxiety meltdowns are then described. Finally, baseline 
ASD profile measurements of participant social, communication and sensory 
difficulties are reported. Sources of stress reported by participants are also 
described.  
Analysis of demographic information was carried out on the initial sample recruited 
into the study. This demographic information is important to assess whether the 
sample of participants in this study reflects the wider population of people with 
ASD in the UK. Further statistical analysis of data on particpiants who provided 
data on pre and post measures is reported in Chapter six.  
 
 
 Recruitment of Participants 
The initial study aim was to recruit forty participants, twenty adults and twenty 
children. The initial ethical application had specified that the initial participants 
recruited for the first three months should be adults with their carers to evaluate if 
there were any concerns about using this intervention that might highlight 
difficulties or risks which would preclude use of the intervention with children.  
 
 




Recruitment therefore began with meetings and participant information booklets 
being given out to the members of the adult ASD team in May 2016. There were 
however significant difficulties recruiting adult participants in the 18-24-year-old 
age group. No participants were recruited from May to September 2016 (see  
 
Figure 5.1). Of note was the fact that during this period repeated enquiries were 
made by members of children’s teams regarding the availability of potential 
participants within children’s teams. 
The study protocol stated that initial recruitment would begin by directly recruiting 
from clients attending clinical teams, but that if recruitment was poor it would 
proceed by contacting participants discharged from services.  
It had also been agreed with the PI and CI that no recruitment would take place 
from current waiting lists as this could be deemed as offering a potential early 
intervention service and would potentially put undue pressure on people waiting 
for services to participate in the study.  
Therefore, by September 2016 a further meeting was held with the PI and it was 
agreed that recruitment would commence of adults who had recently been 
discharged from adult or children’s services who were now 18 years or over. This 
recruitment strategy led to immediate contact from a number of young adults who 
had recently been discharged from services due to their age. After evaluating these 
adults with ASD over a three-month period, recruitment then opened to both adults 
and children with ASD for the remainder of the study. 
Participants involved in the study were either recruited directly by their keyworker, 
or by a letter sent by the ASD clinic secretary to recently discharged clients.  All 
clients were given the same information packs and cover letter.  
 
A time line showing the different phases of recruitment over the course of the study 
with time periods and numbers recruited is shown in Figure 5.1. 
 















Figure 5.1 Recruitment methods time line showing initial recruitment of adults only 
followed by recruitment of children and adults from May 2016 - April 2017. 
 
Twenty participants were recruited over the course of the study, 10 into the child 
group and 10 into the adult group. A decision was made to stop recruitment in April 
2017 after the first twenty participants were recruited. This was due to a high level 
of requests for repeat ECG checks from the cardiac physiologist and also due to the 
need to include all intervention sessions before the trial end date in July 2018.  
Twelve participants were recruited directly by their keyworker. Eight participants 
recruited were not receiving any service and were recruited by letters sent by the 
team secretary to recently discharged clients Recruitment of participants by method 
of recruitment and referral team is shown in Figures 5.2 to Figure 5.3.  
Recruitment of adults via keyworker
no recruitment of current clients from 
adult ASD team 
May - September 2016
n = 0
Recruitment of adults
recruitment of discharged clients from 
child and adult ASD teams
September - December 2016
n = 5
Recruitment of children & adults
recruitment of clients from both child
and adult ASD teams
January - April 2017
n = 15 (12 via keyworker + 3 via letter)  





Figure 5.2 Summary of two different methods to recruit participants.  
 
Of those attending clinical services the majority (10) were attending Child and 
Adolescent Mental Health Services (CAMHS). Of those attending CAMHS only 
two reported that the service was helping with their problems.  Only one adult was 
recruited from the adult ASD team and one was recruited from a client being 
discharged from the children’s disability team – see Figure 5.3.    
 
 
Figure 5.3 Summary of different types of clinical service involved with participants at time 
of recruitment.  
 
discharged clients 
















Type of Clinical Service




 Randomisation of Participants  
Randomisation into groups was planned in two blocks of 20 to ensure not all 
participants were allocated to one group initially. No concerns were reported by 
participants about randomisation into immediate or delayed intervention groups.  
Randomised allocation of devices was also planned in two blocks of 20. However, 
two participants who were initially allocated to the StressEraser group were unable 
to use this device due to concerns using the finger sensor. Both participants wanted 
to continue with the trial and a decision was made to allow participation by 
allocating them to the second group. Thus, despite an initial attempt to randomly 
assign participants to different devices this randomisation procedure was 
discontinued.  
 Retention and Drop-out of Participants from Pilot  
The study aimed to follow guidelines for reporting of pilot and feasibility studies 
with data collected on numbers contacted and recruited with reasons for drop-out 
recorded (Eldridge, 2016). Records were kept of the numbers of potential 
participants contacted and the method of recruitment contact. Overall, 59 
participants were contacted for screening either by letter or directly by their 
keyworker. Of this sample 20 participants eventually volunteered for the study. 
Thus 34% of the initial screening sample volunteered to take part in the study. Four 
participants were excluded after randomisation into groups, three due to cardiac 
concerns highlighted by ECG, and one due to a significant change in mental health 
highlighted at the 6 weeks follow up. Three participants of the initial twenty 
recruited dropped out after 6 or 8 weeks but before the full 12 weeks of intervention 
had been completed. Reasons reported for drop out were ‘not wanting to continue’ 
(n=2) and ‘family stress’ (n=1). Of the three who dropped out, two consented to all 
data being used in the study, however one declined further questionnaire and 
physiological assessment, leaving 15 participants whose full data was included in 
the final analysis.  A summary of initial screening and enrolment; randomisation 
into groups; participant retention over the course of the study, follow-up and 
analysis of data is shown in Figure 5.4. 
 
































Figure 5.4 CONSORT 2010 flow diagram summarising numbers for screening and 
enrolment; allocation into groups; follow-up and final analysis. 
 




 Data analysis plan  
An intention to treat approach was adopted in analysing results (Ferguson 2002). 
Thus, participants who dropped out early or had continuing difficulties using their 
biofeedback device after randomisation had their data included for further analysis 
provided, they had consented for this data to be collected. This type of approach 
has been described under the adage of “as randomised so analysed” (LaValley 
2003, p12) and argued to provide more real-world information on the outcomes of 
a clinical intervention following CONSORT guidelines and may reduce the level 
of type 1 errors in analysis (Newell 1992; Gupta 2011). 
Qualitative data was obtained from demographic information questions; 
standardised interview and from short debriefing reports. Due to the limited nature 
of qualitative data collected it was felt that more detailed thematic analysis such as 
Braun and Clarke’s framework (2006) was not appropriate. Qualitative data was 
therefore analysed using frequency counts and manifest content analysis of reports 
given (Graneheim 2004; 2017). Quantitative data from questionnaires and 
physiological recordings was analysed using statistical tests assessing paired 
samples of data from the same subjects. Correlational analyses were also carried 
out to review associations between baseline measurements and HRV data.  
A number of participants were excluded post randomisation due to meeting 
exclusion criteria and their pre-post data was therefore not included in the 
quantitative data analysis. Several participants dropped out prior to 12 weeks and 
this data was included, provided consent had been obtained. A summary of how 
data was analysed from the participants who did not complete the full 12 weeks of 
intervention is shown both in the CONSORT diagram and in Figure 5.5 below. 
Table 5.1 Number of participants who were excluded or lost to drop out during the 
course of the intervention and subsequent analysis of outcome data.  




Excluded after randomisation  4 yes no 
Dropped out before 12 weeks  2 yes yes 
Dropped out before 12 weeks  1 no no 




 Demographic information 
Demographic information collected from the 20 participants who were initially 
recruited into the Phase 2 study is now described below. 
 Gender and Age  
Overall 20 people were recruited into the study, 16 males and 4 females. The age 
range of participants recruited was 13-22 years, with a mean of 16.3 years – see 
Table 5.2 Participant gender.   
Table 5.2 Participant gender.  
Gender Frequency (Percentage)  
Male 16 (80) 
Female 4 (20) 
 
This gender distribution mirrors that found in a Northern Ireland school census 
which indicated a gender ratio of 4:1 males to females diagnosed with ASD (Waugh 
2017).  
 Age of ASD Diagnosis  
Only one participant had received a diagnosis of ASD before five years of age. The 
majority of participants (13 out of 20), were diagnosed during their primary school 
years between 5-11 years of age. Six participants were not diagnosed with ASD 
until 12-17 years of age – see Table 5.3.  
 
Table 5.3 Age when participant was diagnosed with ASD. 
Age  Frequency (Percentage) 
Under 5 years 1 (5) 
5-11 years 13 (65) 
12-17 years 6 (30) 
These findings reflect research indicating that most children with ASD are still 
being diagnosed with ASD in primary school years (Daniels and Mandell 2013).  




 Education  
The majority of participants were in school or college.  However, 4 out of 20 of 
participants were at home and were not receiving any form of education or 
employment.  Participants reported anxiety regarding the educational environment 
as the reason they were not attending either school or college – see Table 5.4.  
Table 5.4 Type of education or employment reported by participants.  
Education  Frequency (Percentage) 
Not in education or employment  4 (20) 
Secondary / grammar school 13 (65) 
College / university 3 (15) 
An  NAS review has indicated that only 16% of adults with ASD are in full time 
employment or education (Madders, 2010). The sample in this pilot highlights non-
attendance in teenage years at school, which may be a precursor to this problem. 
 Physical Activity  
Eight participants reported that they undertook less than 1 hour of physical activity 
per week. A further six reported that they completed 1-2 hours per week. The two 
participants reporting more than 3 hours of physical activity per week were the 
youngest participants in the study – see Table 5.5. 
Table 5.5 Levels of physical activity reported by participants.  
Physical Activity Frequency  (Percentage)  
Less than 1 hour per week 8 (40) 
1-2 hours per week 6 (30) 
2-3 hours per week 4 (20) 
3+ hours per week 2 (10) 
Department of health guidelines recommend  2 ½ hours per week of moderate 
physical activity for adults and 1 hour per day for children (DiSantis et al., 2013).  
The levels of activity reported by participants were below this level, with 14 out of 
20 participants not completing recommended levels for adults (DiSantis et al., 
2013).  




 Sleep Problems  
Fifteen out of 20 participants also reported some form of sleep problems, a 
difficulty also highlighted in a recent ASD stress survey (Research Autism 2016). 
Table 5.6 Level of sleep problems reported by participants.  
Sleep Frequency (Percentage)  
No problem sleeping 5 (25) 
Sometimes problems sleeping 5 (25) 
Frequent problems sleeping 10 (50) 
 
 Prescribed Medication  
Participants were also asked if they took any prescribed medication. Ten out of 20 
reported that they did not take any prescribed medication. Of the ten participants 
taking medication, 6 were taking antidepressants, followed by 4 out of 10 who were 
taking some form of stimulant medication. Despite a majority of participants 
reporting some degree of sleep disturbance (Table 5.6), only three were reported to 
be taking Melatonin, a drug frequently prescribed for sleep problems in people with 
ASD. A further finding was that three participants also reported needing to carry 
auto injectors with adrenalin (EpiPen®) – see Table 5.7.  
Table 5.7 Types of prescribed medication taken by participants.  
 Frequency  (Percentage)*  
Not taking medication 10 (50) 
Antidepressant  6 (30) 
Stimulant medication  4 (20) 
EpiPen 3 (15) 
Melatonin 3 (15) 








 Additional Diagnoses 
Participants also reported having a number of additional comorbid diagnoses, 
which were related to some of the prescribed medication listed in Table 5.7 Types 
of prescribed medication taken by participants above. Thus, four participants had 
an additional diagnosis of Attention Deficit Hyperactivity Disorder, and three 
participants had a form of severe anaphylaxis. 
 Use of Technology 
Participants were asked questions regarding their use of technology. Results are 
reported in Table 5.8 - Table 5.12. 
Participants were first asked about their access to different types of technology. Six 
out of ten child participants and eight out of ten adult participants reported that they 
had access to tablet computer iOS devices.   
Table 5.8 Participant access to iOS or android technology device. 
Participant Group   Frequency (Percentage) 
Children 13-17 years iOS device 6  (60)  
(n=10) no iOS device available 4 (40) 
Adults 18-24 years  iOS device 8  (80)  
(n= 10) no iOS device available 2 (20) 
 
The majority of participants had access to a smartphone. One child participant was 
not allowed access to their phone due to inappropriate use. Two adult participants 
also reported that they also had limits set on their phone.  
Table 5.9 Participant access to smartphone for personal use.  
Participant Group  Use of Smart phone Frequency (Percentage) 
Children 13-17 years not allowed phone 1 (10) 
(n=10) limits on phone use 9 (90) 
 unlimited phone use 0  
Adults 18-24 years limits on phone use 2 (20) 
(n=10) unlimited phone use 8 (80) 
 




Participants were also asked about the amount of time they spent using technology 
or ‘screen time’. Three out of ten children and 4 out of ten adults reported that they 
spent more than five hours per day using some form of device such as computer, 
tablet or gaming console.  
 
Table 5.10 Participant reports on time spent using technology per day.  
Participant Group Time on screens  Frequency (Percentage) 
Children 13-17 years 3-5 hours per day 7 (70) 
(n=10) 5+ hours per day 3 (30) 
    
Adults 18-24 years 3-5 hours per day 6 (60) 
(n=10) 5+ hours per day 4 (40) 
 
Nine out of the ten child participants reported that gaming was their favourite type 
of technology. This was also the favourite activity reported by six out of the ten 
participants in the adult group. 
 
Table 5.11 Participant reports on favourite type of technology.  
Participant Group  Favourite technology  Frequency (Percentage) 
Children 13-17 years gaming 9 (90) 
(n=10) TV/ YouTube / video 1 (10) 
    
Adults 18-24 years gaming 6 (60) 
(n=10) TV/ YouTube/ video 3 (30) 










Participants were then asked whether they had experienced any problems using 
technology. Seven out of ten child participants reported that they had experienced 
some form of problem with using technology, with use of social media reported as 
the most common source of problems.  
A similar pattern was seen in the adult group with six out of ten adults reporting 
that they had experienced a problem with some form of technology. Social media 
was reported as the most common source of problems, with both adults and children 
reporting difficulties with the use of social media.  
Table 5.12 Participant reports on problems with technology. 
Participant group  Frequency (Percentage) 
Children 13-17 years problems with gaming 1 (10) 
(n=10) problems with TV/ YouTube  1 (10) 
 problems with social media 4 (40) 
 problems with phone 1 (10) 
 no technology problems  3 (30) 
    
Adults 18-24 years problems with gaming 1 (10) 
(n=10) problems with TV/ YouTube 0 (0) 
 problems with social media 4 (40) 
 problems with phone 1 (10) 
 no technology concerns 4 (40) 
 
 Smoking, Illegal Drug use and use of Alcohol  
Participants were also asked whether they smoked or used e-cigarettes, took illegal 
drugs or drank alcohol. None of the participants reported smoking or taking drugs.  
Two participants in the adult group reported drinking alcohol at a level which was 
within the UK Department of Health (DOH) recommended limit of 14 units per 









 Demographic information on drop-out and exclusions  
A review of those particpiants who dropped out or were excluded from the study 
was carried out to assess whether any specific group was more likely to drop out or 
meet exclusion criteria.  
The gender of participants who dropped out was two males to one female. Ages 
ranged from 13 – 18 years. Reasons for drop-out were also recorded and were 
reported as ‘family stress’ (1 participant) and ‘device useful but don’t want to 
continue with further assessment’ (1 participant) and ‘device not useful’ (1 
participant). A summary is reported in table 5.13. 
 
Table 5.13 Participant age gender and reported reasons for drop-out. 
Gender Age Reported reason for dropout from study  
Male 13 Family stress 
Male 18 Device not useful  
Female 18 Device useful but don’t want further assessments  
 
 
A number of participants who were initally screened and recruited then later met 
exclusion criteria post randomisation. A summary of the age and gender of 
participants who were excluded from the study with the reason for exclusion is 
reported in table 5.14. 
Table 5.14 Participant age gender and reasons for exclusion from study.   
Gender Age Reason for exclusion from study  
Male 13 Cardiac problem  
Male 18 Cardiac problem  
Male  15 Mental health problem  
  




 Carer Interview  
Carers were asked standardised questions regarding their main concerns; whether 
there were any triggers for participant anxiety attacks or ‘meltdowns’ and any 
strategies used to manage anxiety.  
 Triggers for anxiety  
The main concern reported by all families was anxiety. The three main triggers for 
anxiety attacks reported by 14 out of 20 families were sensory issues such as ‘loud 
noise’, ‘bright lights’, ‘touch’, ‘change in routine’ and increases in workload or 
exams. Busy or crowded places e.g. ‘shopping centres’ or ‘school’ were also 
mentioned as frequent triggers for anxiety reported by 11 out of 20 families. 
Problems with friends’, and ‘’being away’ or ‘separated’ from parent or carer were 
also common triggers for anxiety. All families reported more than one trigger for 
anxiety. Triggers for anxiety reported are summarised in Figure 5.5. 
 
Figure 5.5 Frequency of different triggers for meltdowns reported by carers (n=20) at 











































 Strategies used to manage anxiety  
Carers and participants were also asked what strategies they used to manage 
participant anxiety. Carers and participants reported using a number of different 
strategies to help them cope when feeling anxious.  
The most frequently reported strategy described by 17 out of 20 families involved 
reducing sensory information e.g. ‘reduce noise or ‘turn down lights. The second 
most common strategy reported by 8 out of 20 families was engaging in favourite 
activities to ease feelings of anxiety. Further strategies reported were physical 
activity; spending time with parent or carer; time with pet; music; and escaping 
from the source of stress, by fighting or running away. Carers and participants all 
reported more than one strategy for managing anxiety. A summary of strategies 
reported is shown in Figure 5.6.  
 
Figure 5.6 Frequency of different strategies reported by carers and participants to help 











































Strategies  used to manage Anxiety 




 Carer Questionnaire Reports  
Following initial interview, carers were then asked to complete two questionnaires, 
the Social Communication Questionnaire (Rutter et al. 2003), and the Sensory 
Profile (Brown and Dunn 2009), to provide information on the level of social, 
communication and sensory difficulties in each participant. Further information on 
both questionnaires used is reported in chapter 4 and samples copies of reports are 
shown in appendix III. 
All participants had previously been diagnosed with ASD. However as ethical 
permission had not been sought to access medical records, detailed diagnostic data 
was not accessible to the researcher. These two questionnaires were therefore used 
to give a profile for each participant on some of the key difficulties seen in ASD.  
 
 Social Communication Questionnaire  
Findings from the Social Communication Questionnaire (SCQ: Rutter et al. 2003) 
are reported in Table 5.15. 
Table 5.15 Carer reports of participant social and communication difficulties (n=20).  
SCQ (Lifetime) Symptoms Score 
Mean (standard deviation) 20.80 (6.45) 
Median  19 
Range (minimum – maximum)  21(12-33) 
 
The mean score for the SCQ in the participant sample was 20 with a maximum 
score of 33. The recommended cut-off level on the SCQ for possible diagnosis of 
ASD is 15. The minimum score reported in the sample was 12 however, as all 
participants had previously been referred for a more detailed assessment and had 
been diagnosed with ASD within a specialist assessment clinic, this participant was 
included in the study.   
 




 Sensory Profile Questionnaire  
This 60-item questionnaire assessed sensory related difficulties which were then 
summarised into four types of sensory functioning, ‘Low registration’; ‘Sensation 
seeking’; ‘Sensory sensitivity’ and ‘Sensation avoidant’, based on the Model of 
Sensory processing (Dunn 1997a). Group mean raw scores and standard deviations 
for child and adult participants, and classification categories with regard to the 
normative distribution of scores on the four domains are reported in Table 5.16.  
Table 5.16 Sensory profile scores reported by children and adults with ASD over four 
different categories of sensory difficulty (n=16.) * 
Sensory Category Children (13-17 years) Adults (18-24 years) 
   
1.Low registration   
Mean (standard deviation) 32.16 (5.23)  44.9 (6.31) 
Classification  Similar to most people  Much more than most people  
   
2.Sensation seeking    
Mean (standard deviation) 44.66 (11.57) 40.6(10.33) 
Classification  Similar to most people  More than most people  
   
3.Sensory sensitivity    
Mean (standard deviation) 32.83(8.56) 46.1(11.44) 
Classification  Similar to most people  More than most people  
   
4.Sensation avoiding    
Mean (standard deviation) 38.66(13.51) 50.0(9.45) 
Classification  Similar to most people  Much more than most people  
   
*Four families did not complete the Sensory Profile questionnaire. 
 
Children showed scores which were categorised as ‘similar to most people’ on all 
four domains of sensory behaviour. In contrast, adults showed scores which were 
either ‘more than most people’ (between the 84th and 98th percentile) or ‘much 
more than most people’ (greater than the 98th percentile) compared to the original 
study population (Brown and Dunn 2003, p.32).  
 




 Participant Baseline measurements   
Participants provided questionnaire reports on their levels of anxiety and 
depression prior to the start of the intervention. The questionnaires used provided 
raw scores and clinical category ratings for both anxiety and depression compared 
to normative ranges (see Chapter 4).  
 Anxiety  
Clinical category ratings for anxiety reported by both children and adults are shown 
in Figure 5.7 - Figure 5.8.  
 
Figure 5.7 Anxiety reported by children aged 13-17 years (n=10) at initial assessment, 
using the Beck Youth Inventory–II, showing mild moderate and severe levels of anxiety. 
 
 
Figure 5.8 Anxiety reported by adults aged 18-24 years (n=10) at initial assessment, using 

















 Depression  
Clinical category ratings for depression reported by both children and adults are 
shown in Figure 5.9 and Figure 5.10.  
 
 
Figure 5.9 Depression reported by children aged 13-17 years (n=10) at initial assessment, 
using the Beck Youth Inventory–II showing mild, moderate and severe levels of depression. 
 
 
Figure 5.10 Depression reported by adults aged 18-24 years (n=10) at initial assessment, 






















 ECG measurements  
Initial ECG were carried out on all 20 participants. Four sets of data were excluded 
from analysis due to participants meeting exclusion criteria. One further participant 
dropped out and declined to provided further information.  
Initial measurements from the first four minutes of ECG recording are presented in 
Table 5.17. Results are shown in comparison to some of the existing reference 
values for heart rate and HRV. Some reference values are available for children 
(e.g. Seppala 2014) however these values are for a younger sample of 6-8-year olds 
and do not provide similar measurement scores. The current sample of young 
people aged 13-24 is therefore compared to the large-scale norms produced by 
Nunan (2010) and to an age stratified sample from a single cohort of adults 
produced by (Dantas et al. 2018).  
Table 5.17 Initial measurements from the first four minutes of ECG recording that 
include Heart Rate, HRV time domain and HRV frequency domain calculations. 
Heart Rate and  
Heart Rate Variability  
(Baseline measurements from 
short term ECG recording)  
ASD sample 
13-24 years 
n = 15  
(Nunan 2010) 
reference values 
n = 21,438  
(Dantas 2018) 
 35-44 years  
n = 982  
 
Mean (SD) Mean (SD) Mean (SD) 
Heart Rate (bpm) 75.55 (9.92) n/a 66 (9) 
HRV time domain  
measurements 
Mean (SD) Mean (SD) Mean (SD) 
SDNN (ms) 50.86 (20.7) 50 (16) 45.7 (17) 
RMSSD (ms) 49.28 (31.5) 42 (15) 34.9 (17.5) 
    
HRV frequency domain 
measurements  
Mean (SD) Mean (SD) Mean (SD) 
HF (n. u.) 40.49 (18.4) 40 (10) 45.1 (19.2) 
HF (ms2) 1254.13(2077.2) 657 (777) 575.5 (667.6) 
 
Results from the current ASD sample show values within one standard deviation 
of the mean, although mean heart rate and actual values of HF-HRV for the ASD 
sample are above one standard deviation of the mean for adults aged 35-44 years.  
This difference is likely to reflect the relatively younger age range of the current 
ASD sample (13-24 years) compared to the norms for adults (35-44 years).





 Overview  
Information has already been presented on the development of design, methods and 
procedures for the Phase 2 pilot trial (Chapter 4). The demographic characteristics 
of the participant sample have been described with figures on recruitment, numbers 
excluded and levels of dropout (Chapter 5).  
This chapter now focuses on the main study findings. This information is at the 
core of any clinical study where new data is presented as a basis for future research.  
 
The research objectives for the overall study are restated below. 
Research study objectives   
1. To provide a home based HRV biofeedback intervention to people with 
autistic spectrum disorder.  
2. To assess participant anxiety, depression and physiological arousal before 
and after using a biofeedback device.  
3. To assess the adoption of HRV biofeedback technology.  
4. To evaluate the risks and benefits of this technology.   
5. To develop recommendations on the use of HRV biofeedback for people with 
autistic spectrum disorder.  
 
Research objective 1 has been addressed through the development of study 
methods, presented in Chapter 4. The results of the Phase 2 pilot now presented 








This chapter now reports findings from the Phase 2 pilot following guidelines for 
randomised controlled pilot trials (Eldridge et al. 2016). Results are presented in 
separate sections each linked to a specific research objective, as outlined below. 
 
Research objective 2: ‘Pre-post data collection’  
Information is presented on pre-post data from a number of measures including 
participant anxiety and depression from questionnaires, carer reports on 
frequency of meltdowns from interview, and physiological measurement of 
participants from ECG, before and after the intervention.  
Research objective 3: ‘Adoption of Technology’  
Information is presented on the level of training given; participant use of device 
during the intervention, and participant ratings of device usability. This 
information was collected from researcher records and from online surveys 
collected from participants during the intervention and from ratings and 
interviews carried out at the final debriefing session. 
Research objective 4: ‘Assessment of Risks and Benefits’ 
Information is presented on risks and potential harms encountered, reported 
benefits and any unintended consequences of the intervention. This information 
was provided via debriefing interviews with carers and participants, and by 
reviewing procedural difficulties recorded by the researcher during the study.  
 
 
Results are then summarised and associations between the ASD profile 











 Research Objective 2 ‘Pre-post Data Collection’  
 Summary  
This section provides the results of group data collected to assess pre-and-post 
changes over the course of the intervention.  
Information is presented on three main areas of assessment, each of which used 
different methods of measurement. These approaches included (i) carer reports on 
participant frequency of anxiety attacks or ‘meltdowns’ via pre-post interviews (ii), 
participant self-reports via pre-post questionnaires and (iii) direct physiological 
assessment of participants via pre-post recording of Heart Rate and HRV.  
Carers reported frequency rate of participant anxiety meltdowns before and after 
the intervention. Young people with ASD were asked to give direct self-reports via 
questionnaires on their levels of anxiety and depression using standardised 
questionnaires (Beck et al.1988; 1996; 2005) before and after using their 
biofeedback device over the course of the intervention. Due to the different scales 
used for adults and children results of anxiety and depression questionnaires were 
analysed separately.  
Group data on the above measures was collated and analysed using a standard 
statistical analysis software package (IBM SPSS, version 24). Analyses were 
carried out to review group changes over time. In addition, more detailed analyses 
of physiological data acquired from single lead ECG were carried out using 
specialised software (Kubios HRV Premium, version 3.0.0). 
 
The key areas of information in this section with results on each area are now 
presented as outlined below.  
• CARER REPORTS – assessed via pre-post interview questions   
• PARTICIPANT SELF-REPORTS – assessed via pre-post questionnaire  
 
• PARTICIPANT PHYSIOLOGY – assessed via pre-post ECG recording 




 Carer Reports of Frequency of ‘Meltdowns’  
Carers were asked to assess the frequency of anxiety attacks often referred to as 
meltdowns in the initial interview, and then again at a debriefing interview at the 
end of the study.  
Reports from carers on the frequency of anxiety attacks / meltdowns were collated 
and then rank ordered into ordinal data with scores ranging from 1 (once per month) 
to 5 (daily). Four participants were excluded; one did not provide any follow-up 
data for analysis therefore data was included from fifteen sets of carer ratings for 
analysis. Carer pre-and-post reports on frequency of anxiety attacks are shown in 
order of recruitment in  Figure 6.1. 
 
 
Figure 6.1 Carer ratings of frequency of participant meltdowns at initial interview (pre-































Individual carer ratings pre and post intervention (n=15)  
Pre intervention Post intervention




Statistical analysis – Frequency of Meltdowns   
Statistical analysis was carried out to assess change in reports over time. 
Calculations made were based on within subject comparisons.  The non-parametric 
Wilcoxon Signed Ranks test was performed due to the use of ordinal data. Results 
are shown in Table 6.1, below. 
Table 6.1 Results of Wilcoxon Signed Ranks Test, based on within subject comparisons of 
carer reports on the frequency of participant meltdowns, at initial interview and at 
debriefing. 
Carer reports on frequency of  
Meltdowns (n=15) 
Percentiles Z p value  
(2 tailed) 
 25th 50th  75th -3.33* 0.001 
Initial interview 3.00 5.00 5.00   
      
Debriefing 1.00 1.00 2.00   
      
*based on positive ranks  
 
Carers reported a significant difference in the frequency of meltdowns between the 
initial interview and the final debriefing interview, Z = -3.33; p = 0.001. Effect size 
calculations carried out indicated a large effect size, r = 0.65. All scores except one 
(tied no change) reported lower anxiety scores at time two.  
  
                                                 
5 Effect size calculations for the Wilcoxon Signed Ranks test were based on paired 
difference values, using the formula,  𝑍 ÷ √𝑛(𝑐𝑎𝑠𝑒𝑠 𝑥 2) where n = the number of 
observations over the two different time points rather than the number of cases.   
Thus, the calculation using this formula was therefore   3.33 ÷ √(15𝑥2) using criteria of 
0.1 = small, 0.3 = medium and 0.5 = large effect for non-parametric tests (Cohen 1988).  
 




 Sources of stress during intervention 
Participants were also asked to report directly on sources of stress for them during 
the intervention period, by completing online reports which were sent daily to their 
smartphone or PC. The online report asked for responses via smartphone to indicate 
one of five different sources of stress. Overall 417 reports were sent by 18 out of 
the 20 participants over the course of the intervention period.  
The most frequent source of stress reported was a ‘school problem’, with 34% of 
the sample reporting this as their main source of stress. ‘Home’ or ‘relationship’ 
problems were also reported as sources of stress for participants in 18% of 
responses. A similar number of responses, from 18% of participant responses 
simply indicated ‘I don’t know why I am stressed’.  
Results of data collected on sources of stress during the intervention are 
summarised in Figure 6.2.  
 
 
Figure 6.2 Daily sources of stress reported by participants during the intervention (n=18). 
 
 








don’t know why I 
am stressed 18%




 Participant Questionnaire Reports – Anxiety  
Levels of anxiety reported by children and adults pre-and-post intervention are 
shown in order of recruitment in Figure 6.3 and Figure 6.4. Participant pre-and-post 




Figure 6.3 Individual ratings of anxiety from children aged 13-17 years (n=7), using the 
Beck Youth Inventory Anxiety Scale, pre and post intervention.  
 
 
Figure 6.4 Individual ratings of anxiety from adults aged 18-24 years (n=8), using the 
Beck Anxiety Inventory, pre and post intervention.  
1 2 3 4 5 6 7
Pre 25 17 19 21 33 16 40



























   
   
Individual  participant ratings pre and post intervention (n=7) 
Pre Post
1 2 3 4 5 6 7 8
Pre 33 10 20 30 36 22 12 6




























Individual participant ratings pre and post intervention (n=8) 
Pre Post




Statistical analysis – Anxiety measures  
Overall, 15 participants were analysed; 8 adults and 7 children. Statistical analyses 
were carried out to assess mean group differences in reports of anxiety from both 
children and adults at the beginning and at the end of the intervention. Anxiety 
score at baseline did not deviate from normality as indicated by both the 
Kolmogorov–Smirnov and Shapiro Wilks tests (p > 0.05). There were no extreme 
outlier’s in observed data. One child participant showed an increase in anxiety in 
the post intervention score. Parametric statistical tests were conducted using Paired 
Sample T-tests for repeated measures. Results are summarised in Table 6.2. 
 
Table 6.2 Paired Samples T-tests for self-reported anxiety via questionnaire from child and 
adult participants pre and post intervention.  
Age group  Pre – 
intervention 
Post – 









      
Mean (SD)  24.43 (8.98) 14.43 (10.97) 10.00 (10.39) 0.472 2.55 0.04 
       
Adults  
 (n=8) 
      
Mean (SD) 21.12 (11.2) 15.0 (11.49) 6.125 (4.39) 0.925 3.95 0.006 
       
 
Children showed a significant difference in reports of anxiety pre and post 
intervention: t (6) = 2.55; p = 0.04; d = 0.96. Adults also showed a significant 
difference in mean scores pre and post intervention: t (7) = 3.95; p = 0.006; d = 
1.39. Effect size calculations carried out indicated a large effect size6. 
                                                 






    
which takes into account the correlation between the two means for within subject’s 
comparisons (Morris and DeShon 2008, p.111) and using Cohen’s d standard deviation 
units of small 0.2; medium 0.5 and large 0.8 effect sizes (Cohen 1988, p.22). 
 




 Participant Questionnaire Reports – Depression  
Levels of depression reported by children and adults pre-and-post intervention are 
shown in Figure 6.5 and Figure 6.6. Participant pre-and-post intervention scores are 
reported separately for children and adults due to the use of different measures. 
 
Figure 6.5 Individual ratings of depression from children aged 13-17years (n=7) using the 
Beck Youth Inventory Depression Scale, pre and post intervention.  
 
 
Figure 6.6 Individual ratings of depression from adults aged 18-24 years (n=7) using the 
Beck Depression Scale, pre and post intervention.  
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Individual participant ratings pre and post intervention (n=7) 
Pre Post
1 2 3 4 5 6 7
Pre 14 22 36 29 12 0 6






























Inidividual participant ratings pre and post intervention (n=7) 
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Statistical analysis – Depression measures  
Statistical analyses were carried out on pre-and-post intervention reports of levels 
of depression for both adults and children using Paired Samples T-tests for single 
sample repeated measures. Both the Kolmogorov–Smirnov and Shapiro Wilks tests 
were performed which reported no significant deviations from normality (p > 0.05). 
Four participants were excluded, and one further participant dropped out and 
provided no further data for analysis. One adult participant did not complete 
depression questionnaires at the start of the intervention therefore only matched 
pairs from seven adults and seven child participants were analysed. Results are 
reported in Table 6.3. 
Table 6.3 Paired Samples T-tests for self-reported depression via questionnaire from child 
and adult participants pre and post intervention.  
Age group  Pre- 
intervention  
Post- 








 (n=7)  
  
 
   
 
 
Mean (SD) 20.43 14.04) 13.71(14.16) 6.71(9.53) 0.0772 1.86 0.11 
       
Adults  
 (n=7) 
      
Mean (SD) 17.0 (12.74) 13.86 (10.91) 3.14(4.85) 0.928 1.72 0.14 
       
 
 
Neither children or adults showed a significant difference in depression over the 
12-week intervention period. There was variability in scores at both time points 
suggesting more heterogeneity in depression scores.  
Between group comparisons were planned to compare six weeks of intervention in 
the immediate group to six weeks of no intervention in the delayed group. The small 
sample size and dropouts from the study prevented these comparisons from being 
carried out. 
 




 Participant Pre-Post ECG Assessment   
Participants each carried out a short 15-minute single lead ECG assessment to 
record resting state heart rate and HRV before and after the intervention.  
Participant ECG recordings followed a set structure designed by the researcher, as 
outlined in Chapter 4. Each recording contained three sections. The first section 
allowed a baseline recording of heart rate and HRV to be acquired. The second 
section involved the Reading the Mind in the Eyes Test (Baron- Cohen 2001). This 
served as a ‘stress’ test for the study as it has been found to be more challenging 
for people with ASD compared to neurotypical peers (Baron-Cohen 2008).  The 
third section involved watching images viewed as neutral or relaxing from the 
International Affective Picture System (Lang 1997;2005). This section served as a 
‘recovery’ task to assess heart rate and HRV following the stress task.  
Four participants met exclusion criteria post randomisation and therefore their data 
was not included for further analysis. One participant dropped out and declined the 
ECG recording and therefore data was unavailable for analysis. Thus, group HRV 
data is presented on the remaining 15 paired sets of participant data. 
Baseline measurements from the initial part of the recording are reported in Chapter 
5. HRV measurements are expressed in multiple formats that include time domain, 
frequency domain, and non-linear interpretations that provide multiple 
measurements in each domain. Graphical results and statistical tests are reported 
on heart rate and on the root mean square of successive differences (RMSSD); a 
commonly reported time domain measurement for short term recordings, which 
refers to the successive differences between adjacent normal R to R or interbeat 
intervals (Camm et al.1996; Shaffer and Ginsberg 2017). Heart rate values are 
reported in beats per minute (BPM). RMSSD is reported in measured in 
milliseconds (ms).  
Results from participant pre and post ECG recordings are reported for both the 
‘stress test’ and the ‘recovery’ task below.  
 




Psychophysiological assessment – Stress Task   
Values for heart rate and time domain HRV (RMSSD) from 15 participants during 
the Reading the Mind in the Eyes Test are shown in Figure 6.7 and Figure 6.8.  
 
Figure 6.7 Participant Heart Rate (n=15) during ‘stress test’ using Reading the Mind in 
the Eyes Test (Baron-Cohen 2001), pre and post intervention.  
 
 
Figure 6.8 Participant HRV time domain measurements showing RMSSD values (n=15) 
during Reading the Mind in the Eyes Test (Baron-Cohen 2001), pre and post intervention.  
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
HR pre 65.45 81.12 72.15 77.7 87.54 72.95 84.58 74.72 68.99 65.33 77.74 100.3 69.42 84.4 63.9



















Participant heart rate (HR) values pre and post intervention (n=15) 
Participant heart rate during 'stress task' 
Reading the Mind in Eyes test (Baron-Cohen 2001)
HR pre HR post
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
RMSSD pre 43.9 29.5 35.7 96.3 18.9 56.7 35.7 33.6 56.3 95.1 56.3 20.3 21.9 24.5 62.4



















Participant RMSSD values pre and post intervention (n=15)  
Participant HRV during 'stress task'
Reading the Mind in Eyes test (Baron -Cohen 2001)
RMSSD pre RMSSD post




Statistical analysis – Reading the Mind in the Eyes Test 
Statistical analyses were carried out to assess mean group differences in both heart 
rate and HRV at the beginning and at the end of the intervention. One participant 
had unreadable recordings at the pre-intervention assessment point and data from 
their earlier control recording was imputed into the baseline time point for analysis. 
Initial tests were carried out using the Kolmogorov–Smirnov and Shapiro Wilks 
statistics to establish the normal distribution of scores, with both tests returning   
p-values > 0.05 for HR and RMSSD. Parametric statistical tests were then carried 
out using Paired Samples T-tests for repeated measures. Results are summarised in 
Table 6.4. 
Table 6.4 Paired Samples T-tests for repeated measures pre and post intervention of Heart 
Rate and RMSSD during the Reading the Mind in the Eyes Test.  
READING 

















      
Mean (SD) 76.42 (9.95) 81.45(11.87) 0.817 -5.03 -2.84 0.01 
       
RMSSD  
(n=15) 
      
Mean (SD) 45.81(24.81) 44.34 (22.87) 0.706 1.47 0.31 0.76 
       
 
Statistical tests showed a significant difference in heart rate pre and post 
intervention: t (14) = -2.84; p = 0.01; d = 0.73.  Effect size calculations carried out 
indicated a medium effect size7.  
There were no significant differences in RMSSD values pre and post intervention.  
 
                                                 
7 Effect size calculations were again conducted using the same formula taking into account 
the correlation between the two means for within subject’s comparisons (Morris and 
DeShon 2008, p.111) and using Cohen’s d standard deviation units of small 0.2; medium 
0.5 and large 0.8 effect sizes (Cohen 1988, p.22).  




Psychophysiological assessment – Recovery task  
Values for heart rate and RMSSD during the International Affective Picture System 
(Lang et al. 1997) ‘recovery’ task are shown in Figure 6.9 and Figure 6.10.  
 
Figure 6.9 Participant Heart Rate (n=14) during ‘recovery’ task, using International 
Affective Picture System (Lang et al. 1998), pre and post intervention. 
 
 
Figure 6.10 Participant HRV time domain measurements showing RMSSD values (n=14) 
during recovery task using International Affective Picture System (Lang et al. 1997), pre 
and post intervention. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14
pre 68.28 82.49 79.09 77.05 85.78 68.23 67.31 74.25 71.42 71.13 83.42 98.86 71.16 67.9























Heart Rate pre and post intervention  (n=14)
Participant Heart Rate during 'recovery task'
International Affective Picture System (Lang et al. 1997) 
pre post
1 2 3 4 5 6 7 8 9 10 11 12 13 14
pre 39 21.5 22.4 77.5 13.1 44.8 75.3 35.2 56 69.3 36.7 131.8 26.1 61.9




















RMSSD pre and post intervention (n=14)
Participant RMSSD during 'recovery task' 
International Affective Picture System (Lang et al. 1997)
pre post




Statistical analysis – recovery task  
Statistical analyses were carried out to assess mean group differences in both heart 
rate and HRV at the beginning and at the end of the intervention on the recovery 
task using the International Affective Picture System (Lang et al.1997). Initial tests 
were carried out using the Kolmogorov–Smirnov statistic to establish the normal 
distribution of scores. One participant had unreadable data from the final part of the 
physiological assessment and therefore only 14 sets of paired data were available 
for analysis. Parametric statistical tests were carried out using Paired Samples T-
tests for repeated measures. Results for both heart rate and RMSSD are summarised 
in Table 6.5. 
Table 6.5 Paired Samples T-tests for repeated measures pre and post intervention of Heart 















Heart Rate  
(n=14) 
      
Mean (SD) 76.17 (9.02) 83.34 (12.10) 0.59 -7.17 -2.69 0.01 
       
RMSSD  
(n=14) 
      
Mean (SD) 50.76(31.23) 41.60 (23.65) 0.24 9.16 0.99 0.34 
       
 
Statistical tests showed a significant difference in heart rate pre and post 
intervention, t (13) = -2.69; p = 0.01; d = 0.72.  Effect size calculations indicated a 
medium effect size8. There were no significant differences in RMSSD values pre 
and post intervention. Further analyses carried out on both time domain (SDNN) 
and frequency domain (HF-HRV; LF-HRV) variables also showed no significant 
differences pre and post intervention.  
 
                                                 
8 Effect size calculations were again conducted using the formula taking into account the 
correlation between the two means for within subject’s comparisons (Morris and DeShon 
2008, p.111) and using Cohen’s d values of small 0.2; medium 0.5 and large 0.8 effect 
sizes (Cohen 1988, p.22).  
 




 Research objective 3: ‘Adoption of technology’ 
 Summary  
This section reports the results of information collected to evaluate the adoption 
and use of this technology by participants during the intervention. Information is 
provided on problems using the device and level of training given to participants; 
participant use of the biofeedback device over the intervention period, and 
participant reports on the usability of the biofeedback device and the ECG recorder. 
Reports were obtained from 18 families. All available debriefing data was included 
to further review information on those who had a risk identified, provided they 
consented to provide data.  
Several different methods were used to collect data at different time points during 
the course of the study. These included (i) researcher records made regarding 
training and notes of reported problems using device; (ii) participant feedback on 
use of their device collected during the intervention via a daily online survey; and 
(iii) participant questionnaire reports on overall usability of the device taken at the 
end of the intervention.  
 
Results are reported as outlined below in sections covering the initial training 
period; participant use of biofeedback device over the 12-week intervention period, 
and evaluation of usability of the equipment used in the intervention assessed at the 
final debriefing session.   
• TRAINING and PROBLEMS USING DEVICE – assessed via researcher notes 
taken at start of intervention. 
 
• USAGE OF DEVICE – assessed via participant survey during intervention. 
 








 Problems with training in use of Biofeedback Device 
Record was made of the level of training given to each participant and any reported 
problems using each device. A breakdown of amount of training given to 
participants by type of device is shown in Figure 6.11 and Figure 6.12. 
 
Figure 6.11 Participant reports of difficulties during training with StressEraser 
biofeedback device.  
 
  
Figure 6.12 Participant reports of difficulties during training with HeartMath biofeedback 
device.  
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The initial study protocol described in Chapter 4 had planned to provide all 
participants with the same amount of training. However, eight out of the ten 
participants initially allocated to a StressEraser device reported difficulties and 
required two or more sessions of training. In contrast, only one of the ten 
participants allocated to a HeartMath device reported difficulties which required 
additional training.   Importantly, the participants who required less training all 
reported positive effects. 
Random allocation to devices was initially planned, however, two participants who 
were initially allocated to the StressEraser group experienced difficulties during 
training and were unable to obtain a reading from the finger sensor unable to use 
this device due to difficulties experienced during training. 
Following the ‘intention to treat’ principle (Newell 1992), a decision was made to 
allow participants to continue in the study with an alternative device. Both of the 
participants who were unable to use the StressEraser expressed a desire to continue 
to participate in the trial and were therefore allocated to the second device group. 
Thus, despite an initial attempt to randomly assign participants to different devices 
this type of randomisation was not possible. The final allocation of devices is shown 
in Table 6.6.  
 
Table 6.6 Final numbers of participants allocated to different biofeedback devices.   
Type of device  Number  Percentage  
StressEraser 8 40 
HeartMath  12 60 
 
Furthermore, one participant allocated to the HeartMath group had no access to 
phone or tablet computer and subsequently used the emWave2 device; all other 
participants in the HeartMath group used the Inner Balance; both HeartMath 
devices employed a HeartMath PPG ear sensor and employed the same underlying 
processing algorithms.   
 




 Usage of Biofeedback Device  
Once the intervention had commenced, participants were then asked to provide 
information about their regular usage of the biofeedback device over the course of 
the intervention period.  
Participants completed short online survey reports which monitored use of the 
biofeedback device during the intervention period. Data was included and analysed 
from all participants who consented to provide this information, in order to capture 
data from those who dropped out of the study. There was a wide range in the 
frequency of reporting between different individual participants, with users sending 
between 2 – 70 reports over the course of the study.  
Participants were asked how much time they had spent using their biofeedback 
device. Overall, 418 reports were collected from 18 participants regarding time 
spent using their biofeedback devices. Results are reported in Figure 6.13.  
 
Figure 6.13 Participant reports on time spent using biofeedback device.  
The majority of responses from participants indicated that the device had been used 
for up to five minutes with a quarter of the responses indicated use for between five 
to ten minutes. Overall 88% of participants reported using their device for 
somewhere between 0-10 minutes, with only a small minority using the device for 
longer than ten minutes.  
used device today 
for 0-5 minutes
63%
used device today 
for 5-10 minutes
25%
used device for 
more than 10mins  
12%
0-5 minutes 5-10 minutes More than 10 minutes




 Reasons for not using Biofeedback Device 
Participants who hadn’t used their device were also asked to report the reasons for 
not using the device. A summary of 145 reports provided by participants detailing 
reasons why the device had not been used is reported in Figure 6.14.  
 
Figure 6.14 Summary of reasons for not using biofeedback device reported by participants 
via daily text survey.   
 
The most frequent reason reported for not using the device was simply that the 
participant did not feel stressed. Other reasons reported were ‘too busy’ (14%); 
‘device not with me’ (12%); ‘forgot to use it’ (6%); ‘practicing the device later’ 
(4%) and ‘error on device’ (2%).  Seventeen percent of participants gave no clear 






Device not with me 
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Forgot to use 6%
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 Usability of Equipment  
The System Usability Scale (SUS) originally devised by Brooke (1996) was used 
to gather information from participants at the end of the intervention period 
regarding the overall usability of the biofeedback device. This 10-item 
questionnaire asked questions regarding ease of use, complexity of system, and 
amount of learning needed to use the device.  
The SUS scale was also used to gather information regarding the overall usability 
of the Actiwave ECG recorder, which had been used for pre-post physiological 
recordings of heart rate variability, and the usability of the SMS text message 
survey used to monitor use of the device over the intervention period. Seventeen 
SUS reports rating the usability of biofeedback devices were provided (two 
participants completed ratings on both devices due to a change of device). Fifteen 
participants completed ratings on the Actiwave ECG recorder. Fifteen participants 
completed ratings on the text survey. Mean scores were then calculated to give an 
overall usability score for each separate type of equipment used in the study. 
Results are shown in Table 6.7.  
Table 6.7 System Usability Scale (SUS) ratings of biofeedback devices; ECG recorder and 
Text survey.  
Type of equipment  SUS score 
Mean (SD) 
‘benchmark’ SUS score 
Mean (SD) 
StressEraser  76.6 68 (12.5) 
HeartMath  83.6  
Actiwave ECG recorder  70.0  
Online text survey  78.5  
The mean SUS scale score for the StressEraser was 76.6, whilst the overall mean 
score for HeartMath was 83.6. A review of 446 studies using the SUS has been 
carried out (Sauro 2011). In this review the global benchmark mean score on the 
SUS scale is calculated as 68, with scores above this considered to be above average 
(Sauro 2011, p. 54). All usability ratings indicated above average or above average 
mean scores for equipment and biofeedback devices used in the study. These 
findings provide ratings of the basic usability of the equipment involved in the 
study but do not elucidate potential risks or benefits, which will now be described. 




 Research Objective 4: What are the Risks and Benefits of 
using this technology with this population? 
 Summary 
Information is now presented on risks and potential harms encountered, and on 
unexpected findings. In addition, information is presented on perceived benefits 
and problems with the intervention, from the perspectives of both participants and 
carers. This information was provided using qualitative data collection obtained 
from final debriefing interviews with carers and participants, and by reviewing data 
collection and procedural difficulties recorded by the researcher during the study.  
 
Reports were obtained from 18 families. All available debriefing data was included 
to further review information on those who had a risk identified, provided they 
consented to provide data. Results are presented as summarised below.  
 
• RISKS; POTENTIAL FOR HARM and UNEXPECTED FINDINGS – 
assessed via researcher records, carer and participant reports  
 
• BENEFITS and PROBLEMS – assessed via researcher records, and 









 Risks  
Risks highlighted in protocol prior to intervention.  
Two main risks had been identified in the initial study protocol as potential risk 
areas requiring monitoring during the study. These were the potential for finding 
previously unknown cardiac conditions highlighted by the ECG recording, and the 
potential for finding a more severe mental illness in participants during the course 
of the intervention – see Figure 6.15.  
Risks identified during intervention  
Risks were identified in four participants during the course of the study. These 
participants were then excluded, three due to previously unidentified cardiac risks 
and one due to the development of a severe mental health problem.  
 
Figure 6.15 Identification of risks in participants during the course of the intervention 
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 Potential for Harm  
ECG induced anxiety  
All ECG recordings were reviewed anonymously by a senior chartered cardiac 
physiologist. All ECG recordings were screened as being within normal limits, 
however a high level of precaution was adopted due to the exploratory nature of 
this research. Therefore, all recordings showing any unusual wave forms were 
recommended for further 12 lead ECG assessment, to ensure there was no risk of 
undetected cardiac problems. Of the 20 participants assessed, 10 were 
recommended for further assessment 12 lead ECG assessment. One participant was 
immediately identified as having cardiac problems and was then excluded from the 
study. Two further participants were also subsequently identified and referred to 
cardiologists for assessment after cardiac concerns were identified from 12 lead 
ECG.  
There was potential for these further ECG checks to have caused undue anxiety for 
participants. To assess this possibility, a review of records was undertaken to check 
if any of the participants who had shown an increase in anxiety had also been in the 
group that required an additional ECG check. Demographic information and 
debriefing reports were also included from these participants to assess any 
concerns.  
One case was identified that showed an increase in anxiety in the group of cases 
requiring further ECG checks. This participant also had difficulties with using their 
device, and debriefing interviews indicated concerns regarding their device rather 
than the ECG assessment.  
Two cases also reported concerns regarding pain or itchiness during removal of 
electrodes, however, neither of these participants reported concerns regarding use 









Biofeedback induced anxiety  
Another potential risk identified in the study protocol was the possibility of the 
biofeedback intervention itself causing increased anxiety. Increased anxiety was 
reported in several participants, and therefore notes and reports were reviewed to 
assess any potential links between use of device and increased anxiety.  
One child participant showed increases in self-reports of anxiety and depression 
over the course of the intervention and reports obtained at debriefing did indicate 
difficulty regarding use of the device. In this case, there was evidence of 
biofeedback induced anxiety and potential for harm from the intervention. 
One adult participant also showed increases in anxiety and depression over the 
intervention period, and reports at debriefing indicated some difficulties using the 
biofeedback device. Both of these participants were allocated to the StressEraser 
device.  
Device records and clinical notes were also reviewed in the participant who 
developed severe mental health difficulties at the six weeks follow up. This 
participant had only practiced the device at the initial training session and had not 
used the device after initial training. These reports were also confirmed by review 
of device records which showed no further use of device. Thus, no linkage was 
found from records between use of the biofeedback device and the development of 








 Unexpected findings  
Cold fingers  
One unexpected finding of the intervention was that many participants were found 
to have cold fingers during initial training. Of the ten participants initially allocated 
to the StressEraser, seven reported some degree of difficulty over the course of the 
study. Cold fingers can, in some individuals, be a sign of a shut down in peripheral 
circulation as a result of stress (Barlow 2006). This symptom alone, however, is not 
generally a cause for concern and was not reported by participants at initial 
recruitment as a known problem. However frequent difficulties using the finger 
sensor in participants allocated to the StressEraser device led to checks indicating 
this difficulty. This symptom was reported by two participants as the reason for not 
being able to use their device at all, and two further participants were only able to 
use their device after warming their fingers. Three further participants experienced 
intermittent difficulties. Participants were asked to complete the Nijmegen scale 
(van Doorn 1983) if they reported having any difficulty with their device. This short 
16 item questionnaire looked at levels of symptoms that can be seen in individuals 
with chronic hyperventilation. Further assessment of this scale has indicated 
discriminant validity as a screening instrument for chronic hyperventilation 
syndrome (van Dixhoorn 1985). A sample of the Nijmegen questionnaire is 
presented in appendix III.  
Definitive assessment of hyperventilation difficulties is only possible using 
capnography measurement of exhaled C02, however, authors of the scale propose 
that scores above 23 out of a total possible score of 64 suggest possible signs of 
hyperventilation syndrome (van Dixhoorn 1985). Results summarised in Table 6.8 
indicate that some participants in the study who had difficulties with cold fingers 
may have also been experiencing symptoms of hyperventilation. 
Table 6.8 Hyperventilation symptoms assessment – Nijmegen Scale. 
Assessment of Hyperventilation symptoms  Score  
Mean (Standard Deviation) 23.85(10.14) 
Minimum-maximum scores (Range) 2.00 – 41.00 (39) 




 Perceived Benefits and Difficulties with Intervention 
Reports on Effect of Biofeedback (during Intervention)  
Participants were asked in the online survey during the intervention period if the 
device had helped when they used it. Results are reported in  
Figure 6.16. 
  
Figure 6.16 Participant reports effect of biofeedback device during intervention.  
 
Overall 474 reports were provided from 18 participants on use of the biofeedback 
device and its effect. The majority of reports from over 65% of responses indicated 
that that the biofeedback device had been used and that ‘it helped’ when used. Only 
4% of questionnaire reports indicated that it ‘didn’t help’ when used. Thirty percent 
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 Debriefing Reports 
In the final part of the study, participants and carers were both asked to give brief 
written comments on their experiences, both positive and negative at the final 
debriefing. Samples of debriefing reports are shown in appendix III. Reports 
obtained from eighteen participants, on problems with the intervention is shown in 
Figure 6.17. 
Participant Reports of Problems  
 
Figure 6.17 Problems reported by participants at debriefing. 
 
A sample of direct quotes from participants is reported below; full results are 
reported in appendix V. 
 “the first device made me more stressed ...errors because my hands so cold”  
 “ear clip kept slipping hard to get pulse awkward on the finger and on the ear”  
“didn’t work if extreme stress… too difficult to use”  
“don’t remember to use it... I didn’t use it when stressed” 
“hard to get smooth waves …  
didn’t practice it… couldn’t get a lot of points” 
 “need to set precise times for practice”  

























Types of Problem Reported




Participant Reports of Benefits  
Reports obtained from 18 participants, on positive experiences or perceived 
benefits of the intervention are shown in Figure 6.18. 
 
 
Figure 6.18 Benefits of biofeedback intervention reported by participants at debriefing. 
 
A sample of direct participant quotes regarding positive experiences / benefits is 
reported below, full results are reported in appendix V.  
“used after stressful day and helped … helped when people were annoying me”  
 “the information presented was calming allowed for me to collect my thoughts”   
 “it helped me sleep every time I used it… it helped with my problems” 
“easy to use / comfortable / look like earphones. comfortable using it in public” 
 “visuals good / if stressed used it and helped / helps get to sleep at night “  
“used same breathing but without device when in bed as don’t want to get up”  
“will continue… helped focus”  
 “showed my heart rate / it gave me a rating / has helped me control anxiety”  
“I felt better / excellent and simple to use”   
“it helped me be happier”    





















Type of benefit reported 




Carer Reports of Problems  
Carers were also asked to review the intervention at the final debriefing interview. 
Carer descriptions of ‘main problems’, ‘triggers for anxiety’ and ‘obstacles to 
managing anxiety’ remained the same. However, as reported earlier many carers 
did report a reduction in the frequency of anxiety attacks / meltdowns (see page 
155).  Carers were also then asked to give asked to give brief written comments on 
any perceived benefits or problems encountered during the intervention. Reports 
from carers are summarised in Figure 6.19. 
 
Figure 6.19 Problems with biofeedback intervention reported by carers at debriefing.  
A sample of direct quotes s from carers is reported below, full results are reported 
in appendix V. 
 “problems with errors if fingers cold”  
 “prompts to use it would be good “ 
“hard to remember to use it every day”  
“… felt self-conscious using it in public”  
“not compatible with android devices”  






















Type of problem reported  




Carer Reports of Benefits  
Reports from carers on perceived benefits or positive experiences were collated and 
summarised. Results are reported in Figure 6.20.  
 
 
Figure 6.20 Benefits of biofeedback intervention reported by carers at debriefing.  
 
A sample of direct quotes from carers on the positive effects of the intervention are 
outlined below, full results are reported in appendix V. 
“easy to understand and use / good because visual / sound can be controlled” 
 “… was good on the phone / could take it everywhere”   
“helped … calm down before going to … 
 “especially good at decreasing stress for exams”   
“being able to see effect of your breathing … helped learn to control breathing”  
“giving more control to person directly / visual /  
“something to focus on”  























Type of benefit reported 




Additional reports from researcher records 
Participants and carers were asked whether they had any additional concerns or 
whether they needed any follow up support. None of the participants or carers 
reported concerns regarding the intervention, however, three families requested 
further information regarding other support services available.  
Some participants also commented further during debriefing on their stress levels 
and reasons for wanting to participate in the study. Examples of quotes from 
participants are listed below,  
“I get frustrated when people don’t understand me and won’t listen to … what 
I need”  
 
 “I wanted to do the research project to understand my anxiety more and see if 
biofeedback would help me more”  
“I took on this program because I felt like it will help my problems” 
 
 
Some carers also commented further during debriefing on reasons for wanting to 
participate in the study and the intervention itself. Examples of quotes from carers 
are listed below,  
 “… could monitor his own progress which was great” 
  
“no major meltdowns despite some very difficult exams” 
 
“very visual instant feedback that was easy to understand” 
 
 
Several unexpected changes reported by some carers were increases in participant’s 
awareness of the physical symptoms of stress and ability to generalize the breathing 
and use it without the device and reports of increased confidence and social skills. 
 “real benefits in helping develop awareness of physical symptoms / increased 
ability to identify patterns as they developed”  
 
“… increased ability to anticipate and take greater control managing anxiety”  
“better at socialising and teacher has noticed also / more smiles and eye 
contact”  
“…really helped with confidence”   
 




 Integration of findings 
 Demographic and physiological variables  
In order to review associations between some of the different types of data 
collected, correlations between initial baseline data and ECG data were carried out.  
Thus, Pearson Bivariate correlations were conducted to compare physiological 
variables measured at the initial pre-intervention assessment with age, ASD and 
sensory symptoms. Similar correlations were also conducted to compare age, ASD 
and sensory symptoms with final post intervention physiological variables. Results 
are reported in Table 6.9 and Table 6.10. 
Table 6.9 shows that at the initial assessment, participant age was significantly 
correlated with sensory (Low registration) symptoms (p < 0.01) and with HRV 
variables (p < 0.05). HRV variables were also strongly correlated with one another 
(p < 0.01) and negatively correlated with heart rate (p < 0.05). ASD symptoms were 
positively correlated with heart rate (p < 0.05). 
Table 6.10 shows ASD symptoms, as measured by the SCQ, were negatively 
correlated with HRV variables recorded at the final assessment (p < 0.05). ASD 
symptoms, were also positively correlated with heart rate recorded at the final 
assessment (p < 0.05). HRV variables were also significantly correlated with one 
another (p < 0.01), and negatively correlated with heart rate.  
 




Table 6.9 Pearson correlation statistics at initial assessment between physiological measures recorded during Reading the Mind in Eyes Test (Baron-Cohen 
2001) with participant age; sensory symptoms and level of ASD symptoms.  
Pre-intervention         
 Age ASD Sensory HFHRV RMSSD SDNN Heart Rate 
Age  Pearson 
Correlation 
1 -0.250 0.647** -0.580* -0.596* -0.548* -0.012 
ASD  Pearson 
Correlation 
 






1 -0.291 -0.288 -0.119 -0.158 
HFHRV Pearson 
Correlation 
   1 0.929* 0.902** -0.562* 
RMSSD Pearson 
Correlation 
    1 0.946** -0.514* 
SDNN Pearson 
Correlation 
     1 -0.465  
HR Pearson 
Correlation 
      1 













Table 6.10 Correlations between physiological measures recorded at final assessment during the Reading the Mind in Eyes Test (Barn-Cohen 2001), with 
participant age and level of ASD symptoms. 
Post intervention        
 Age ASD  Sensory  HFHRV RMSSD SDNN Heart Rate 
Age  Pearson 
Correlation 
1 -0.250 0.647** -0.250 -0.381 -0.522* -0.062 
ASD  Pearson 
Correlation 
 






1 -0.181 -0.023 -0.142 -0.118 
HFHRV Pearson 
Correlation 
   1 0.892** 0.905** -0.733** 
RMSSD Pearson 
Correlation 
    1 0.897** -0.467* 
SDNN Pearson 
Correlation 
     1 -0.694** 
HR Pearson 
Correlation 
      1 








 Summary of findings  
This chapter has described findings from three separate research objectives and 
involved reporting of pre and post changes in participants; reporting on usage of 
the device over the intervention period; a review of risks, unexpected consequences 
and any problems or benefits reported at the end of the intervention.  
Research objective 2: Pre-post data collection  
• Participants reported a reduction in anxiety over the course of the intervention, 
whilst carers reported a reduction in participant meltdowns. 
• There was no significant change in measures of depression in either the adult 
or the child group, over the intervention period.  
• Physiological assessment highlighted an increase in heart rate but found no 
clear change in the HRV measures analysed during physiological assessment at 
the end of the intervention, compared to initial assessment.   
Research objective 3: Adoption of technology  
• Whilst most participants used the device for short periods (0-5 minutes), the 
majority of participants (65%) reported the device helped when they used it.  
• Differences were also noted between the two different devices used, with the 
StressEraser device being prone to sensor error.  
Research objective 4: Risks and benefits  
• Risks relating to unidentified cardiac and mental health concerns were 
identified in four participants. The possibility of the intervention itself inducing 
anxiety was identified in two participants.  
• Unexpected findings were that seven out of ten participants using the 
StressEraser had cold fingers which led to difficulties using the device. The 
number of participants requiring input from cardiology was also unexpected.  
• Debriefing reports obtained at the end of the intervention indicated a range of 
benefits and difficulties with the intervention with similar issues being 
highlighted by both participants and carers.  
 
The results presented above will now be discussed in more detail in Chapter 7.  





  Overview  
This thesis reports on a ‘proof of concept’ study which aimed to answer two 
questions. First, ‘Can people with ASD use portable HRV biofeedback devices?’ 
and second, ‘Does use of these devices help to manage anxiety in people with 
ASD?’  
This chapter aims to answer these questions by discussing the main findings from 
the pilot study undertaken. First, the chapter reviews the limitations with the design, 
methods and procedure, and highlights confounding variables which may have 
affected the results. Second, the overall aim and objectives are restated, and the 
importance of the study findings is critiqued, in light of what is already known 
within the research literature about ASD, anxiety and HRV. Potential explanations 
for the positive and negative results are considered by interpreting these findings 
with reference to current research and theory.  
Finally, the strengths of the current study and how it has moved forward knowledge 
in this area are considered. Chapter 8 will then address potential solutions to some 
of the problems highlighted within the current study, with an aim to address the 
final research objective (Objective 5), to ‘develop recommendations for the use of 
















 Study limitations 
 Ethical considerations  
There were a number of ethical considerations which affected the overall study 
design. The study involved assessment of a vulnerable clinical population who have 
by definition intrinsic social and communication difficulties and who also may have 
poor insight into their stress levels and mental health.  
The need to protect patient confidentiality led to ethical permission for access to 
medical records not being sought which could have added important demographic 
information, regarding developmental history; diagnostic assessments and medical 
information on those who were referred on for further ECG.  
In addition, when a number of participants requested to not have further training 
sessions this information was recorded and was respected.  In the same manner, 
when two participants reported that that they could not use a device, but wanted to 
continue in the study, this request was accommodated at the expense of formally 
conducting a randomised controlled design.  
 Bias and independence  
The study was conducted by one investigator who carried out all assessment; 
training; data collection; data inputting, and the majority of data analysis. Attempts 
were made to introduce blinding and independence into as many aspects of the 
study as possible as outlined in Chapter 4, however, it is possible that unconscious 
bias regarding the study aims and objectives may have affected some of the 
findings.  
It is possible that unconscious bias may have occurred within carer interviews and 
participant reports due to a wish for the treatment to succeed. However, it is of note 
that several carers reported that the device did not help their child despite initial 
hopes that it would be beneficial, and that these carer reports were in concordance 
with participant reports. 
 
 




 Study design  
Participants were randomised into immediate and delayed groups, and this study 
design meant that all participants eventually received an intervention. The 
increased wait in the delayed group may have increased expectations which could 
have affected reports on questionnaires and possibly internal physiology as well. 
Participants who were randomised into the delayed group were given the same 
number of assessments to ensure there was no increased burden of participation in 
this group, however this compromised the number of comparisons that could be 
made at similar time points.  
Due to the limited sample size, it was not then possible to carry out one of the key 
statistical tests planned which would have enabled comparisons to be made 
between six weeks of intervention in the immediate group, to six weeks of no 
intervention in the delayed intervention group.  
The study design also meant that participants in the delayed group had already had 
experience of assessment when they were assessed a second time at the beginning 
of the intervention.  This difference means that there may have been an effect on 
participants in the delayed group which was simply related to assessment, 
sometimes termed the ‘Hawthorne’ effect (McCambridge 2014).  
 
 Recruitment and selection of sample  
A key limitation in this study was the small sample size. Initial estimates involved 
recruiting 50 participants, to enable at least 10 participants to be recruited into each 
subgroup. However, early recruitment issues with adults, combined with limited 
time and researcher capacity, meant that only 20 participants were recruited.  
The difficulty recruiting adults may indicate potential for problems with future 
studies; however, two issues are important which may have affected recruitment. 
First, the sample of adults was limited to a narrow range between 18 to 24 years. 
Employing a wider age range may have resulted in increased recruitment.  




Reports from the adult ASD team at the end of the study did suggest that 
recruitment of older adults would have been possible, and that the age range chosen 
may be one where young adults are reluctant to attend services. Second, it was of 
note that all initial contact with the researcher was made by parents irrespective of 
whether participants were adults or children. Whilst all participants involved did 
give clear assent and consent, it may have been difficult for some young adults with 
ASD to make initial contact with the researcher to discuss the study because of their 
social and communication difficulties.  
 
 Equipment  
One of the limitations in this study relates to the use of physiological assessment 
equipment. The initial study had been designed to utilise one of the large-scale 
professional biofeedback systems advocated by certified biofeedback practitioners. 
This type of system can be used to conduct pre-post multi modal 
‘psychophysiological stress profiles’, assessing a number of physiological 
variables.  
However, initial equipment feedback by stakeholders suggested that this type of 
assessment using multiple sensors could be too anxiety provoking, which led to the 
adoption of single lead ECG recorder, already used with people with ASD. This 
device was indeed found to be acceptable by participants, as seen in the usability 
scale ratings from participants, however, this was at the expense of collecting fewer 
physiological measures.  
Importantly, the single lead ECG provided less comprehensive information on ECG 
waveform characteristics and the subsequent interpretation of anonymised single 
lead ECG recordings by the cardiac physiologist, resulted in repeat 12 lead ECG 
being requested in 10 out of the 20 participants to confirm normality of ECG 
waveforms. Three participants from this group were subsequently identified as 
having cardiac concerns which required further follow-up. Thus, whilst this device 
did detect difficulties the less comprehensive reading from a single lead ECG 
recorder entailed further unwarranted investigation for seven participants.   




 Measures  
The methodology chosen for collection measurement and analysis of data in the 
study was predominantly quantitative rather than qualitative. It is acknowledged 
that detailed case study analysis could have been carried out if a different 
methodology had been chosen. Further case study analysis was not possible in this 
study due to the methods chosen to collect data and the level of ethical permission 
requested for more detailed information regarding cases to be collected. Future 
studies could employ case study methodology to detail further the individual case 
stories of participants. This type of design and methodology might further elucidate 
the reasons for some participants dropping out and provide examples of how this 
intervention was used in real world situations. It could potentially also highlight 
how individuals practiced and incorporated use of this intervention into their daily 
lifestyle and routines.  
The current study used separate questionnaire measures for child and adult groups 
to assess anxiety and depression. The Beck adult scales were reviewed by people 
with ASD and deemed to be suitable, however, a decision was made by the 
researcher not to use these scales for the child group and to instead use the child 
and adolescent Beck scales. This was influenced by the question relating to sexual 
functioning in the adult scale, which was felt to be inappropriate for children. In 
addition, the Beck Youth scales report that the language in these scales is more 
suitable for children. 
 However, an accepted limitation of this change meant that the participants who 
completed the study could not be compared as one overall group when assessing 
theses variables and mean scores for anxiety and depression had to therefore be 
divided into two separate smaller groups. This decision to prioritise a clinical 
decision, over a research-based decision which would have provided a larger 
unified group of data, is an accepted limitation of the study.  
  




 Usage of biofeedback devices  
A further important area not addressed by this study is the need to accurately 
capture and record data from the biofeedback devices, used by participants. In this 
study, ethical and clinical decisions were again made which compromised the level 
of detail in the collection of participant data, in favour of protecting participant 
information.  
Thus, participants using HeartMath devices could have uploaded their data onto a 
cloud-based server managed by the parent company, however, as this server was 
located outside of the UK it could have been vulnerable to foreign laws surrounding 
privacy and, therefore, the confidentiality of data uploaded could not be guaranteed.  
A compromise was to, therefore, to record screen shots of sample recordings of 
data from participant devices data, which were then used to check participant usage 
rather than to measure progress.  
 
 Training  
One further difficulty which may have confounded results was the variation in 
training given to participants as the amount of training time requested by some 
participants was much less than the time that had been allocated in the study design.  
 
Biofeedback can only work effectively if the user understands and adheres to 
instructions in its use (Pastor 2008). Concerted attempts were made by the 
researcher to ensure fidelity of training offered by giving all participants the same 
instructions from the researcher regarding breathing, and by offering two 60-minute 
individual training sessions to each participant.  
Despite this, there was a variation in the amount of training given in this study, as 
several participants declined the second training session offered, reporting that they 
already knew what to do. These participants all used the Inner Balance device from 
HeartMath and were able to quickly establish slow breathing which presented as 
‘coherence’ on the device.  




The variation in training time constitutes an issue with intervention fidelity, in that 
not all participants received the same amount of training time in use of the device.  
However, a review of participant training records indicated that importantly, 
participants who required less training all reported positive effects. Results 
therefore did not suggest that lack of training was a factor in participants reporting 
problems; in fact, the converse was true, in that participants requiring extra training 
sessions all reported difficulties using the device and increased anxiety and 
depression.   
 
 HRV assessment 
Despite attempts to standardise the HRV assessment process, several limitations 
were noted. One clear limitation in the assessment process was the variation in 
environments, due to the decision to carry out home based assessments. Whilst 
attempts were made to standardise the assessment as much as possible, factors such 
as ensuring bladder emptying; no prior caffeine intake; recording height and 
weight, were not all taken into account. In addition, whilst time of day was 
controlled within each participant assessment, the time of assessment was not 
consistent between participants.  
The use of a mean score for 13-24 olds for resting HRV is acknowledged as a 
limitation of the study. Comparisons were not made with the study on 6-8-year-old 
children as there was inadequate information available from these norms. The two 
adult reference studies used provided similar measurement scores which could be 
compared to the current sample. In addition, it was felt that the 13-24-year sample 
would be more similar to adult norms, than the 6-8-year-old sample. However, it is 
recognised that the age range for the current sample of 13-24-year olds was 
compared to reference studies on adults and the natural variation in resting HRV 
due to age presents a confounding factor which would have affected interpretation 
of resting HRV scores for this younger sample. 
  




  Review of aim and objectives  
The overall study aim was to investigate the use of HRV biofeedback in people 
with ASD. This was achieved by addressing the following objectives: 
  
1. To provide a home based HRV biofeedback intervention to people with ASD.  
2. To assess anxiety, depression and physiological arousal before and after 
using a biofeedback device.  
3. To assess usage of the HRV biofeedback technology.  
4. To evaluate the risks benefits and acceptability of this technology.  
5. To develop initial recommendations on the further use of HRV biofeedback for 
people with ASD. 
 
Detailed information was acquired on a small sample of young people with ASD, 
on both demographic characteristics and on a number of outcome indicators. The 
specific research objectives of providing a home-based intervention and assessing 
anxiety; depression and physiology were achieved. Usability of the technology was 
measured in this pilot, and the potential benefits and risks of HRV biofeedback 
were evaluated. 
Despite a range of limitations, the overall aim of the study, to carry out an 
investigation into the use of HRV biofeedback in people with ASD, was achieved. 
To understand and interpret the meaning of study findings, it is essential to place 
them in the context of research literature. Therefore, the study results are discussed 
in these subsequent sections taking into account the relevant theory on ASD, 
anxiety, and HRV and by considering the context of ongoing developments 
involving HRV biofeedback.  
 




 Interpretation of findings  
 Demographic information  
The initial demographic information reported by participants and their carers does 
suggest that this was a representative sample of young people with ASD. For 
example, the gender ratio of 4:1 male to female in this sample mirrors that reported 
by other studies (Waugh 2017).  
Demographic reports obtained indicated both high levels of screen time and low 
levels of physical activity in this sample, compared to nationally recommended 
guidelines (DiSantis et al., 2013). These behaviours have been linked to increased 
risk of cardiovascular events in adults (Stamatakis et al.2011), and also to lower 
academic performance in children and teenagers (Corder et al.2015).  
High levels of gaming-based screen time have also been associated with 
internalising mental health problems such as anxiety (Lobel et al.2017). Teenagers 
with ASD have also been reported to show significantly higher obesity levels than 
other developmental disorders (Philips et al.2014), and the low levels of physical 
activity reported in this sample may highlight one of the possible risk factors for 
this problem.  
Reporting of the demographic information from the initial sample recruited rather 
than the final sample who completed the study is seen as a potential limitiation of 
the study. Demographic information from the three participants who dropped out 
of the study did not show clear group differences from the initial sample of 
participants recruited and no consistent reason for drop-out. However, this was a 
small pilot sample and any future study larger scale study should collect further 
data on the characteristics of those who dropped out and reasons for drop-out. 
Future studies should report on both the initial sample recruited and the final sample 
who completed the study. 
Overall, the information from demographic reports portrays a picture of a sample 
of participants typical of young people with ASD, with a number of important risk 
factors for possible future mental and physical health difficulties.  




 Participant reports  
The direct reports from participants suggest that there was a reduction in anxiety 
over time in the direction predicted by the research hypothesis. This finding 
suggests there may be a positive effect of HRV biofeedback in self-reported anxiety 
in young people with ASD. This finding reflects similar outcomes which have been 
reported in studies of clinical populations (Reiner 2008); young people with anxiety 
(Ratanasiripong 2012) and findings from the systematic review and meta-analysis 
which indicated an overall positive effect of HRV biofeedback (Goessl et al. 2017). 
It is important to note, however, that reductions in self-reported anxiety do not 
explain the underlying mechanism of effect produced.  
It is also possible that the presence of the researcher simply carrying out 
assessments may have of itself caused a reduction in anxiety, an effect described as 
‘the Hawthorne effect’ (McCambridge 2014).   
The small sample size in this study was a limitation which prevented important 
between group comparisons from being carried out to assess whether this change 
would have happened over time without any intervention being provided.  
There were no significant changes in reports of depression on questionnaire reports.  
Depression was measured in this study primarily to monitor risk. Whilst depression 
and anxiety are often noted together in the same individual (Ghaziuddin 2005) it 
may be that the depression symptoms reported relate to signs of a more pervasive 
and intractable condition, which is less subject to change over a 12-week period.  
 
 Carer reports  
The frequency of participant meltdowns reported by carers did show a change 
which was statistically significant and was in the direction predicted by the research 
hypothesis. This finding may also indicate a positive effect of biofeedback, and 
whilst this data does not elucidate the mechanism behind any reported changes, it 
draws attention to potential for an important area of behaviour change which is 
particularly relevant for people with ASD (Lipsky 2011).  




However, changes reported by carers regarding the frequency of participant 
meltdowns may have been influenced by other external factors not related to 
biofeedback. Thus, the range of external triggers for meltdowns reported by carers 
such as increased workload; holidays; separation from parents may have changed 
over time irrespective of any intervention and may have affected these reports.  
In addition, this data was reported by carers rather than participants and there may 
have also been an unconscious expectation of reduction in this behaviour, which 
influenced these reports.  
The presence of the researcher asking questions of carers regarding their concerns 
may also have caused an effect due to the influence of the non-specific therapeutic 
variables sometimes termed ‘unconditional positive regard’ related to the 
researcher being an experienced therapist (Farber and Lane 2001). 
 
 Risks and unexpected findings identified    
A subgroup of participants reported difficulties using biofeedback particularly with 
use of the PPG sensor in one of the devices (StressEraser). Two participants were 
completely unable to use the StressEraser device and requested that they 
immediately change device. Both of these participants subsequently reported 
positive effects when using a HeartMath device.  
Two further participants who also had difficulties using the StressEraser opted to 
continue using this device and reported increased anxiety and depression on 
questionnaires and reported increased stress in debriefing reports at the end of the 
12-week intervention. These participants were noted during training to have 
symptoms such as cold fingers and difficulties suggesting possible difficulties such 
as chronic hyperventilation. In these cases, use of one type of biofeedback device, 
(StressEraser) was associated with increased anxiety and depression as indicated 
by participant questionnaire and also in reports obtained from carers at debriefing.  
 
 




The difficulty noted during initial training sessions which highlighted participants 
showing cold fingers was an unexpected finding and occurred only in the device 
which used a finger sensor (StressEraser). The difficulties encountered by these 
participants were unlikely to be related to the device itself as each time this problem 
arose, multiple checks were made to ensure the device was functioning effectively.  
The StressEraser device was selected for use within the study because it had already 
been employed in a range of studies which had consistently demonstrated positive 
effects (Karavidas et al. 2007; Reiner 2008; van der Swan 2015; Meier and Walsh 
2016). This device has now been discontinued, however, none of the studies 
utilising it reported the specific problems highlighted in this study with people with 
ASD. Moreover, prior to the study commencement, two researchers reported 
positive effects from its use (personal correspondence with J. van der Swan and R. 
Gevirtz January 2016), in other non-ASD populations. No other evidence of these 
difficulties was found in the literature review.  
Importantly, the difficulties reported with the StressEraser device were not reported 
with the Inner balance device which used a PPG sensor which could be attached to 
the ear. Potential reasons for the difficulties recorded include possible presence of 
chronic hyperventilation in participants, and high levels of stress causing peripheral 
vasoconstriction. This finding may also be related to underlying ANS differences 
seen in people with ASD and may affect the type of device which would be useful 
for this particular population.  This difficulty would not have been highlighted in a 
study which simply recorded these participants as drop outs. Thus, it is argued that 
including all participants and recording all problems reported has added valuable 
information to the study, which can also inform future research. 
A further unexpected finding was the need to request repeat ECG recordings in ten 
out of the twenty participants and the subsequent identification of three participants 
who were referred to cardiology for further assessment.  
This difficulty may be related to less comprehensive information provided by 
anonymised single lead ECG recordings, however the identification of concerns in 
three participants following 12 lead ECG may indicate underlying physiological 
difficulties in people with ASD, particularly those with anxiety.  




Currently there is limited data on the risk factors for cardiac problems in people 
with ASD. The high levels of anxiety and depression seen in this population; the 
frequent use of medication and potential underlying ANS differences may place 
them at increased risk and further research into this area is warranted.  
 
 Benefits of using biofeedback 
Despite the problems and unexpected findings noted above, the majority of young 
people with ASD who participated in this study were able to use small ‘home 
trainer’ HRV biofeedback devices and reported positive effects as a result of their 
use.  
For example, 65% of responses collected from participants during the intervention, 
indicated that the device helped when they used it. The majority of carers also 
provided positive reports regarding HRV biofeedback, with carers noting changes 
in participants which were similar to participant direct reports.  
In addition, verbal reports from carer interviews indicated a significant reduction 
in the frequency of meltdowns observed in participants. These reports may indicate 
a direct effect of the intervention or may be related to therapeutic effects caused by 
the researcher, or to unconscious bias in the reporting of effects of the intervention.  
  




 HRV data  
“Short term heart rate variability: Easy to measure, difficult to interpret” 
(Lombardi et al. 2018, p.1). 
The complexity of assessing, analysing and interpreting HRV data should not be 
underestimated, and this growing issue is highlighted in the review quoted above. 
This study involved undertaking single lead ECG recording which was used to 
collect data on measures of both heart rate and HRV. There is ongoing debate 
regarding the meaning of   HRV variables and the interpretation of results (Borrione 
and Kemp 2018). Interpretation of HRV data in this small sample is therefore made 
tentatively due to the nature of the study design, and the complexity of this area.  
Baseline data from ECG recordings showed increased heart rate and deceased HRV 
indices compared to some of the normative reference values available for adults 
(Nunan 2010; Dantas et al. 2018). Baseline HRV calculations were made using 
combined mean score data from participants aged 13-24 years and compared to 
norms for older adults.  Comparisons were not made with the study on 6-8-year-
old children as there was limited information available from these norms.  
There is now a growing recognition of the importance of using age matched HRV 
frequency bands and the need for more normative data (Shader et al. 2017). Resting 
HRV does naturally change with age and an important limitation of the method of 
baseline comparison used in this study is that the natural variation in age range for 
HRV was not accounted for. Future studies should divide baseline HRV 
measurements into younger and older age groups to compare them to similar norms.  
Pre and post data indicated a significant increase in heart rate and no significant 
changes in HRV indices over time, either in the stress task, or in the recovery task. 
Therefore, the research hypothesis, which had predicted a reduction in HRV indices 
over time, was not supported. There are a number of possible explanations for these 
findings. First of all, this was a small pilot sample using two different devices, for 
a relatively short time period which has added to the complexity of study design 
and makes interpretation of results more tenuous.  




Whilst attempts were made to control the environment and conditions for HRV 
measurement, tighter controls such as using a standardised clinic-based assessment 
and ensuring additional factors such as bladder emptying and no intake of caffeine 
prior to assessment were not undertaken which could have influenced findings.  
In addition, whilst expert advice was sought on both ECG and HRV, the complex 
process of recording; extraction of data and analysis of results may have been 
subject to error due to the inexperience of the researcher. For example, a large 
number of non-linear HRV variables were not reviewed which may have provided 
further information.    
Findings may, however, indicate an increase in stress due to anticipatory anxiety 
when the stress task was repeated. Similar findings of increased heart rate during 
stress tasks have also been reported in ASD (Groden 2005; Kushki et al. 2014). In 
addition, findings suggest that people with ASD may not show quick recovery from 
stress due to what has been termed sympathetic nervous system hyperarousal 
(Goodwin 2006; Kushki et al. 2014). 
Correlations of HRV indices at baseline with demographic variables indicated that 
HRV indices were significantly correlated with age, a finding which has been 
reported in a number of large-scale population studies (Lombardi et al. 2018). This 
finding suggests that age may be one of the most important factors which predict 
HRV indices and it is possible that this factor alone may outweigh any effect of 
interventions such as HRV biofeedback.   HRV indices at the final ECG recording 
were correlated with level of ASD symptoms. It may be that the nature of the 
psychophysiological ‘stress’ and ‘recovery’ assessment used with people with ASD 
was too anxiety provoking and that the assessment itself accounted for changes in 
HRV. The use of a psychophysiological stress profile assessment for people with 
ASD may simply be too anxiety provoking to use as an assessment of HRV 
physiology pre and post intervention. 
However, it is important to also consider the original research hypothesis and the 
theoretical framework used, to review whether the actual biofeedback intervention 
itself may have caused the physiological changes in people with ASD. 




 Theoretical framework  
Polyvagal theory which was used to develop the research hypothesis, led to 
predictions regarding a change in HRV indices over time, based on the assumption 
that participants would be able to use HRV biofeedback to regulate their ANS.  
Thus, establishing resonant frequency breathing would increase ‘respiratory sinus 
arrhythmia’, help to activate the ‘social engagement system’ (Porges 2009) and 
cause subsequent reductions in anxiety. The initial plan to use the resonant 
frequency (RF) breathing protocol which is argued to increase HRV (Lehrer 2000) 
using a multisensory biofeedback system was not employed. It was therefore not 
possible to determine if all participants were actually breathing at their resonant 
frequency on the portable home trainer devices used in this study.  
Reports obtained from both participants and carers did indicate reductions in 
anxiety which may be related to the use of the HRV biofeedback intervention. 
However, whether any underlying regulation of ANS function or any activation of 
the ‘social engagement system’ occurred remains uncertain and a number of other 
variables may have also influenced the changes in anxiety.  
A new theoretical framework to explain and interpret HRV using an approach 
called ‘Neurovisceral integration across a continuum of time’ may help to explain 
some of the findings in this study (Kemp et al. 2017). This framework, outlined in 
Chapter 2, emphasises the complex and dynamic series of systems which are 
regulated by the vagus nerve. Thus, HRV indices represent the state functioning of 
the vagus nerve and the overall regulation of these systems, at the particular time 
of measurement.  
This theoretical approach advocates a more complex approach to interpretation of 
HRV, which can change as a result of multiple internal and external factors. Thus, 
the importance of rigorously accounting for and controlling all factors which may 
influence HRV becomes increasingly apparent, for any accurate interpretation of 
these indices within a research framework to take place.  
 




 Integration of study findings  
“Anyone who isn’t confused, really doesn’t understand the situation” 
(Bryan 1969, p.14). 
This study involved multiple methods of data collection from both participants and 
carers and there is a danger of confusion and ‘not being able to see the wood for 
the trees’ in any such study. Whilst statistical tests on group data were carried out 
in this study, all results involved analysis on a small sample size with two different 
devices being used with participants. Thus, all statistical results are interpreted 
cautiously and require replication before any conclusions regarding the efficacy of 
HRV biofeedback can be made. 
Demographic findings indicated that this was likely to be a representative sample 
of people with ASD, who exhibited a profile of difficulties which may increase 
their risk of future health difficulties.  
Results showed that the equipment used for the assessment was reported as 
relatively easy to use with few problems noted. With regard to the proof of concept 
question ‘can people with ASD use HRV biofeedback devices’ usability ratings for 
both devices were above average. However direct reports showed underlying 
differences, with the majority of participant using the finger sensor device reporting 
some degree of problem with its use. Several participant’s reporting difficulties 
with use of this device showed increased anxiety, which may have been caused by 
the intervention. Findings overall suggest that it is possible for people with ASD to 
use HRV biofeedback devices although use of devices employing ear sensors may 
be preferable.   
With regard to whether these devices did ‘help to reduce anxiety in people with 
ASD’ direct reports from participants and their carers suggest a possible reduction 








Information obtained from questionnaire reports and debriefing reports showed 
concordance, with participants reporting decreases in anxiety on questionnaires, 
also giving debriefing reports of signs such as ‘feeling calm’.  However participant 
reports and HRV indices were more varied, with some participants showing 
changes in the direction predicted by the research hypothesis on questionnaire 
reports, but not on HRV indices. It is notable that many other studies have not 
shown a clear concordance between questionnaire reports and measures of HRV 
and further research into the mechanisms behind HRV biofeedback has been 
advocated (Wheat 2010).  
A study has been published which was not available for the current literature review 
reporting on combined use of HRV biofeedback and neurofeedback using a 
professional biofeedback system in 15 people with ASD aged between 6-18 years 
(Goodman et al. 2018).  This study represents the first published study using the 
RF breathing protocol in people with ASD (Lehrer 2000; 2013). It is of note that 
participants in this study were excluded if they were not able to tolerate the 
electrodes and equipment used and were also excluded if they could not establish 
RF breathing (Goodman et al. 2018, p 12). Results were reported to suggest that 
HRV biofeedback either alone or in combination with neurofeedback, ‘may 
improve behavioural features of ASD’ (Goodman et al. 2018, p 9).  
New theoretical approaches may help to guide future research by highlighting the 
complexity of systems indexed by HRV data, and the need to take into account a 
wide range of variable when measuring, analysing and interpreting HRV. In 
addition, the availability of further normative reference values for HRV, and the 
development of guidelines for the assessment analysis and reporting of HRV data, 
in psychiatric populations should enable increased rigour in future research studies.  
Determining the exact underlying mechanism of HRV biofeedback is beyond the 
limits of this study, however, the study findings do add further information 
regarding the use of small scale HRV biofeedback devices in this new population. 
The mechanism of effect in HRV biofeedback may not actually be related to 
resonant frequency breathing and further assessment of the reasons for changes 
reported as a result of this intervention are warranted.  




More specifically it is argued that it has been important to include information from 
individual cases who became worse as a result of using biofeedback and that the 
information from these cases is as valuable as cases who improved as a result of 
biofeedback.  
The differences and specific problems noted highlight a number of areas for future 
research to explore. For example, the finding of cold fingers in many participants 
was not a planned outcome part of the study protocol; however, this significantly 
affected the ability of some to use this type of device. This issue should be 
investigated further and may represent one reason for not using HRV biofeedback 
devices which use a finger sensor, particularly in this population. Once again it is 
important to remember that interventions designed for neurotypical populations 
may have different outcomes in people with ASD (Mottron 2017). 
Further understanding the frequency and severity of the difficulties highlighted in 
this study could potentially help to uncover the mechanisms of effect in HRV 
biofeedback and may further highlight some of the physiological difficulties 
experienced by people with ASD.  
  




 Study strengths and contribution to knowledge  
“Despite significant challenges it is possible to reduce cost and improve 
lives” (Iemmi et al. 2017, p.10). 
Recent reviews have highlighted the lack of funding for ASD, in comparison to 
other conditions, in addition to the high costs of meeting the needs of this increasing 
population (Buescher 2014; Iemmi et al. 2017). One key strength of this study was 
the testing of a new intervention in a population where there is high need, and where 
little research exists on areas that directly affect the individuals concerned 
(Pellicano and Charman 2014).  
A further strength was the assessment of people with ASD by using direct reports 
from participants themselves in multiple formats, rather than simply focussing on 
carer reports. Research suggests that parent reports are not always congruent with 
direct reports from the person with ASD (Vasa 2014). Some research has also 
suggested that direct child reports correlate better with physiological measures of 
stress or anxiety than parent reports (Bitzika 2015). Thus, the combined use of text 
survey; questionnaires and debriefing reports from participants combined with 
carers adds strength to the validity of findings of both positive and negative effects.  
 
The development of an assessment protocol for assessing HRV in young people 
with ASD can also be viewed as an additional strength. Despite limitations in the 
design of the study, results indicate that the type of assessment used was tolerated 
well by participants. Further adjustments should be made which would enable more 
detailed information to be gathered in this area, to add to the current literature on 
HRV in different populations.   
 
Overall, the current study has contributed new knowledge on the early stage testing 
of a new intervention in people with ASD and provides a new data set of short term 
HRV recordings for this population. 




 Recommendations  
 Overview  
This study has contributed new information on the use of a home-based 
biofeedback intervention to manage anxiety in a vulnerable population. A number 
of important limitations to the current study have been reported in Chapter 7. 
Potential solutions to address the problems identified are now outlined.  
This study was funded by the Public Health Agency of Northern Ireland and 
involved NHS staff and patients, and therefore early stage recommendations for 
future studies are outlined using a logic model, indicating how a larger scale study 
might practically operate within a health research framework. 
 Potential solutions to problems within current study   
 Study design  
A number of additional changes to study design could be made in future studies, 
which could help to further elucidate the effects of this intervention. Thus, future 
studies could employ an ‘active’ control group and randomly assign participants to 
one of two different interventions. Studies which have tested HRV biofeedback 
have used alternative interventions such as meditation (van der Swan 2015); 
physical activity (Meier and Welch 2016), or ‘sham biofeedback’ as (Lehrer 1997). 
An important potential control intervention which could be employed in future 
studies assess would be to use breathing exercises only, without biofeedback. A 
study assessing HRV biofeedback for performance anxiety in musicians found that 
a short session of slow-paced breathing was as effective as HRV biofeedback 
(Wells 2012). Studies investigating longer term interventions could use a breathing 
pacer app for mobile smartphone use (such as ‘E-Z Air’ from www.bfe.org) which 
could assess and feedback paced breathing alone in comparison to HRV 
biofeedback.   
Future studies could also consider employing case study design and methodology 
to assess the engagement of individual participants with this type of intervention. 




 Recruitment and selection of sample  
A key limitation in this study was the small sample size. Future studies could, 
therefore, increase the age range for recruitment and allow for more varied methods 
of initiating contact with the research team such as leveraging social media, seeking 
recruitment support from voluntary sector organisations, or repeat contacting 
within NHS teams. This study did not attempt to recruit potential participants a 
second time after initial letters were sent, and it is possible that further contact calls 
could be considered in future studies.  
Larger scale studies should collect further data on the characteristics of those who 
dropped out and record reasons for drop-out. This was collected in the current study 
however larger samples would enable statistical comparisons to assess whether this 
intervention was preferred by one particular group of participants. 
Selection criteria in the current study did exclude medications such as beta blockers 
and tricyclic antidepressants known to affect HRV; however, some participants 
were taking other types of medication for treatment of anxiety or depression. Future 
larger scale studies could either include only those not taking medication, or 
separate participants into those who were taking prescribed medication and those 
who were medication free for further analysis.  
 Equipment  
Estimates for appropriate sample size for any study depend upon the likely effect 
size for the primary outcome. This in turn depends upon accurate measurement with 
safe valid and reliable equipment. Professional multi sensor biofeedback 
assessment systems in clinic-based assessments could be employed when clients 
were attending therapy sessions, however, this could lead to increased anxiety in 
this population. Alternatively, a reduced lead system, such as the EASI-lead 
configuration, which has been shown to provide accurate 12-lead ECG 
reconstruction, using only 4 electrodes (Finlay et al. 2007; Guldenring et al. 2012), 
or a 24-hour home ambulatory recording device, using single lead ECG, could be 
employed. Based upon experience gained in this study, home-based recording may 
still be preferable for this population. 




 Measures  
The current study used separate questionnaire measures for child and adult groups 
to assess anxiety and depression. Since the initial user review conducted in 2014, a 
new ASD specific anxiety questionnaire has been produced (Rodgers et al. 2016b). 
Interestingly this questionnaire asks for responses on some of the areas which were 
highlighted as triggers for anxiety in people with ASD in the interviews with carers 
in the current study. The development of this new ASD specific anxiety 
questionnaire may help future researchers understand and describe the symptoms 
experienced by people with ASD more accurately (Rodgers et al. 2016b).  
A further issue, which could be addressed differently in future, is the reporting of 
information from carers.  A systematic review of outcome measures has highlighted 
that there currently are few measures available for assessment of outcome of 
intervention trials in people with ASD (Brugha et al. 2015). The Autism Treatment 
Evaluation Checklist (ATEC) has been used to assess change (Berger 2011; 
Goodman et al.2018) and future studies could include use of this questionnaire to 
provide more quantified data on parent reports of change.  
 
 Usage of biofeedback devices  
A further important area not fully addressed by this study is the need to accurately 
capture and record data from the biofeedback devices used by participants. The use 
of a large-scale biofeedback system (such as the NeXus-10®) enables detailed 
information on participant progress to be recorded during each training session, as 
adopted in a study by Goodman et al. (2018). Other studies employing small 
portable devices (e.g. HeartMath) permit recording of length of practice and level 
of coherence for later analysis (Whited 2014; Westlake 2015).  
Potential solutions for future studies could be to either adopt the approach of (i) 
using large scale biofeedback monitoring systems which record information locally 
on a computer or (ii) to employ small portable biofeedback intervention devices 
and to transmit data from these to a secure cloud service. To comply with 
Governance regulations, these servers should be based in the UK.  




 HRV assessment 
Despite attempts to standardise the HRV assessment process, several limitations 
are noted. One limitation in the assessment process was the variation in 
environments, due to the decision to undertake home based assessments.  
Whilst attempts were made to standardise the assessment as much as possible each 
participant was assessed at home and thus in a different environment. Future studies 
should ensure factors such as bladder emptying; no prior caffeine intake; recording 
height and weight are taken into account. Adherence to GRAPH guidelines 
(Quintana 2016) would help to provide more standardised information on the 
assessment and analysis of HRV. Nevertheless, this study showed that home-based 
recording is achievable and preferred.  
The importance of also analysing the respiration frequency of each participant to 
understand and interpret any changes in HRV has been emphasised (Weise et al. 
1989: Billman 2015). Future studies could also use a respiration gauge, in 
conjunction with ECG, to obtain detailed information on both cardiac and 
respiration indices. 
Future studies assessing the ANS profile of people with ASD could employ 
methods for carrying out more detailed physiological assessment, which use 
psychophysiological assessment equipment including peripheral temperature 
measurement and use of capnography to measure exhaled CO2 (Khazan 2013). This 
would enable more accurate estimation of the physiological profile of people with 
ASD. However, this type of more complex assessment may well induce anxiety 
particularly in this population. 
 Data analysis 
Finally, there is also potential for unconscious researcher bias in the collection and 
analysis of data. Further research involving collection and analysis of HRV data 
could resolve this problem by employing additional researchers to allow for 
blinding of both data inputting and data analysis, independent of data collection. 
Data analysis should also review further the demographic characteristics of both 
drop-outs and exclusions from the study. 




 Framework to guide future research  
Program theory can be used to help to give a practical framework to explain the 
intent of a clinical intervention and to offer clear guidance on how it should be 
implemented in practice (Cooksy et al. 2001).  
A logic model is frequently used as an illustration of a how a program theory should 
work (Rodgers 2008). Determining how the intervention should work in practice 
can also help to estimate the costs involved in setting up any larger scale study in 
the future. A logic model has therefore been outlined to illustrate inputs and 
activities needed to set up a future study employing an HRV biofeedback. The 
inputs required, and activities needed to assess outputs and outcomes of the study, 
are presented in Figure 8.1.  
 
Figure 8.1 Illustration of a simple logic model to inform inputs and activities needed; 
outputs expected and predicted outcomes to assess a future intervention using HRV 
biofeedback. 
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 Inputs needed  
An initial assessment of the amount of time and the equipment needed involved 
should be carried out to determine costs of this intervention, both in terms of staff 
time and purchase of equipment needed. One of the potential challenges within any 
larger study will be to engage clinicians. The development of a detailed 
implementation plan agreed with key stakeholders will be essential to aid in the 
ongoing engagement of clinicians working within a complex health service 
framework (Joseph et al. 2011; NHS Improvement 2018). In addition, it will be 
important to monitor recruitment into the study and assess adherence to the 
intervention and levels of dropout (Moullin 2007; Moore et al. 2010). 
 
 Activities planned 
Recruitment will be important as this will have a direct impact on the data collected 
and analysis of outcomes. The current study highlighted difficulties recruiting 
adults aged 18-24 and therefore inclusion of a wider age range for adults or 
inclusion of younger participants should be considered. 
Pre-intervention assessment should involve ASD diagnostic profile assessment and 
possible psycho-physiological stress profiling to rule out hyperventilation and 
peripheral vasoconstriction prior to intervention. The actual HRV biofeedback 
intervention itself should involve either use of the Lehrer protocol (2013) using a 
professional clinic-based system or an alternative home trainer device that does not 
use finger sensors. Measurement of HRV over a 24-hour recording period may be 
more useful to further assess this variable. Strict adherence to an HRV assessment 
protocol for short term recordings should control for environmental factors that 
may cause changes in HRV.  
During the intervention, repeat HRV assessment to monitor change over time 
should be conducted. Further expert advice on HRV analysis should be sought, or 
example using other forms of HRV analysis, such as Poincare plot indices (Rahman 
2018). Regular monitoring of participants using ecological momentary assessment 
was seen as a strength of the current study and further use of this technique could 
be incorporated into future research. 




The use of pre and post questionnaire for carers as well as participants will provide 
further standardised information on reports of behavioural change. To avoid bias, 
carers’ data should be seen as supplementary, rather than as primary outcomes. The 
measurement of time spent using use of HRV biofeedback devices will be 
important to try to establish whether there are dose-response relationships when 
using these devices. Importantly, randomisation using an active control group will 
be needed to eliminate the effects of researcher training and user expectation of 
positive response.  
 Outputs expected 
The outputs expected will be information on use of device; anxiety; behaviour and 
HRV indices. Quantitative data should therefore be collected on measures of 
participant resting state HRV and participant self-reports of anxiety. In addition, 
carers should be asked to provide both qualitative and quantitative information on 
any changes in participant behaviour before and after using the intervention. Data 
should be collected on usage and acceptability of the device over the period of the 
intervention, to assess dose-response relationships.   
The views of participants, carers and also health care providers should be collected 
to obtain broader perspectives on the acceptability of the intervention, within a 
health service framework. Qualitative data from debriefing interviews and ratings 
will be important to provide information regarding the impact of this intervention 
from the perspectives of users and their carers, and health professionals. 
 Outcomes predicted  
It is hypothesised that HRV biofeedback will be able to help people with ASD to 
reduce anxiety. The predicted outcomes are a reduction in participant anxiety. 
Secondary outcomes should detail signs of changes in participant behaviour 
observed by carers. The potential for HRV biofeedback to regulate underlying ANS 
dysfunction via establishment of resonant frequency breathing remains unclear. It 
is therefore important to further assess HRV in a more rigorously controlled manner 
with recording of additional confounding factors that may affect HRV to assess the 
extent to which participants can improve resting state HRV as a result of using 
HRV biofeedback.  




 Potential Impact  
The potential impact of reducing levels of anxiety in people with ASD relates to 
both the individual and also to the impact on society. Thus, the potential impact of 
this type of intervention if shown to be effective would be improvements in mental 
health within the individual and reductions in burden to health service and society 
as a whole.  
 Additional areas for future research  
Further investigation of the utility of a ‘biofeedback stress profile’ assessment for 
people with ASD which had originally been planned for this study may be a useful 
area for future research. This would entail carrying out multimodal assessment of 
EMG; ECG; EDA; temperature and respiration in a more controlled clinic setting 
in a suitable number of participants to fully explore the associated physiology. 
Measurement of the physiological reactions of people with ASD could contribute 
to our understanding of this condition, and in addition may eventually represent an 
important method for assessment of the outcome of existing interventions such as 
CBT or medication. It is important to note that this type of assessment could also 
be used to assess traditional forms of treatment such as CBT or medication in other 
populations as well as people with ASD.  
Further assessment of the risk factors for cardiac problems in people with ASD is 
viewed as another important area for further research.  The sample of young people 
assessed in this study had similar characteristics to the wider population of people 
with ASD. High levels of anxiety and depression in conjunction with frequent use 
of medication; low levels of physical activity and possible underlying ANS 
differences may place people with ASD at increased risk of cardiovascular 
problems. Findings from this study suggest further investigation of potential 
cardiac difficulties in this population is warranted. 
Finally, further attempts at teaching resonance frequency breathing to people with 
ASD could be attempted with additional use of a home trainer device for continued 
practice. 
 




 Conclusion  
“The substantial direct and indirect economic effect of ASDs emphasizes 
the need to continue to search for effective interventions that make best 
use of scarce societal resources” (Buescher et al.2014, p.721). 
The high costs and continued lack of effective interventions to meet the needs of 
people with ASD have been emphasised in research reviews, as highlighted above. 
The Lancet Global Mental Health Group (Horton 2007) recommended the 
introduction of innovative and easily accessible strategies for treating common 
mental health disorders such as anxiety and depression. A review of the cost of 
biofeedback treatment in clinical settings (Schneider 1987) found biofeedback to 
be cost effective on a number of measures such as reduced medication and clinical 
visits. Despite this, a review of complementary and alternative treatments by 
Kessler et al. (2001) indicated that biofeedback represented less than 2% of 
treatments reported for anxiety or depression. 
HRV biofeedback has been argued to be an important adjunct to current 
interventions available for people with a range of conditions (Lehrer 2017). The 
use of technology has also been advocated as one possible solution to address the 
increasing burden of mental illness on society (Kazdin and Blase 2011).  
Many people with ASD either do not want or cannot access mental health services 
and HRV biofeedback may represent a method for enabling people with ASD to 
reduce anxiety at home and utilise their existing skills more effectively. HRV 
biofeedback technology may represent one method of aiding or enhancing existing 
interventions for people with ASD.  
However, for people with ASD future research is essential to further assess some 
of the questions raised by this study. Once again, the inherent problems trying to 
map existing interventions for neurotypicals onto people with ASD noted by 
Mottron (2017) are important to acknowledge. Anxiety management for people 
with ASD using HRV biofeedback offers potential but requires further research.  




HRV biofeedback has been argued to combine a method of delivery, in area of 
interest, with the aim to intervene in an area of possible underlying dysfunction, in 
people with ASD.  
Decisions were made several times in this study which compromised the overall 
study rigour as a result of ethical considerations. The equipoise that exists between 
strictness of research design, and ethical needs of participants, was swayed in 
favour of accommodating participant needs. This was felt to be necessary due to 
the exploratory nature of this research, and the high degree of vulnerability in this 
population. It is argued that the intention to treat principle (Newell 1992; Gupta 
2011) which guided the study design and method of analysis enabled important 
information to be gathered which can inform future directions for research in this 
area.  
A systematic review has highlighted the potential of biofeedback as a cost effective, 
non-pharmacological intervention (Schoenberg and David 2014). A further 
systematic review and meta-analysis has indicated efficacy of HRV biofeedback as 
an intervention for management of stress and anxiety across a range of populations 
(Goessl et al. 2017). Findings from this study suggest positive effects reported in 
both participants and their carers, and also a number of negative or inconclusive 
effects which should be investigated further.  
In conclusion, HRV biofeedback has shown some promise as a potential low-cost 
pervasive intervention for people with ASD, however, the mechanism of effect 
remains unclear and further research is both important and warranted.  
Finally, this study involved different groups of people with ASD and their carers, 
who proved to be active and interested participants, in both the development and 
the implementation of the study. Their enthusiasm showed that it is possible to carry 
out research with this vulnerable population. 
“Sometimes it is the people no one can imagine anything of, who do the 
things no one can imagine.” (Moore 2014, The Imitation Game, p.116).  
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Appendix II: Biofeedback Equipment  
StressEraser safety information  
 
The StressEraser is registered with the United States Food and Drug Administration with 
an indication for “Relaxation, Relaxation Training, and Stress Reduction.” Registration 
Number: 3005357367  
StressEraser training guidelines  
All devices have been used according to manufacturer’s instructions using existing training 












Inner Balance and emWave2 safety information  
The Inner balance and emWave 2® devices have been issued with a declaration of 
conformity as outlined below. The Inner Balance and emWave2 products are not 
registered as medical devices.  
They are described as ‘educational devices designed for relaxation’.  

















HeartMath is a registered trademark of the Institute of HeartMath. Inner balance 
and emWave2® are trademarks of Quantum Intech, Inc.  
HeartMath training guidelines 
All devices have been used according to manufacturer’s instructions using existing 












Appendix II: ECG Equipment  
ECG assessment equipment – Actiwave Cardio 
Actiwave 
cardio 
Supplier   
   
The Actiwave 










a wide range 







Available from  
At the end of 
the recording, 
the Cardio is 
removed from 
the electrodes 
and placed on 
a dock 







recorder to the 
PC via the 
dock and USB 
cable.  
CamNtech Ltd,  
Upper Pendrill 
Court, 








Available from   








and sebum  
Unomedical, stock 
2121m 
Cardiac services  
6 Wildflower way  
Boucher Road 
Belfast BT12 6TA 
 






Available from   
The Actiwave 
Cardio 










Cardiac services  
6wildflower way  
Boucher Road 
Belfast BT12 6TA 
 
 
ECG equipment safety information – Actiwave Cardio 
Actiwave Cardio Regulatory Information 
Medical Devices Directive (EU) 
CamNtech operates a certified Quality Management System in compliance 
with relevant Directives and Standards. The following list provides details of 
QMS and regulatory compliance with links to certificates and/or regulatory 
listings. 
ISO13485 UKAS: 
CamNtech has been audited by the Notified Body SGS UK Ltd and certified 










ECG assessment equipment safety information – Actiwave Cardio 
The Actiwave is a Class 2a Medical Device conforming to the essential safety 
and health requirements and provisions of EC Council Directives93/42/EEC, 
Annex V. 
CamNtech Ltd has been assessed and certified as meeting the requirements 
of the above directive by SGS United Kingdom Ltd, Notified body number 
0120 (Certificate numberGB06/67703). 
 
 
Assessment Equipment safety information– Actiwave Cardio 
FDA 510(k) Clearance (USA) 
 
CamNtech has submitted the required documentation to the United States 
Food and Drug Administration (FDA) under the 510(k) program. Each 
device has been found to be substantially equivalent to predicate devices 
in terms of Indications for use, design and safety. Each device has been 
cleared by the FDA to be marketed as a medical device in the USA with 
the following 510(k) numbers: 
Device Class (US FDA) 510(k) number 
Actiwave cardio 2 K052489 
   
 
Manufacturer 
CamNtech Ltd, Upper Pendrill Court, Papworth Everard, Cambridgeshire, 
CB233UY, UK 
Tel: 01480 831223    Fax: 01480 831733 
email:t echnical@camntech.co.uk   Web: www.camntech.com 
 
  




Procedure for skin preparation and attachment of sensors  
Procedure for skin preparation and attachment of sensors for ECG 
assessment – Actiwave cardio  
 
The skin should simply be cleaned with warm water and soap. 
Alcohol is not recommended as this can potentially cause skin irritation. 
Shaving is also not recommended unless this is done several days 
before application. Participants with hair on the chest area who are 
keen to participate will be advised to use the alternative Nexus 
equipment. 
 
Skin should be lightly exfoliated using Cardio prep to remove any existing 
dead skin, sweat and sebum (e.g. Uno medical, stock code 2121m) 
Electrode pads should then be applied to the sternum area of the chest (e.g. 
Cleartrace electrodes) 
 
The first pad should be placed onto the centre of the chest and the Cardio 
unit attached onto it. 
Then the second pad is attached to the other clip on the Cardio unit and 
connecting cable is used to position the second electrode, so the two 
pads are aligned horizontally – 
two different positions are suitable depending on the participant’s 















Appendix III: Anonymised samples of Measures   





















































































Progress report via survey monkey  
 
How are your stress levels today?  
❑ no stress 
❑  slight stress 
❑  moderate stress 
❑  very stressed  
❑  totally stressed  
 
If you are stressed do you know what is making you 
stressed? 
❑ School problem 
❑ Work problem  
❑ Home problem  
❑ Relationship problem 
❑ Other reason I am stressed _________ 
❑ Don’t know why I am stressed  
 
Did you use your biofeedback device today?  
❑ Didn’t use it 
I didn’t use it because ______________  
❑ Used it and it helped  
❑ Used it and didn’t help  
 
How long did you use your device for? 
❑ Less than 5minutes  
❑ 5-10 minutes 

































































International Affective Picture System (IAPS)– list of images used  
 
International affective picture system  Image numbers   





















HRV assessment using Three-Part Visual task – Timings for 
analysis  
Visual task   Timing   
Section  Type of task Start slide  Finish slide  
1.  IAPS-1  3  14 
2.  MIND IN EYES task  17 31 
3.  IAPS-2  34 45 


































































Participant debriefing – sample of Inner Balance report   
 
 


































Appendix IV:  Procedure  


























Participant information sheet 
 
 






















































Eczema / psoriasis?  
  








Cardiac condition / pacemaker?  
  
Drug / alcohol addiction?  
  













                        REC reference 15/NI/ 0255  IRAS project ID 139122   
 
Participant Assent form – 13-17 years     
I say it is OK for me to take part in the study on  
 
Biofeedback to help manage stress in people with  
Autistic Spectrum Disorder 
 
I have read the information leaflet about the study. 
I understand what will happen.  
I had a chance to ask questions about it. 
I am happy for Helen to ask my carer more information about me 
and let my doctor know I am taking part. 
 
I agree to be in the study.    
  




I say that it is OK for Helen to record my heart rate with my carer 
present whilst I look at a series of pictures. 
 
YES      NO   
 
 
If I start the study and then later on want to stop being in the study, 
I can do this whenever I want to.  
 
I can tell Helen at any time if I do not want to be in the study.  
 
Helen will write and record what I say and what I do but no one will 
know it was me. 
 
I can phone Helen if I want to know more about the study. 





My signature    Date    
 
 
_________________________            ___________________ 
Helen’s signature   Date   




Client confidential information form  
 






Telephone (mobile)   
  
Telephone (home / work)   
  
Address   
  
Emergency contact name   
  
Emergency contact telephone  
  
GP information   
Name   
  




Key worker information   
Team  Adult ASD / Child ASD/ CAMHS / Other 
  
Telephone  Address 
  
  




Demographic information form  
Information about yourself Information about your lifestyle 
 Gender Male  Activity level < 1hour per week   
      
 Female   1-3hrs per week   
 Other   >3hrs per week  
      
Age 13-17  Smoking  Yes / no  
 18-24  Drugs Yes / no    
   Sleep difficulty Yes / no   
      
Education  Grammar school   Alcohol intake   
 Secondary school     
 University / 
College 
  < 14units per week  
 NEET     
    >14units per week  
Employm School      
 College 
/university 
    
 Employed     
 Unemployed     
ASD diagnosis 
 
     
MH diagnosis Anxiety   Medication   
 Depression     
 Other     








Technology information form  
Technology and internet access  
  
Does participant have Internet access  
 
Yes / no  
  
Have participants and carers accessed web links   
 
Yes / no 
  
How will participant complete reports  
 
Email / smartphone (check no 
cost) / written reports  
  
Does participant have iPad available for Inner Balance 
  
iPad / no iPad 
  
Participant level of expertise using technology  Expert / advanced / 
intermediate / beginner / 
unskilled 
  
Type of technology accessed Gaming /video and TV / 
texting / social media / email / 
phone call / other 
  
Frequency of use  
 
 














Interview and assessment protocol 
 
RESEARCHER SCRIPT FOR INITIAL HOME INTERVIEW v2 
 
WELCOME 
 “Good morning / afternoon. First of all I would like to thank you for agreeing to 
participate in this interview and I look forward to hearing your contributions. My 
name is Dr Helen Coulter and I am a Consultant Clinical Psychologist working in 
SEtrust. I am carrying out research at Ulster University and would like to look at new 
ways of helping people with autism manage stress and anxiety by using biofeedback 
technology.”  
The researcher will read out the following reminder about confidentiality: 
 “If you do decide to take part in the study, I will let your <GP / keyworker > know 
you are involved and will also let them know when you have finished.  The information 
you give in interviews, questionnaires and clinic recordings will remain confidential 
and will not be sent to your GP. If, however you tell me about something that puts 
either yourself or others in danger then I will have to let others know about this – 
however I will always tell you / your carer if I have to do this” 
 
CARER INPUT  
“An important part of this research study is that I would like with your permission to 
ask both you and your carer information about yourself and your stress levels – I 
would also like to ask your carer to be present whilst you have your heart rate 
recorded – please let me know now if you have any concerns or questions about this” 
    
DEMOGRAPHIC INFORMATION FORM 
Researcher now completes demographic information form and confirms eligibility 
 
REVIEW OF EQUIPMENT 
Researcher now shows and demonstrates use of equipment to be used in both home training 
and assessment to both participant and carer.  
 “I am now going to show you the equipment that will be used both in the clinic 











OFFER OF FURTHER TIME  
 “If you wish we can now go ahead with the assessment – however if you would like 
more time to think about everything or to talk to someone else you can say so now.  




The researcher will ensure that the participant and carer have read and reviewed the 
participant information sheet and assent / consent form  
 “I want to check that you have read the Participant information sheet and assent / 
consent forms and ask if you have any further questions”  
“Are you now happy to sign the written assent / consent form?” 
 
Researcher now checks written consent / assent forms signed 
 
 
DEMOGRAPHIC INFORMATION and QUESTIONNAIRES 
Researcher now completes and questionnaires with participants and carer.  
 
“I am now going to ask you / your carer some questions which will enable me to 
complete a short contact details form. After this I will give you a 3-digit PIN code 
which will then be the only identification we use on all the questionnaires and 
recordings. Your name will only be on your consent form and the initial contact form, 
but I will store these separately in a locked filing cabinet at Ulster University”.  
  






PARTICIPANT PHYSIOLOGICAL ASSESSMENT  
“I am now going to ask you to complete the physiological assessment of your heart 
rate. The sensors will stay on whilst you look at some images on the computer. Once 
attached the sensors should feel comfortable but please do tell me if you do experience 
any discomfort. The whole assessment will take about 15 minutes.” 
 
Researcher attaches sensors to participant and begins recording (carer present) 
Researcher asks participant to watch PowerPoint presentation on laptop and records time 
on pc for start of 15-minute visual task  
 
 
REMOVAL OF SENSORS  




I would now like you to complete some questionnaires. This will take about 15 minutes. 
 
 
CARER REPORT ON PARTICIPANT STRESS PROFILE 
 “I now want to ask your carer how they feel you react to stress and how often you 
become stressed – everyone reacts in their own unique way – so I want to find out 
what your specific reactions are”  
1.  “Can you tell me how (Participant) reacts when they are stressed?” 
2.  “What are the triggers for (Participants) stress reactions (meltdowns)?” 
3. “How often does (Participant) show stress reactions (meltdowns)?” 
4.  “What do you think helps (Participant) to manage their stress levels?” 





   “We can now open the sealed envelope to see which type of device you will be getting 
and whether you will be starting immediately or waiting 6 weeks before you get the 
device”.  
 











FURTHER DATES FOR TRAINING  
 
“I would now like to agree dates for the home training sessions so that I can come back to 
teach you how to use the biofeedback device. We can also arrange the dates for the other 
two visits at the mid-point and at the end of the study.”  
 




SUMMARY AND CONCLUSION 
 
 “Finally, I would like to give you details of the support services available should you wish 
to access them – these include 24-hour support helplines should you need to talk to 
someone when other services are unavailable”. “Do you have any further questions?” 
 
Researcher offers Support helpline information sheet to both participant and carer. 




The duration of the Home interview will be approximately 120 minutes. 
This schedule will be repeated for the mid-point interview  
(except for consent and appt planning). 
 
 




Support Helpline form  
 
  




Appendix V: Direct Reports  
PHASE 1 NHS and Voluntary sector expert reports  
Evaluation of design; participant information; measures; equipment; procedure and risks by NHS and voluntary sector experts (n=6). 
 Dates of meetings with ASD professional experts: 27th June; 9th July; 2nd Sept; 10th November 2014; 15th June 2015 
Area of study  Problems highlighted Changes made as a result 
Study design  “waiting 12 weeks seems too long - people may drop out or just go and 
buy the device” 
Reduce time to 6 weeks for waiting list group.  
Intervention to remain 12 weeks  
 “Many people with autism have poor insight into their levels of stress 
and their triggers for stress”  
“need to involve carers in pre- and post-interviews”  
“Carer interview needed even in high ability ASD adults”. 
Include carer interview for all participants.  
If adult participant, then also request consent to include interview 
from trusted adult.  Carers viewpoint essential for both groups.  
 “Significant level of sensory sensitivities seen in many people with autism 
which may affect use of this technology” 
Inclusion of an additional sensory profile questionnaire to monitor 
progress of those participants with sensory difficulties. 
Participant 
information 
“Need to have photos and video clips to explain both assessment process 
and the intervention.”  
“Words confusing for people with autism”  
Include photos of researcher using equipment in written PIS. Include 
video format. Include training videos from existing device materials  
 “People with autism take a literal approach to information and will be 
distracted by any inconsistencies in pictures in PIS leaflet” 
Consistency of visual images used in PIS and consent important – 
use identical photos of researcher using equipment  
Measures “Autism Stress Survey Schedule; Achenbach and STAI too long confusing 
– ‘use simpler scales’ ‘include sensory check’  
“measure depression as well as anxiety – both linked”  
“Carers will want to talk about problems and any changes in an 
interview rather than a questionnaire - may get more information”  
 
Use Beck questionnaires.  
Include Sensory Profile questionnaire  
Use standard interview with carers  
 “Use technology to aid reporting of symptoms - this is less stressful and 
increases compliance”  
Use online progress reporting via text / email rather than using 
written reporting materials. 




PHASE 1 NHS and Voluntary sector expert reports 
Evaluation of design; participant information; measures; equipment; procedure and risks with NHS and voluntary sector experts (n=6), showing 
problems highlighted and changes made to final study.  
Area of study  Problems highlighted Changes to pilot study made as a result 
Equipment  “No studies like this on ASD – need to collect information on 
potential problems with devices” “Good rationale – visual, 
portable, and uses technology” “Devices not specifically licensed 
for use in children – however high need for support in young 
people with ASD”  
“Need to have early success or could cause increased anxiety”  
Use devices already trialled in research in non ASD populations.  
 
Ensure devices have FDA approval / CE mark 
Use with teenagers and young adults – ensure assent as well as 
consent Do not use with younger children or learning disability 
 
 “Be aware of those with significant sensory issues – they will be 
unlikely to cope with the assessment process”  
“Physiological assessment task may trigger high anxiety” 
“Sensor attachment may trigger high anxiety “ 
Carry out sensory profile screening at beginning of study. 
Review of all equipment with participant at home prior to consent 
Simplify physiological assessment task, sensors and 
equipment used 
 
Procedure  “The clinic assessment seems too stressful for people with 
autism”  
“Unlikely to recruit or will induce anxiety in those already 
recruited”  
“significant anxieties experienced by this client group attending 
unfamiliar clinic settings”. 
Remove clinic assessment.  
Consider having physiological assessment completed at home 
using standardised procedure.  
 
 “Training needs to include more visual material and fewer written 
instructions 
 
Use video clips as well as written user guides.  
Simplify guidelines. 
Risks  “Use technology to check progress” 
 “People with ASD may form strong attachment to researcher and 
want continual follow up or alternately may become aggressive 
during visits”   
 
Ensure carer / trusted adult present during home visits 
Have lone worker protocol  
Have clear debriefing plan / offer limited follow up service or 
information on other services. 
 
Dates of meetings with ASD professional experts: 27th June; 9th July; 2nd Sept; 10th November 2014; 15th June 2015 




PHASE 1 ASD adult reports 
Evaluation of design; participant information; measures; equipment; procedure and risks by ASD adult groups (n=15) showing problems 
highlighted and changes made to final study.  
Area of study  Problems highlighted Changes to pilot study made as a result 
Study design  Will not want to wait 12 weeks to get device  Reduce waiting time for control group 
  
Participant information  
 
(Visual strength in ASD)  
“Include more pictures” “Pictures should be specific and accurate”   
“Need pictures of researcher rather than someone you will not 
actually meet” “Visual information good – no need for long 
discussion”  
 
Include pictures of researcher using equipment 
instead of generic photos.  
Measures  
 
(short and simple) 
“use simpler scales” 
“prefer to text or email” (rather than telephone or interview)  
“don’t want to be recorded” 
“tick boxes or write a few words”   
 
Use Beck depression and anxiety questionnaires  
Use text messaging service to check progress 
Equipment  
(Sensory sensitivity)  
 
(Training)  
“Velcro and wires (on Nexus assessment equipment) too stressful for 
some with sensory issues” “Too many wires”  
 
“Training video good for device” “Can show me how stressed I am 
…can show others”  
Allow potential participants to see and try out 
equipment at home prior to consent. 
Consider alternative assessment equipment.  




“Clinic assessment (physiological assessment with sensors) may 
cause high anxiety” 
“Would be better at home”  
Remove assessment in clinic. Physiological 
assessment to be completed at home using 
standardised procedure  
 
Risks  “Need to be able to work it or else will get more stressed” 
 
Clear training to ensure success - offer follow up 
if needed 
Dates of workshops with ASD user groups: 2nd April 2014; 20th March 2015 





 PHASE 1Undergraduate student reports 
 Evaluation of psychophysiological assessment procedure using Nexus-10 Mark II biofeedback system with undergraduate students (n=9).   




Number of tasks confusing.  
IAPS task “too long” 
IAPS questionnaire “confusing” and could not 
be completed 
 
Simplify assessment by reducing number of visual image tasks.  
 
questionnaire removed from study 
Sensor 
attachment  
Wires and straps may upset some people – may 
be a problem for people with sensory issues. 
Final decision on type of equipment to be made after 2nd ASD user 
group review 
Consider using wireless equipment 
 
Sensors  Explain more about what each sensor will 
record. 





“Too many wires” in Nexus assessment 
equipment  
 
Consider using wireless equipment  
 “Can’t complete questionnaires if sensors on 
fingers or arms”  
Complete questionnaires separately from physiological assessment  
OR use wireless equipment 
 
 “Arms can feel a bit wet”  Use different electrodes to attach to sensors Sensitive skin wipes can 
also be provided for cleaning any residue from sensors at end of 
procedure for participants if needed 
 
Data recording   Unusual heart rate recordings.  Review with Cardiac physiologist and consultant Cardiologist.  
Check equipment and data collection procedure 
Consider different equipment  
*Dates of clinic assessments with undergraduates: 12th ,19th and 25th February; 5th March 2015 




 PHASE 2 Problems reported by participants at debriefing  
PROBLEMS REPORTED BY PARTICIPANTS         
- first device made me more stressed / getting errors because my hands so cold  
       
- I found no issue with the device  -  -  
         
- nothing  -  -  -  -  -  
         
- nothing everything was fine  -  -  -  
         
- earclip kept slipping -  -  -  
         
- didn’t like the way it wouldn’t access my finger/ kept having errors especially if very stressed/ didn’t work if extreme stress too difficult to use  
 
- problems switching on and off sound / date and time reset on device / if very stressed dont remember to use 
it  
    
- not very modern/ hard to turn the light on at night/ difficult to control heart rate when very anxious / date and time resetting / not practicing all the 
time  
- none -  -  -  -  -  
         
- hard to get smooth waves / didn’t practice it / couldn’t get a lot of points /didn’t use it when stressed 
     
- doesn’t work if fingers are cold / sticky pads painful when removing / its harder to get smooth waves if stressed but I was able to 
do it   
  
- NOT REPORTED  -  -  -  -  
         
- need to set precise times for practice / hard to get sensor to stay on ear / hard to get pulse  
      
- awkward on the finger and on the ear / don’t want to practice  
        
- NOT REPORTED  -  -  -  -  
         
- struggled to obtain points and it caused me a bit of stress to get points / found it difficult to get 
points  
     
- hard to remember to practice / would be better if on phone / couldn’t use first one errors as cold fingers /sunlight caused errors  
  
- hard to remember to use it everyday   -  -  
         
- time consuming /just didn’t feel it really helped / didn’t use it much  
        
- a lot to learn / assessment too long / not using device now  
         
          




 PHASE 2 Benefits reported by participants at debriefing  
BENEFITS REPORTED BY PARTICIPANTS       
- used after difficult / stressful day and helped / helped when people were annoying me/ helps me 
calm down and relax  
     
- the information presented was calming / it allowed for me to collect my thoughts   -  -  
      
- easy to use / very easy to focus when using it / video tutorial useful  -  -  -  
      
- it helped me sleep every time I used it / there are lots of videos online / it helped with my problems / use it every day / will 
continue to use  
  
- easy to use /comfortable/look like earphones so comfortable using it in public -  -  
      
- efficent and quick / most useful at night / good for mild-moderate stress / liked it / helped easy 
to use 
      
- visuals good / if stressed used it and helped / helps get to sleep at night / used same breathing but without device when in bed as don’t want to get 
up / will continue  
- it was easy and quick to use / helps to wind down at night/use to get to sleep   -  -  
      
- showed my heart rate / it gave me a rating / video tutorial useful / has helped me control 
anxiety  
-  
      
- easy to use/ easy to carry and store  -  -  -  -  -  -  -  
      
- helped me control my breathing / video tutorial / I can see what I am doing / it has given me breathing techniques that I can use / helped 
me calm down  
 
- NOT REPORTED  -  -  -  -  -  -  -  -  
      
- made it clear and easy to control my breathing /made me more relaxed / infromation clear 
also  
-  
      
- I felt better  -  -  -  -  -  -  -  -  -  
      
- NOT REPORTED  -  -  -  -  -  -  -  -  
      
- excellent and simple to use / showed me more about breathing and stress -  -  -  
      
- it helped me be happier /use at night / would use again  -  -  -  -  -  
      
- its easy to use / it helped with breathing slowly/  -  -  -  -  -  
      
- easy to understand / its easy to use/seem to be accurate  -  -  -  -  
      
- breathing better now / have used breathing without the device / might use another device if on 
android  
      
                




 PHASE 2 Problems reported by carers at debriefing   
CARER    PROBLEMS REPORTED 
  
 
       
- no negative 
reports  
           
- had no 
difficulties 
-  
   
 
       
- finding time to fit into routine   
  
 
       
- none  -  -  
   
 
       
- none  -  -  
   
 
       
-  didn’t help when very upset possibly required too much 
concentration 
      
-  not always immediately available when stressed / prompts to use it would be good 
    
- none  -  -  
   
 
       
-  too many introduction pages in manual - this increased 
anxiety  
      
-  started at stressful time - would have benefitted more if started at less stressful time / didn’t use it enough to get any benefit   
- cold fingers and could not get a reading / bulky  
 
 
       
- NO REPORTS  -  
   
 
       
- finding time 
to do it  
   
 
       
- P wouldn’t use it - no point in continuing / didn’t practice  -  
       
- if sweating couldnt use it / kept stopping  
 
-  
       




       
-  P didn’t use it enough / was useful but stopped using it / behaviour better but not sure if due to device / couldn’t use first device  
- hard to remember to use it every day  
  
 
       
- not compatible with android devices  
  
 
       
-  nothing its very simple / hard to know how much practiced / not using 
now   
     




 PHASE 2 Benefits reported by carers at debriefing   
CARER BENEFITS REPORTED  
           
- easy to understand and use / good because visual / sound can be 
controlled / P was given control 
           
- enabled P to focus and be still / encouraged techniques to help 
self regulate  
-  
            
- good on the phone / could take it everywhere /helped P calm down 
before going to college  
            
- really helped with confidence   -  -  -  -  -  
            
- real benefits in helping develop awareness of physical symtoms/increased ability to identify patterns as they developed /increased ability 
to anticipate and take greater control managing anxiety  
  
- a particularly satisfying fidget toy / helped for mild stress  -  -  -  
            
- understood how to use it/ felt valued / special because just for P/ portable / easy to access / 
easy to understand / less stimming 
        
- can use any time or place without anyone being aware of it / easy to use on a regular basis / 
can see results and get record of effects  
        
- very visual / instant feedback / easy to understand / P could monitor own progress /   could recognise symptoms of early stress / especially good at 
decreasing stress for exams / better at socialising and teacher has noticed also / more smiles and eye contact  
- good idea / easy to use  -  -  -  -  -  -  
            
- portable / fun / easy to use /recent holiday increased anxiety travelling and it helped / especially good at helping to wind down at night and to get 
through difficult situations / gives P control / visual feedback good / helped with panic attacks  
- really helped P get hold of anxiety before it escalated into full meltdown / have no doubt P was able 
to complete exams because of this   
       
- seemed good  -  -  -  -  -  -  -  
            
- helped P relax   -  -  -  -  -  -  -  
            
- being able to see effect of your breathing / helpful learn how to control breathing when anxious /easy to use / increased awareness of stress and 
effect on body / have learnt useful technique for future   
 
- easy to use / couldn’t fault it / -  -  -  -  -  -  
            
- easy to use / very useful during exams / practiced before going in for exams /helped to decrease 
anxiety and increase focus / will use again  
       
- good to diffuse situation if P upset / easy to use  -  -  -  -  
            
- giving more control to person directly / visual / something to 
concentrate on / simple to use   
            
 
